
<html lang="en"     class="pb-page"  data-request-id="30284383-03bf-41a0-be32-709e46923f53"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.1c00628;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Self-Masked Aldehyde Inhibitors: A Novel Strategy for Inhibiting Cysteine Proteases" /></meta><meta name="dc.Creator" content="Linfeng  Li" /></meta><meta name="dc.Creator" content="Bala C.  Chenna" /></meta><meta name="dc.Creator" content="Kai S.  Yang" /></meta><meta name="dc.Creator" content="Taylor R.  Cole" /></meta><meta name="dc.Creator" content="Zachary T.  Goodall" /></meta><meta name="dc.Creator" content="Miriam  Giardini" /></meta><meta name="dc.Creator" content="Zahra  Moghadamchargari" /></meta><meta name="dc.Creator" content="Elizabeth A.  Hernandez" /></meta><meta name="dc.Creator" content="Jana  Gomez" /></meta><meta name="dc.Creator" content="Claudia M.  Calvet" /></meta><meta name="dc.Creator" content="Jean A.  Bernatchez" /></meta><meta name="dc.Creator" content="Drake M.  Mellott" /></meta><meta name="dc.Creator" content="Jiyun  Zhu" /></meta><meta name="dc.Creator" content="Andrew  Rademacher" /></meta><meta name="dc.Creator" content="Diane  Thomas" /></meta><meta name="dc.Creator" content="Lauren R.  Blankenship" /></meta><meta name="dc.Creator" content="Aleksandra  Drelich" /></meta><meta name="dc.Creator" content="Arthur  Laganowsky" /></meta><meta name="dc.Creator" content="Chien-Te K.  Tseng" /></meta><meta name="dc.Creator" content="Wenshe R.  Liu" /></meta><meta name="dc.Creator" content="A. Joshua  Wand" /></meta><meta name="dc.Creator" content="Jorge  Cruz-Reyes" /></meta><meta name="dc.Creator" content="Jair L.  Siqueira-Neto" /></meta><meta name="dc.Creator" content="Thomas D.  Meek" /></meta><meta name="dc.Description" content="Cysteine proteases comprise an important class of drug targets, especially for infectious diseases such as Chagas disease (cruzain) and COVID-19 (3CL protease, cathepsin L). Peptide aldehydes have ..." /></meta><meta name="Description" content="Cysteine proteases comprise an important class of drug targets, especially for infectious diseases such as Chagas disease (cruzain) and COVID-19 (3CL protease, cathepsin L). Peptide aldehydes have ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 21, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.1c00628" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00628" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.1c00628" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00628" /></link>
        
    
    

<title>Self-Masked Aldehyde Inhibitors: A Novel Strategy for Inhibiting Cysteine Proteases | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.1c00628" /></meta><meta property="og:title" content="Self-Masked Aldehyde Inhibitors: A Novel Strategy for Inhibiting Cysteine Proteases" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0014.jpeg" /></meta><meta property="og:description" content="Cysteine proteases comprise an important class of drug targets, especially for infectious diseases such as Chagas disease (cruzain) and COVID-19 (3CL protease, cathepsin L). Peptide aldehydes have proven to be potent inhibitors for all of these proteases. However, the intrinsic, high electrophilicity of the aldehyde group is associated with safety concerns and metabolic instability, limiting the use of aldehyde inhibitors as drugs. We have developed a novel class of self-masked aldehyde inhibitors (SMAIs) for cruzain, the major cysteine protease of the causative agent of Chagas disease—Trypanosoma cruzi. These SMAIs exerted potent, reversible inhibition of cruzain (Ki* = 18–350 nM) while apparently protecting the free aldehyde in cell-based assays. We synthesized prodrugs of the SMAIs that could potentially improve their pharmacokinetic properties. We also elucidated the kinetic and chemical mechanism of SMAIs and applied this strategy to the design of anti-SARS-CoV-2 inhibitors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.1c00628"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00628">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.1c00628&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.1c00628&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.1c00628&amp;href=/doi/10.1021/acs.jmedchem.1c00628" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, XXXX</span><span class="cit-fg-issue">, XXX</span><span class="cit-fg-pageRange">, XXX-XXX</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/0/0" title="Return to Articles ASAP" id="returnToASAP" class="content-navigation__btn--return"><span>RETURN TO ARTICLES ASAP</span></a><a href="/doi/10.1021/acs.jmedchem.1c00565" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.1c00940" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Self-Masked Aldehyde Inhibitors: A Novel Strategy for Inhibiting Cysteine Proteases</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Linfeng Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Linfeng Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Biophysics, Texas A&M University, 300 Olsen Blvd, College Station, Texas 77843, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Linfeng++Li">Linfeng Li</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0001-6185-4999" title="Orcid link">https://orcid.org/0000-0001-6185-4999</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bala C. Chenna</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bala C. Chenna</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Biophysics, Texas A&M University, 300 Olsen Blvd, College Station, Texas 77843, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bala+C.++Chenna">Bala C. Chenna</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-2660-5302" title="Orcid link">https://orcid.org/0000-0002-2660-5302</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kai S. Yang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kai S. Yang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Texas A&M University, 580 Ross Street, College Station, Texas 77843, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kai+S.++Yang">Kai S. Yang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-1890-4169" title="Orcid link">https://orcid.org/0000-0002-1890-4169</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Taylor R. Cole</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Taylor R. Cole</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Biophysics, Texas A&M University, 300 Olsen Blvd, College Station, Texas 77843, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Taylor+R.++Cole">Taylor R. Cole</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zachary T. Goodall</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zachary T. Goodall</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Biophysics, Texas A&M University, 300 Olsen Blvd, College Station, Texas 77843, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zachary+T.++Goodall">Zachary T. Goodall</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Miriam Giardini</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Miriam Giardini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 9500 Gilman Dr, La Jolla, California 92093, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Miriam++Giardini">Miriam Giardini</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zahra Moghadamchargari</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zahra Moghadamchargari</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Texas A&M University, 580 Ross Street, College Station, Texas 77843, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zahra++Moghadamchargari">Zahra Moghadamchargari</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Elizabeth A. Hernandez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Elizabeth A. Hernandez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Biophysics, Texas A&M University, 300 Olsen Blvd, College Station, Texas 77843, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Elizabeth+A.++Hernandez">Elizabeth A. Hernandez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jana Gomez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jana Gomez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Biophysics, Texas A&M University, 300 Olsen Blvd, College Station, Texas 77843, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jana++Gomez">Jana Gomez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Claudia M. Calvet</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Claudia M. Calvet</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 9500 Gilman Dr, La Jolla, California 92093, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Claudia+M.++Calvet">Claudia M. Calvet</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jean A. Bernatchez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jean A. Bernatchez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 9500 Gilman Dr, La Jolla, California 92093, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jean+A.++Bernatchez">Jean A. Bernatchez</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-8309-1627" title="Orcid link">https://orcid.org/0000-0002-8309-1627</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Drake M. Mellott</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Drake M. Mellott</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Biophysics, Texas A&M University, 300 Olsen Blvd, College Station, Texas 77843, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Drake+M.++Mellott">Drake M. Mellott</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-8043-8170" title="Orcid link">https://orcid.org/0000-0002-8043-8170</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jiyun Zhu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jiyun Zhu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Biophysics, Texas A&M University, 300 Olsen Blvd, College Station, Texas 77843, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jiyun++Zhu">Jiyun Zhu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Andrew Rademacher</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andrew Rademacher</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Biophysics, Texas A&M University, 300 Olsen Blvd, College Station, Texas 77843, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andrew++Rademacher">Andrew Rademacher</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Diane Thomas</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Diane Thomas</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 9500 Gilman Dr, La Jolla, California 92093, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Diane++Thomas">Diane Thomas</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lauren R. Blankenship</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lauren R. Blankenship</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Texas A&M University, 580 Ross Street, College Station, Texas 77843, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lauren+R.++Blankenship">Lauren R. Blankenship</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Aleksandra Drelich</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Aleksandra Drelich</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Microbiology and Immunology, University of Texas Medical Branch, 301 University Blvd, Galveston, Texas 77555, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Aleksandra++Drelich">Aleksandra Drelich</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Arthur Laganowsky</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Arthur Laganowsky</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Texas A&M University, 580 Ross Street, College Station, Texas 77843, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Arthur++Laganowsky">Arthur Laganowsky</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0001-5012-5547" title="Orcid link">https://orcid.org/0000-0001-5012-5547</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chien-Te K. Tseng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chien-Te K. Tseng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Microbiology and Immunology, University of Texas Medical Branch, 301 University Blvd, Galveston, Texas 77555, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chien-Te+K.++Tseng">Chien-Te K. Tseng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wenshe R. Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wenshe R. Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Biophysics, Texas A&M University, 300 Olsen Blvd, College Station, Texas 77843, United States</div><div class="loa-info-affiliations-info">Department of Chemistry, Texas A&M University, 580 Ross Street, College Station, Texas 77843, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wenshe+R.++Liu">Wenshe R. Liu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">A. Joshua Wand</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">A. Joshua Wand</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Biophysics, Texas A&M University, 300 Olsen Blvd, College Station, Texas 77843, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=A.+Joshua++Wand">A. Joshua Wand</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0001-8341-0782" title="Orcid link">https://orcid.org/0000-0001-8341-0782</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jorge Cruz-Reyes</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jorge Cruz-Reyes</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Biophysics, Texas A&M University, 300 Olsen Blvd, College Station, Texas 77843, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jorge++Cruz-Reyes">Jorge Cruz-Reyes</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jair L. Siqueira-Neto</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jair L. Siqueira-Neto</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 9500 Gilman Dr, La Jolla, California 92093, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jair+L.++Siqueira-Neto">Jair L. Siqueira-Neto</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0001-9574-8174" title="Orcid link">https://orcid.org/0000-0001-9574-8174</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Thomas D. Meek</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Thomas D. Meek</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Biophysics, Texas A&M University, 300 Olsen Blvd, College Station, Texas 77843, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#2e5a4a434b4b456e5a4f435b004b4a5b"><span class="__cf_email__" data-cfemail="285c4c454d4d43685c49455d064d4c5d">[email protected]</span></a>. Tel.: +1-979-458-9789.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+D.++Meek">Thomas D. Meek</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-1931-8073" title="Orcid link">https://orcid.org/0000-0002-1931-8073</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00628&amp;href=/doi/10.1021%2Facs.jmedchem.1c00628" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, XXXX</span><span class="cit-issue">, XXX</span><span class="cit-pageRange">, XXX-XXX</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 21, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>6 April 2021</li><li><span class="item_label"><b>Published</b> online</span>21 July 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.1c00628" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00628</a></div><div class="article_header-article-copyright"><strong>© 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1%26pageCount%3D21%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DLinfeng%2BLi%252C%2BBala%2BC.%2BChenna%252C%2BKai%2BS.%2BYang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D0%26issueNum%3D0%26contentID%3Dacs.jmedchem.1c00628%26title%3DSelf-Masked%2BAldehyde%2BInhibitors%253A%2BA%2BNovel%2BStrategy%2Bfor%2BInhibiting%2BCysteine%2BProteases%26numPages%3D21%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D21%26publicationDate%3DJuly%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.1c00628"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">705</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.1c00628" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Self-Masked Aldehyde Inhibitors: A Novel Strategy for Inhibiting Cysteine Proteases&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Linfeng&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Bala&quot;,&quot;last_name&quot;:&quot;C. Chenna&quot;},{&quot;first_name&quot;:&quot;Kai&quot;,&quot;last_name&quot;:&quot;S. Yang&quot;},{&quot;first_name&quot;:&quot;Taylor&quot;,&quot;last_name&quot;:&quot;R. Cole&quot;},{&quot;first_name&quot;:&quot;Zachary&quot;,&quot;last_name&quot;:&quot;T. Goodall&quot;},{&quot;first_name&quot;:&quot;Miriam&quot;,&quot;last_name&quot;:&quot;Giardini&quot;},{&quot;first_name&quot;:&quot;Zahra&quot;,&quot;last_name&quot;:&quot;Moghadamchargari&quot;},{&quot;first_name&quot;:&quot;Elizabeth&quot;,&quot;last_name&quot;:&quot;A. Hernandez&quot;},{&quot;first_name&quot;:&quot;Jana&quot;,&quot;last_name&quot;:&quot;Gomez&quot;},{&quot;first_name&quot;:&quot;Claudia&quot;,&quot;last_name&quot;:&quot;M. Calvet&quot;},{&quot;first_name&quot;:&quot;Jean&quot;,&quot;last_name&quot;:&quot;A. Bernatchez&quot;},{&quot;first_name&quot;:&quot;Drake&quot;,&quot;last_name&quot;:&quot;M. Mellott&quot;},{&quot;first_name&quot;:&quot;Jiyun&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;Rademacher&quot;},{&quot;first_name&quot;:&quot;Diane&quot;,&quot;last_name&quot;:&quot;Thomas&quot;},{&quot;first_name&quot;:&quot;Lauren&quot;,&quot;last_name&quot;:&quot;R. Blankenship&quot;},{&quot;first_name&quot;:&quot;Aleksandra&quot;,&quot;last_name&quot;:&quot;Drelich&quot;},{&quot;first_name&quot;:&quot;Arthur&quot;,&quot;last_name&quot;:&quot;Laganowsky&quot;},{&quot;first_name&quot;:&quot;Chien-Te&quot;,&quot;last_name&quot;:&quot;K. Tseng&quot;},{&quot;first_name&quot;:&quot;Wenshe&quot;,&quot;last_name&quot;:&quot;R. Liu&quot;},{&quot;first_name&quot;:&quot;A.&quot;,&quot;last_name&quot;:&quot;Joshua Wand&quot;},{&quot;first_name&quot;:&quot;Jorge&quot;,&quot;last_name&quot;:&quot;Cruz-Reyes&quot;},{&quot;first_name&quot;:&quot;Jair&quot;,&quot;last_name&quot;:&quot;L. Siqueira-Neto&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;D. Meek&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;21&quot;,&quot;issue&quot;:&quot;0&quot;,&quot;volume&quot;:&quot;0&quot;,&quot;pages&quot;:&quot;&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.1c00628&quot;},&quot;abstract&quot;:&quot;Cysteine proteases comprise an important class of drug targets, especially for infectious diseases such as Chagas disease (cruzain) and COVID-19 (3CL protease, cathepsin L). Peptide aldehydes have proven to be potent inhibitors for all of these proteases. However, the intrinsic, high electrophilicity of the aldehyde group is associated with safety concerns and metabolic instability, limiting the use of aldehyde inhibitors as drugs. We have developed a novel class of self-masked aldehyde inhibitors (SMAIs) for cruzain, the major cysteine protease of the causative agent of Chagas disease—Trypanosoma cruzi. These SMAIs exerted potent, reversible inhibition of cruzain (Ki* = 18–350 nM) while apparently protecting the free aldehyde in cell-based assays. We synthesized prodrugs of the SMAIs that could potentially improve their pharmacokinetic properties. We also elucidated the kinetic and chemical mechanism of SMAIs and applied this strategy to the design of anti-SARS-CoV-2 inhibitors.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00628&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00628" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00628&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00628" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00628&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00628" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00628&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00628&amp;href=/doi/10.1021/acs.jmedchem.1c00628" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.1c00628" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.1c00628" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.1c00628%26sid%3Dliteratum%253Aachs%26pmid%3D34288674%26genre%3Darticle%26aulast%3DLi%26date%3D2021%26atitle%3DSelf-Masked%2BAldehyde%2BInhibitors%253A%2BA%2BNovel%2BStrategy%2Bfor%2BInhibiting%2BCysteine%2BProteases%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D0%26issue%3D0%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (4)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292236" title="Aldehydes">Aldehydes</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/0/0" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/medium/jm1c00628_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00628&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Cysteine proteases comprise an important class of drug targets, especially for infectious diseases such as Chagas disease (cruzain) and COVID-19 (3CL protease, cathepsin L). Peptide aldehydes have proven to be potent inhibitors for all of these proteases. However, the intrinsic, high electrophilicity of the aldehyde group is associated with safety concerns and metabolic instability, limiting the use of aldehyde inhibitors as drugs. We have developed a novel class of self-masked aldehyde inhibitors (SMAIs) for cruzain, the major cysteine protease of the causative agent of Chagas disease—<i>Trypanosoma cruzi</i>. These SMAIs exerted potent, reversible inhibition of cruzain (<i>K<sub>i</sub></i>* = 18–350 nM) while apparently protecting the free aldehyde in cell-based assays. We synthesized prodrugs of the SMAIs that could potentially improve their pharmacokinetic properties. We also elucidated the kinetic and chemical mechanism of SMAIs and applied this strategy to the design of anti-SARS-CoV-2 inhibitors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14070" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14070" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cysteine proteases are prospective drug targets for a variety of diseases caused by viruses (e.g., picornaviruses and coronaviruses),<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> bacteria (e.g., <i>Salmonella</i> and <i>Listeria</i>),<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and particularly, many species of parasitic protozoa.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> One of these, <i>Trypanosoma cruzi</i>, is the causative agent of Chagas disease, which affects an estimated 6–7 million people worldwide.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> During the life cycle of <i>T. cruzi</i>, its major cysteine protease, known as cruzain, plays a multifaceted role involving nutrient processing, morphological transformation, invasion into host cells, and evasion of the immune response.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Consequently, cruzain has been widely studied and also serves as a paradigm for inhibitor design for other cysteine proteases.</div><div class="NLM_p">Substrate–analogue peptidomimetic compounds containing a suitable electrophilic warhead comprise the most common classes of inhibitors and inactivators of cruzain, as well as other cysteine proteases.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> A notable example is <b>K777</b> (or <b>K11777</b>), a dipeptide analogue containing a vinyl sulfone warhead, which undergoes irreversible thia-Michael addition to the active-site Cys<sub>25</sub> of cruzain,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and other cysteine proteases including cathepsins K, L, and B (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> However, irreversible binding of small molecules to protein targets is associated with idiosyncratic immunotoxicity,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> especially for drugs which require lengthy regimens. Accordingly, an emerging trend is the development of reversible covalent inhibitors which provide potent inhibition of the desired target, but will not permanently inactivate off-target proteins.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Among the reversible covalent warheads explored for cruzain to date, an aldehyde group often, if not always, affords outstanding inhibitory potency compared to α-keto amides, nitriles, oximes, heterocycles, and so on.<a onclick="showRef(event, 'ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14">(11−14)</a> On the other hand, the inherent electrophilicity of aldehydes contributes to their rapid metabolism, immunotoxicities, and untoward drug–drug interactions,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> which have all but disqualified their use in drug design. Theoretically, these issues can be mitigated by confining the exposure of the aldehyde solely to the germane protein target while eschewing off-target proteins; however, such approaches have been challenging to implement.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/medium/jm1c00628_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Inactivator and inhibitors of cysteine proteases. (A) Structure of <b>K777</b> and its mechanism of covalent inactivation of cysteine proteases. (B) 1,2,4-trioxolane inhibitor <b>PG4b</b> undergoes Fe(II)-catalyzed fragmentation to elaborate aldehyde <b>PG3b,</b> a potent inhibitor of falcipain, and a radical byproduct. (C) γ-lactol inhibitor <b>MN3</b> is a masked aldehyde of <b>SJA0617</b>. It exhibits higher transcorneal permeability and releases the free aldehyde to inhibit μ-calpain.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00628&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">An alternative approach to incorporate aldehydes into drug design is to mask the aldehyde using another functional group. The antimalarial aldehyde inhibitor of falcipain <b>PG3b</b> was “masked” by a 1,2,4-trioxolane structure (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B), resulting in the prodrug <b>PG4b</b> from which the active aldehyde is liberated upon reaction with Fe(II) inside the vacuoles of the plasmodial parasite.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Unfortunately, this clever masked aldehyde resulted in toxicity to the host cells, apparently from the action of free radical byproduct(s). Its utility is also limited by the variable availability of Fe(II) in target cells. The calpain inhibitor <b>MN3</b> is another type of masked aldehyde in which a homoserine at the P<sub>1</sub> position<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> spontaneously forms a cyclic hemiacetal (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C). Compared to the potent free aldehyde <b>SJA6017</b> (with Leu at P<sub>1,</sub> IC<sub>50</sub> = 22 nM), protection of the aldehyde in <b>MN3</b> greatly improved transcorneal permeability despite lower potency against calpain (IC<sub>50</sub> = 880 nM).<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18,19)</a> Herein, we describe an unprecedented class of self-masked aldehyde inhibitors (SMAIs) for cruzain, their kinetic and chemical mechanisms of reversible covalent inhibition, and their effects on trypanosomal infection in cell cultures. In addition, we developed prodrugs of these SMAIs to improve their metabolic stability to optimize their pharmacokinetic properties. We adapted this concept to develop a novel inhibitor for the main cysteine protease (3CL protease) of SARS-CoV-2.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84588" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84588" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Design of SMAIs</h3><div class="NLM_p">The dipeptide aldehyde <b>1</b> (Cbz-Phe-Phe-H, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A) was first prepared for use as an intermediate in the synthesis of other protease inhibitors and proved to be an extraordinarily potent inhibitor of cruzain, as discussed below. To modify its P<sub>1</sub> structure to afford a self-masked aldehyde, we added a hydroxyl group to the 2′ position of the phenyl ring, converting the P<sub>1</sub> group to an <i>ortho</i>-tyrosine (<b>2</b>, Cbz-Phe-<i>o-</i>Tyr-H).The oxygen of the phenol group is in close proximity to the aldehydic carbon permitting a nucleophilic addition reaction to occur, producing a cyclic hemiacetal (δ-lactol) similar to the γ-lactol found in calpain inhibitor <b>MN3</b>.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> We anticipated that a SMAI would remain “locked” in its δ-lactol form before binding to cruzain, after which enzyme catalysis would elaborate the free aldehyde followed by formation of a hemithioacetal adduct with cruzain (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). If true, then the potential advantages of SMAIs include: (a) the intramolecular nature of the δ-lactol likely provides sustained protection of the aldehyde outside of an enzyme active site; (b) compared to the 1,2,3-trioxolane masked aldehyde,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> the cleavage of the hemiacetal does not produce reactive byproducts; and (c) the introduced hydroxyl group on the <i>o</i>-tyrosine sidechain is small enough so as to impose minimal perturbation of the original binding mode of the parent aldehyde <b>1</b>.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/medium/jm1c00628_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Rationale for the design of SMAIs. (A) In compound <b>2</b>, the aldehyde group is expected to be masked by the 2′-phenol group via spontaneous formation of a lactol. It is anticipated that the SMAI will undergo enzyme-catalyzed opening of the lactol ring and subsequently form the hemithioacetal adduct with Cys<sub>25</sub>. The scheme describes a two-step inhibition mechanism in which rapid formation of an <b>EI</b> complex precedes isomerization to <b>EI*</b>, which slowly converts back to <b>EI</b>. (B) Lactol form of <b>2</b> (green) noncovalently docked to cruzain. (C) Opened form of <b>2</b> covalently docked to form a hemithioacetal with Cys<sub>25</sub>. Both structures are superimposed with a covalently bound <b>K777</b> (white) from the crystal structure (PDB ID: 2OZ2).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Colored dashed lines represent corresponding cruzain–inhibitor interactions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00628&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The first question arising from our hypothesis is: could the lactol form of <b>2</b> bind to cruzain and remain closed? To preliminarily address this question, we employed molecular modeling using docking methods conforming to the binding of compound <b>2</b> in both its noncovalent, lactol form (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B) and its free aldehyde form which was docked as a hemithioacetal adduct with the catalytic Cys<sub>25</sub> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C). The covalent adduct of <b>2</b> is predicted to bind in a manner similar to that of the covalent inactivator <b>K777</b> as seen in the cruzain-<b>K777</b> cocrystal structure.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> As expected, the phenoxy substituent of the covalently bound inhibitor <b>2</b> is well tolerated in the cruzain active site and may form hydrogen bonds with Gln<sub>19</sub>, His<sub>162</sub>, or Trp<sub>184</sub>, similar to the sulfone oxygens of <b>K777</b>. Although the Cbz-Phe group in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B adopts a similar orientation to the open form (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C), the lactol displays a puckered conformation in the active site. The bound lactol has a poorer binding free energy (Δ<i>G</i><sub>predicted</sub> = −5.08 kcal/mol) than that of the hemithioacetal (Δ<i>G</i><sub>predicted</sub> = −7.24 kcal/mol), apparently owing to the bicyclic lactol moiety. One may infer that the recognition of the Cbz-Phe scaffold of <b>2</b> by cruzain assists in the binding of the lactol group and orients it for enzyme-catalyzed ring-opening to yield the high-affinity aldehyde.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Kinetic Analysis</h3><div class="NLM_p">A series of SMAIs and related compounds <b>1</b>–<b>12</b> were prepared and evaluated as inhibitors of cruzain (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Time-course data for inhibition of cruzain by many of these compounds conformed to the kinetic scheme shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A, that is, initiation of reaction by adding enzyme to substrate and inhibitor led to curvilinear time courses (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A,C) in which reaction rates demonstrably decreased as the <b>EI</b> complex (characterized by <i>K<sub>i</sub></i>) progressed to the tighter <b>EI*</b> complex (characterized by <i>K<sub>i</sub></i>*). The observation of time dependence may or may not indicate that covalent bond formation has occurred, but it does reflect that <i>K<sub>i</sub></i>* < <i>K<sub>i</sub></i>, arising from either the formation of a hemithioacetal between the enzyme and inhibitor or a slow isomerization step of <b>EI</b> to <b>EI*</b> not involving covalent bond formation.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/medium/jm1c00628_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Kinetic analysis of inhibition of cruzain by <b>1</b>, <b>2,</b> and <b>12</b>. (A–C) Time courses of cruzain inhibition by <b>1, 2</b>, and <b>12</b>. Insets for (A) and (C): the <i>k</i><sub>obs</sub> values were obtained by fitting progress curves to <a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a>. Replot of <i>k</i><sub>obs</sub> vs [<i>I</i>] with the line drawn through data points from fitting to <a class="ref internalNav" href="#eq3" aria-label="eq 3">eq 3</a>. <b>1</b>: <i>k</i><sub>4</sub> = (7.6 ± 0.6) × 10<sup>–4</sup> s<sup>–1</sup>; <b>12</b>: <i>k</i><sub>4</sub> = (1.8 ± 0.7) × 10<sup>–4</sup> s<sup>–1</sup>. Inset for (B): the steady-state rates with (<i>v</i><sub>s</sub>) and without inhibitor (<i>v</i><sub>0</sub>) were obtained at <i>t</i> ≥ 20 min. Plot of <i>v</i><sub>s</sub>/<i>v</i><sub>0</sub> vs [<b>2</b>] with the line drawn through data points from fitting to <a class="ref internalNav" href="#eq4" aria-label="eq 4">eq 4</a>. (D) Proposed mechanism of phenoxy-assisted conversion of <b>EI*</b> back to <b>EI</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00628&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibition Data of SMAIs and Related Compounds with Cruzain<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/medium/jm1c00628_0013.gif" alt="" id="gr12" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">To the assay buffer (50 mM MES, 50 mM TAPSO, 1 mM CHAPS, 1 mM Na<sub>2</sub>EDTA, 5 mM DTT, 10% DMSO (v/v), and pH 7.5) containing variable concentrations of inhibitors (0.02–20 μM) and 10 μM of substrate Cbz-Phe-Arg-AMC (<i>K</i><sub>m</sub> = 0.9 μM) was added cruzain (final concentration of 0.2 nM), and changes in fluorescence were monitored for 20–60 min. Values of <i>K<sub>i</sub></i>* (<i>n</i> ≥ 2) were obtained as described.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last"><b>3</b> contains two diastereomeric <i>anti</i> products, and only one is shown here.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Reported as an apparent IC<sub>50</sub> in ref <a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a>.</p></div></div><div></div></div><div class="NLM_p">We first evaluated cruzain inhibition by time-course data containing fixed concentrations of substrates and variable concentrations of inhibitors for which reactions were initiated by the addition of enzyme. Inhibition of cruzain by the free aldehyde <b>1</b> was characterized by downward-concave curvilinear time courses, often referred to as “burst kinetics” (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A), indicative of time-dependent inhibition for which equilibrium between cruzain and <b>1</b> was slowly established over 30 min. Each curve was fitted to <a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a>, and the resulting values of <i>k</i><sub>obs</sub> were replotted versus inhibitor concentration [<b>1</b>] (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A, inset). The replot was best fitted to <a class="ref internalNav" href="#eq3" aria-label="eq 3">eq 3</a>, implying a lack of saturation of the <b>EI</b> complex by <b>1</b> for which <i>K<sub>i</sub></i> > > <i>K<sub>i</sub></i>*. The unimolecular rate constant for conversion of <b>EI*</b> back to <b>EI</b> was extremely slow [<i>k</i><sub>4</sub> = (7.6 ± 0.6) × 10<sup>–4</sup> s<sup>–1</sup>]. The low value of <i>k</i><sub>4</sub> is likely the reason for the slow onset of inhibition and potency of aldehyde <b>1</b>.</div><div class="NLM_p">Unlike aldehyde <b>1,</b> inhibition of cruzain by <b>2</b> exhibited almost linear time courses with only slight curvature observed at early stages (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B), as was also observed for SMAIs <b>6</b>–<b>10</b> (all containing the Cbz-Phe scaffold, <a href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_001.pdf" class="ext-link">Figure S1A</a>). The nominal burst phase was only observed within the first 1–2 min, after which an apparent steady-state reaction was established, indicating a significantly faster rate (greater <i>k</i><sub>4</sub>) for conversion of <b>EI*</b> back to <b>EI</b> than for compound <b>1</b>. This difference suggests that, compared to a relatively stable hemithioacetal intermediate cruzain-<b>1</b> species, the reverse reaction of this intermediate for a SMAI is likely facilitated by the attack of its phenoxy group on the hemithioacetal (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D). To characterize these inhibitors, we obtained steady-state rates of <i>v</i><sub>s</sub> and <i>v</i><sub>0</sub> at assay times ≥20 min. For instance, upon plotting <i>v</i><sub>s</sub>/<i>v</i><sub>0</sub> versus [<b>2</b>] (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B, inset) and fitting using <a class="ref internalNav" href="#eq4" aria-label="eq 4">eq 4</a>, we obtained a value of the overall inhibition constant (<i>K<sub>i</sub></i>*) of 49 ± 2 nM. For free aldehyde <b>11</b> and SMAI <b>12</b>, both of which incorporated the <i>N</i>-methylpiperazinyl-Phe (NMePip-Phe) scaffold as found in <b>K777</b>, the ratio of their activities as cruzain inhibitors [<i>K<sub>i</sub></i>*(<b>12</b>)/<i>K<sub>i</sub></i>*(<b>11</b>) = 94] was almost identical to that of their Cbz-Phe-containing counterparts <b>1</b> and <b>2</b> [<i>K<sub>i</sub></i>*(<b>2</b>)/<i>K<sub>i</sub></i>*(<b>1</b>) = 110]. Similar to aldehyde <b>1</b>, slow onset of inhibition was observed for <b>11</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_001.pdf" class="ext-link">Figure S1B</a>). Surprisingly, unlike SMAIs containing the Cbz-Phe scaffold, <b>12</b> also exhibited time-dependent inhibition (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C).</div><div class="NLM_p">To explore the reversibility of cruzain inhibition by these compounds, we first preincubated each inhibitor with cruzain followed by a 100-fold rapid dilution accompanying the addition of substrate (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). For inhibitors <b>2</b> and <b>6</b>–<b>10</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B,C), 91% recovery of cruzain activity was observed over the course of minutes, wherein the residual concentration of inhibitor was 0.1× <i>K<sub>i</sub></i>*<sup>app</sup>, capable of affording 9% inhibition, thereby demonstrating that binding of these inhibitors was fully reversible. In comparison, the activity of cruzain preincubated with aldehydes <b>1</b>, <b>11</b>, or SMAI <b>12</b> was restored at much slower rates (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D–F). After fitting these “lag” time courses to <a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a>, the calculated residence times (τ = 1/<i>k</i><sub>obs</sub>) for compounds <b>2</b> and <b>6</b>–<b>10</b> ranged from 2.5 to 5.5 min, whereas <b>1</b>, <b>11</b>, and <b>12</b> exhibited significantly longer residence times of 52, 45, and 26 min, respectively (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_001.pdf" class="ext-link">Table S1</a>). While longer residence times were expected for aldehydes <b>1</b> and <b>11</b>, compound <b>12</b> was the only SMAI to effect significant time-dependent inhibition as evidenced by the observation of both burst and lag kinetic time courses, and the rate of conversion of the <b>EI*</b> complex to <b>EI</b> was comparable to that of aldehyde <b>11</b>. Considering that compound <b>12</b> was equipotent to <b>2</b>, one could infer that the peptidomimetic scaffold of <b>12</b> might also affect the adduct formation so that <i>k</i><sub>3</sub>/<i>k</i><sub>4</sub> remained nearly unchanged for both the SMAI and the free aldehyde. Therefore, a covalent docking study was conducted for <b>12</b>, which predicted a binding free energy (Δ<i>G</i><sub>predicted</sub> = −7.15 kcal/mol) that was close to that of compound <b>2</b> (Δ<i>G</i><sub>predicted</sub> = −7.24 kcal/mol) as formerly mentioned, which was in accordance with their similar <i>K<sub>i</sub></i>* values. Interestingly, an intramolecular hydrogen bond between the P<sub>1</sub> phenol group and P<sub>3</sub> carbonyl group has dragged the two moieties away from their binding subsites (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_001.pdf" class="ext-link">Figure S2</a>). The consequence of this conformation is that the phenol group in <b>12</b> is less likely to take part in the conversion of <b>EI*</b> back to <b>EI</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D), leading to slower dissociation from cruzain and its unique lag kinetics compared to <b>2</b>.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/medium/jm1c00628_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Rapid dilution assay for SMAIs. (A) Dilution scheme for testing the reversibility of a SMAI. Upon 100-fold dilution, the inhibitor concentration decreases from 10-fold > <i>K<sub>i</sub></i>*<sup>app</sup> (91% inhibition) to 10-fold < <i>K<sub>i</sub></i>*<sup>app</sup> (9% inhibition). (B, C) Cruzain activity rapidly recovered from inhibition by <b>2</b> and <b>6</b>–<b>10</b>. (D–F) Cruzain activity recovery showed a significant lag for <b>1</b>, <b>11</b>, and <b>12</b>. All curves were fitted to <a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a> to provide <i>k</i><sub>obs</sub> values as listed in <a href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_001.pdf" class="ext-link">Table S1</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00628&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Structure–Activity Relationships of SMAIs</h3><div class="NLM_p">Inhibition constants for all compounds prepared for this study are shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. The equipotency of SMAIs <b>2</b> and <b>12</b> at ∼50 nM suggests that their different P<sub>3</sub> sidechains have no impact on their inhibition. We prepared compound <b>3</b>, an analogue of SMAI <b>12</b> in which its ether oxygen was replaced with a methylene group, and the resulting compound containing the stable tetrahydro-naphthol did not inhibit cruzain at ≤100 μM, despite its similarity to the chroman-2-ol group of the SMAIs. Substitution of the aldehyde of compound <b>2</b> with a primary alcohol also resulted in the poor inhibitor <b>4</b>, which corroborates the importance of the formation of carbon–sulfur bonds in the cruzain-SMAI complexes. In the free aldehyde <b>5</b>, the phenoxy group was methylated, affording an inhibitor that is 50-fold less active than aldehyde <b>1</b>, implying that a bulkier 2′ substituent sterically hinders the formation of the hemithioacetal.</div><div class="NLM_p last">Another potential feature of SMAIs is the ability to tune the reactivity of the phenol group by installing substituents on the benzene ring. We introduced several substituents at the 5′ position of the <i>ortho</i>-tyrosine, including electron-donating groups (i.e., -OMe and −Me), weak electron-withdrawing groups (i.e., -F and -Cl), and moderate-to-strong electron withdrawing group (i.e., -CO<sub>2</sub>Me). The electron-donating substituents on <b>6</b> (<i>K<sub>i</sub></i>* = 350 nM) and <b>7</b> (<i>K<sub>i</sub></i>* = 100 nM) appear to undermine their potencies, as these inhibitors bind, respectively, 7- and 20-fold more weakly than un-substituted SMAI <b>2</b>. The stronger electron-withdrawing capability of the ester substituent (<b>10</b>; <i>K<sub>i</sub></i>* = 18 nM) provided a 3-fold increase in potency versus <b>2</b>, suggesting that the 5′-methyl ester facilitates the opening of the lactol ring. In addition to the electronic effect, a steric effect is likely operative. The methoxy group of compound <b>6</b> is bulkier than the methyl group of <b>7</b>, which may contribute to its over 3-fold lower activity. Chlorine (0.79 Å, <b>8</b>) has a slightly larger radius than fluorine (0.42 Å, <b>9</b>), and fluorine is similar in size to a hydrogen (0.53 Å, <b>2</b>) (note: the C–F is longer than the C–H bond so that, at that increased length, the fluorine is effectively the same radius as hydrogen),<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> consistent with the differences between their <i>K<sub>i</sub></i>* values. It is interesting that a steric effect apparently dictates the differences in potency between compounds <b>8</b> and <b>9</b>, probably because fluorine and chlorine are only weakly electron-withdrawing. The methyl ester of <b>10</b>, while comprising the bulkiest substituent among this series of compounds, provided the SMAI of the highest potency in this study, apparently because the electron-withdrawing effect afforded by this large substituent overcomes any steric effect. These results suggested that appropriate substitution of the P<sub>1</sub> phenyl ring in SMAIs could optimize their potencies, and further, may affect the stability of enzyme-bound lactol.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Chemical Mechanism of SMAI Binding to Cruzain</h3><div class="NLM_p">Next, we prepared compound <b>12</b> in which the aldehydic carbon was <sup>13</sup>C-labeled, to be used in a study of <sup>1</sup>H-<sup>13</sup>C heteronuclear single quantum correlation (HSQC) nuclear magnetic resonance (NMR) to elucidate the chemical specie(s) of <b>12</b> that are bound to cruzain. First, 0.4 mM of <sup>13</sup>C-labeled <b>12</b> in phosphate buffer (pH 7.5) was analyzed by HSQC NMR. No discernable peak was present at δ(<sup>13</sup>C) >180 ppm, ruling out the existence of minute concentrations of free aldehyde in this aqueous solution (see the <a href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_001.pdf" class="ext-link">Supporting Information</a> for a full-view spectrum).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The two salient peaks, A and B, occurring near δ(<sup>13</sup>C) 90.8 ppm, were consistent with the signal of a carbon occurring in a hemiacetal (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A, red). These signals could not be assigned to an aldehyde hydrate in view of the fact that analysis by liquid chromatography–mass spectrometry (LC–MS) displayed a molecular ion peak corresponding to the hemiacetal but not the hydrate (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_001.pdf" class="ext-link">Figure S3</a>). We propose that peaks A and B are associated with two δ-lactol anomers spontaneously generated during lactol formation. The ratio of anomer A to anomer B is 1:1.32 based on peak volumes (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_001.pdf" class="ext-link">Table S2</a>), yet the exact stereochemistry cannot be assigned at this point.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/medium/jm1c00628_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Studies on the chemical mechanism of SMAI binding to cruzain. (A) Expansion of the superposed <sup>1</sup>H-<sup>13</sup>C HSQC NMR spectra of <sup>13</sup>C-labeled compound <b>12</b> with (blue) and without (red) an approximately equimolar concentration of cruzain, which were obtained at 800 MHz (<sup>1</sup>H) at 25 °C. (B) Time course of phenylhydrazone formation by treating 0.2 mM <b>11</b> (aldehyde) or <b>12</b> (lactol) with 1 mM phenylhydrazine, with a control sample containing DMSO. Data for the curve with compound <b>11</b> were fitted to Abs<sub>282 nm</sub> = <i>a</i>[1–exp.(−<i>k</i><sub>obs</sub><i>t</i>)] + <i>C</i> from which a = 0.279 ± 0.002, <i>k</i><sub>obs</sub> = (2.61 ± 0.05) × 10<sup>–4</sup> s<sup>–1</sup>, and <i>C</i> = 2.63, while fitting the other data to this expression led to negligible values of <i>k</i><sub>obs</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00628&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To the inhibitor sample was added an approximately stoichiometric amount of cruzain, and a new spectrum was acquired after 1 h (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A, blue). The apparent hemiacetal peak B was eliminated while a trace of peak A remained, which indicates a slight preference of cruzain for anomer B over A, in consideration of the ratio of integrated volumes (A:B = 1:1.32). The fact that the cross peaks shifted considerably upon addition of cruzain is strongly indicative of hemithioacetal formation. This is because the new signals observed at δ(<sup>13</sup>C) 76.2 and 79.7 ppm are very similar to those observed for the formation of a hemithioacetal adduct between <i>N</i>-acetyl-<i>L</i>-phenylalanine-[2-<sup>13</sup>C]glycinal and papain (δ(<sup>13</sup>C) 75.1 ppm).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The broadening of peaks A’ and B′ also suggested a protein-bound ligand, because of reduced tumbling and the increased relaxation time of the cruzain-bound <sup>13</sup>C-labeled <b>12</b>. In addition, mass spectrometric experiments of cruzain preincubated with <b>12</b> as well as three SMAIs with the Cbz-Phe- scaffold (<b>2</b>, <b>7</b>, and <b>9</b>) clearly revealed the formation of corresponding enzyme–inhibitor adducts as indicated by the mass changes relative to apo-cruzain (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_001.pdf" class="ext-link">Figure S4</a>), serving as  orthogonal evidence of covalent bond formation.</div><div class="NLM_p last">As phenylhydrazine readily forms phenylhydrazone adducts with aldehydes, we treated 0.2 mM of aldehyde <b>11</b> and SMAI <b>12</b> with 1 mM phenylhydrazine in the same buffer (lacking DTT) used in the NMR study (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B) to determine the fraction of free aldehyde found in <b>12</b>. While aldehyde <b>11</b> was rapidly, and apparently, completely converted to phenylhydrazone, <b>12</b> remained intact after 2 h. This finding showed that even an excess amount of phenylhydrazine cannot drive the equilibrium of <b>12</b> toward the formation of open-form aldehyde, which not only corroborated the chemical stability of lactol, but also indicated that the ring-opening is likely an enzyme-catalyzed process. Therefore, we conclude that SMAI <b>2</b> predominantly maintains its lactol form in aqueous solution in the absence of cruzain, while its binding to cruzain apparently promotes opening of its ring followed by the formation of a covalent bond with Cys<sub>25</sub>.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> SMAIs Display Antitrypanosomal Activity</h3><div class="NLM_p">Subspecies of pathogenic <i>Trypanosoma brucei</i> have essential cysteine proteases (TbCatL, brucipain, or rhodesain) which are close homologs of cruzain and perform similar biological functions.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> We evaluated our compounds in axenic cultures of the bloodstream forms (BSFs) of <i>Trypanosoma brucei brucei</i> (<i>T. b. brucei</i>), which are found in infected mammals (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, <a href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_001.pdf" class="ext-link">Figure S5</a>). The most active inhibitors for BSFs, <b>7</b> and <b>12</b>, exhibited respective EC<sub>50</sub> values of 0.5 and 0.6 μM, which are more potent than the antitrypanosomal drug, diminazene (Berenil, EC<sub>50</sub> = 0.99 μM in <i>T. b. brucei</i> BSFs).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Notably, the free aldehyde <b>1</b>, despite its 100-fold higher potency versus cruzain, was equally or less potent in inhibiting <i>T. b. brucei</i> BSFs compared to the SMAIs. Considering that aldehyde <b>1</b> is nearly four orders of magnitude less effective versus <i>T. b. brucei</i> than versus purified cruzain (EC<sub>50</sub>/<i>K<sub>i</sub></i>* = 7500), while the average value of EC<sub>50</sub>/<i>K<sub>i</sub></i>* for all SMAIs is 74, one may speculate that the SMAIs are more accessible to its cellular target(s) than free aldehyde <b>1</b> in cell culture media. In this sense, masking of the active aldehyde within the SMAIs affords significant protection of its electrophilic group.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Antitrypanosomal Activities of SMAIs and their Prodrugs</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound number</th><th class="colsep0 rowsep0" align="center">cruzain inhibition <i>K<sub>i</sub></i>* (nM)</th><th class="colsep0 rowsep0" align="center"><i>T. b. brucei</i> BSFs EC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>T. cruzi</i>-infected cardiomyoblasts EC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">0.44 ± 0.02</td><td class="colsep0 rowsep0" align="left">3.3 ± 2.1</td><td class="colsep0 rowsep0" align="left">0.5 ± 0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">49 ± 2</td><td class="colsep0 rowsep0" align="left">6.8 ± 1.1</td><td class="colsep0 rowsep0" align="left">2.9 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">350 ± 30</td><td class="colsep0 rowsep0" align="left">2.6 ± 1.1</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">103 ± 5</td><td class="colsep0 rowsep0" align="left">0.5 ± 0.2</td><td class="colsep0 rowsep0" align="left">5.7 ± 0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">74 ± 10</td><td class="colsep0 rowsep0" align="left">5.8 ± 3.4</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">48 ± 2</td><td class="colsep0 rowsep0" align="left">2.7 ± 0.2</td><td class="colsep0 rowsep0" align="left">3.5 ± 0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">18 ± 0.5</td><td class="colsep0 rowsep0" align="left">4.0 ± 0.2</td><td class="colsep0 rowsep0" align="left">3.5 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">47 ± 2</td><td class="colsep0 rowsep0" align="left">0.6 ± 0.1</td><td class="colsep0 rowsep0" align="left">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">13<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">∼1000</td><td class="colsep0 rowsep0" align="left">3.7 ± 0.2</td><td class="colsep0 rowsep0" align="left">13 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">14<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">>5000</td><td class="colsep0 rowsep0" align="left">3.1 ± 0.2</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">15<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">>5000</td><td class="colsep0 rowsep0" align="left">4.0 ± 0.2</td><td class="colsep0 rowsep0" align="left">10 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">16<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">>5000</td><td class="colsep0 rowsep0" align="left">12 ± 0.1</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">17<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">>5000</td><td class="colsep0 rowsep0" align="left">14 ± 0.9</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">K777</td><td class="colsep0 rowsep0" align="left">0.2<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.09 ± 0.06</td><td class="colsep0 rowsep0" align="left">0.04 ± 0.01</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Trypanocidal activities of compounds in axenic cultures of <i>T. b. brucei</i> BSFs and in cardiomyoblasts with <i>T. cruzi infection</i> were all measured as EC<sub>50</sub> values (half maximal effective concentration), along with SEMs from at least two replicates. Typical test concentrations of inhibitors were 0.5–20 μM for <i>T. b. brucei</i> BSF assays and 0.02–40 μM for <i>T. cruzi</i>-infected cardiomyoblast assays.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Structures of 13–17 are shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Reported as an apparent IC<sub>50</sub> in ref <a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a>.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">ND, not determined.</p></div></div></div><div class="NLM_p last">Additionally, aldehyde <b>1</b>, SMAIs <b>2</b>, <b>7</b>, <b>9</b>, <b>10</b>, <b>12</b>, <b>13</b>, and <b>15</b> (the latter two compounds are discussed in the next section) were analyzed in a murine cardiomyoblast model of <i>T. cruzi</i> infection in which the disease-relevant amastigote forms of the parasite were evaluated (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, <a href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_001.pdf" class="ext-link">Figure S6</a>). The parent aldehyde <b>1</b> was the most potent inhibitor in this series (EC<sub>50</sub> = 0.4 μM), yet it still lost most of its activity considering its subnanomolar activity against cruzain. Compounds <b>2</b>, <b>7</b>, <b>9</b>, and <b>10</b> killed <i>T. cruzi</i> at EC<sub>50</sub> values ranging from 2.9–5.7 μM, which were similar in potency to benznidazole, a first-line antichagasic drug with an EC<sub>50</sub> value of 4.0 ± 2.0 μM in this assay (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_001.pdf" class="ext-link">Figure S6</a>). Surprisingly, <b>12</b> exhibited much weaker trypanocidal activity in this assay in contrast to its excellent activity in <i>T. b. brucei</i>, probably because its peptidomimetic scaffold, with higher polarity, had difficulty in penetrating the host cell membrane. Apart from <b>12</b>, these SMAIs were essentially equipotent in axenic cultures of <i>T. b. brucei</i> BSFs and <i>T. cruzi</i>-infected cardiomyoblasts, suggesting that they target a cysteine protease homologue of cruzain in <i>T. b. brucei</i>. Additionally, they exerted no toxicity against the host cardiomyoblasts at up to 40 μM where both aldehyde <b>1</b> and <b>K777</b> exhibited significant cytotoxicity (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_001.pdf" class="ext-link">Figure S6</a>). Accordingly, the self-masking of the aldehyde group in SMAIs provides the apparent delivery of these otherwise reactive compounds to trypanosomes harbored within mammalian cardiomyoblasts, with no apparent untoward effects on the host cells. These results encouraged progressing the SMAIs to preclinical analysis, as well as the development of prodrug forms of SMAIs.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Prodrugs of SMAIs</h3><div class="NLM_p">The pharmacokinetic evaluation of compound <b>12</b> in mice by intravenous administration indicated a short half-life arising from apparent first-pass metabolism (data not shown). Its analogue<b>, K777,</b> has superior pharmacokinetic properties to <b>12</b>, and it was shown that the sites of oxidative metabolism on <b>K777</b> were largely confined to the <i>N-</i>methylpiperazine ring, common to both inhibitors, and the homophenylalanyl sidechain.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Therefore, metabolism of the cyclic hemiacetal of <b>12</b> may be responsible for its rapid clearance in mice.</div><div class="NLM_p">The cyclic α-keto-acetal prodrug for caspase-1, pralnacasan (VX-740), can be regarded as an SMAI, as it is rapidly converted to the active aldehyde inhibitor (VRT-18858) by plasma esterases via formation of a hemiacetal intermediate (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> We designed two types of derivatization of the hemiacetal hydroxyl group, that is, via <i>O-</i>acylation and <i>O-</i>alkylation (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). The <i>O-</i>acylated compounds should be hydrolyzed to compound <b>12</b> by the action of cellular esterases, which are ubiquitous in the ER lumen of mammalian tissues.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> For the O-alkylated compounds, the enzymatic oxidation is likely to occur by the action of liver cytochrome P450 enzymes, thereby elaborating a new hemiacetal that subsequently collapses to form compound <b>12</b>.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/medium/jm1c00628_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Development and assessment of SMAI prodrugs. (A) Pralnacasan is a SMAI prodrug for VRT-18858, an inhibitor for caspase-1. (B) Proposed metabolic routes of O-derivatized SMAIs to <b>12</b>. (C) Time course of remaining <b>13</b>–<b>15</b> in reactions with or without addition of porcine esterase. (D) High-performance liquid chromatography (HPLC) traces of compound <b>15</b> in buffer (control). (E) HPLC traces of <b>15</b> treated with esterase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00628&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To explore this prodrug approach, we prepared <i>O-</i>acylated compounds <b>13</b>–<b>15</b> and <i>O-</i>alkylated compounds <b>16</b> and <b>17</b> (structures shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). These compounds exhibited negligible inhibition against cruzain, with the exception of <b>13</b>, which weakly inhibited cruzain in a time-dependent fashion (<i>K<sub>i</sub></i>* = 1 μM, <a href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_001.pdf" class="ext-link">Figure S1C</a>). Compounds <b>13</b>–<b>15</b> were treated with porcine esterase in buffer (pH 7.5), and the hydrolysis of these prodrugs was monitored by LC–MS (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C). In control samples without esterase, these compounds largely remained intact. Compound <b>13</b> was an exception and degraded about 10% in buffer over 3 h, which likely explains the observed inhibition of cruzain by <b>13</b> because of the formation of <b>12</b>. Upon addition of the esterase, compounds <b>13</b>–<b>15</b> were all converted to compound <b>12</b> at variable rates of reaction with respective half-lives of 48, 24, and 16 min (by fitting curves in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C to <a class="ref internalNav" href="#eq6" aria-label="eq 6">eq 6</a>) and displayed a trend of increased hydrolysis with the increasing steric bulk of the acyl groups. A reasonable interpretation is that the main mammalian esterase, carboxylesterase-1 (CES1), has a preference for larger acyl groups.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Accordingly, modifying the acyl group of <i>O-</i>acylated compounds to obtain a suitable half-life can potentially overcome the apparent first-pass metabolism of <b>12</b>. As observed for compound <b>15</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>D,E), there are two peaks in the chromatograph that presumably correspond to the two anomers, but the conversion of one peak (A, <i>t</i><sub>R</sub> = 4.38 min) to <b>12</b> is faster than the other (B, <i>t</i><sub>R</sub> = 4.52 min). Peak A is largely eliminated after 30 min, while peak B, though it constitutes a smaller proportion of untreated compound, does not decompose completely even after 3 h, suggesting that the anomer in peak A is the more specific substrate for esterase. These results provide a proof of concept that the use of <i>O-</i>acylated prodrugs of SMAIs will provide a means to deliver these inhibitors <i>in vivo</i>.</div><div class="NLM_p">Compound <b>12</b> was also modified to yield two mixed acetals <b>16</b> and <b>17</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B) to yield prodrugs that did not inhibit cruzain. Because cytochrome P450 forms 3A4, 2D6, and 2C9 together account for over 60% of drug-metabolizing P450 isoforms,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> we used these enzymes to conduct <i>in vitro</i> assays to determine if <b>16</b> and <b>17</b> could be transformed to compound <b>12</b> as expected. Both compounds were incubated with different CYPs in the presence of a NADPH-regenerating system for up to 4 h. Unfortunately, no transformation to <b>12</b> was observed for either compound by any of the CYPs. However, the apparent stability versus these purified P450s does not mean that (an)other microsomal oxidase(s) cannot release the active SMAIs from these prodrug forms.</div><div class="NLM_p last">These compounds were tested in cell assays (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Although less active than their parent compound <b>12</b>, compounds <b>13</b>–<b>15</b> showed promising trypanocidal activity against axenic <i>T. b. brucei</i> comparable to other SMAIs (EC<sub>50</sub> = 3–4 μM). Moreover, <b>13</b> and <b>15</b> were also tested in the <i>T. cruzi</i>-infected model. It is notable that they showed moderate anti-<i>T. cruzi</i> effects (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, EC<sub>50</sub> = 13 and 10 μM, respectively), which were more potent than <b>12</b>, indicating that their acyl groups helped them enter host cells probably by increasing the hydrophobicity of these molecules. These results also demonstrated that the <i>O-</i>acylated prodrug forms could well be converted to <b>12</b> inside host cells or parasites by esterases. Interestingly, compounds <b>16</b> and <b>17</b> were able to kill the <i>T. b. brucei</i> in spite of lower activity (<i>K<sub>i</sub></i>* > 5 μM). Because treatment with P450s did not lead to transformation of these prodrugs, the data implied the existence of either a drug-metabolizing enzyme or another potential activating enzyme in <i>T. b. brucei</i>.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Application of SMAIs to SARS-CoV-2 3CL<sup>pro</sup></h3><div class="NLM_p">The SMAI strategy is not limited to cruzain and may also find application in other cysteine proteases. To this end, we attempted to develop SMAIs for SARS-CoV-2 main protease (3CL<sup>pro</sup>), a drug target for COVID-19.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Numerous inhibitors of the homologous cysteine proteases of SARS-CoV, MERS-CoV, and some picornaviruses have shown different levels of inhibition against SARS-CoV-2. Peptidomimetic aldehyde inhibitors of 3CL<sup>pro</sup> contain a nearly invariant 2-oxo-pyrrolidin-2-yl group (γ-lactam) as the P<sub>1</sub> side chain. We propose that 2-pyridone can act as a surrogate for the γ-lactam (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A). Apart from their similarity in size and heteroatom substitution, the tautomerization of 2-pyridone toward 2-hydroxypyridine has been well characterized.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Although the 2-pyridone tautomer is preferred in aqueous solution, the presence of the <i>C</i>-terminal aldehyde could well form a SMAI with the 2-hydroxypyridine.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/medium/jm1c00628_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound <b>18</b> is a potential SMAI for SARS-CoV-2 3CL<sup>pro</sup>. (A) 2-Pyridone is a surrogate for the P<sub>1</sub> γ-lactam. (B) Structure and activity of compound <b>18</b>. (C) Surface representation of the 3CL<sup>pro</sup>-<b>18</b> complex (PDB ID: 7M2P). The 2<i>F</i><sub>o</sub>–<i>F</i><sub>c</sub> electron density map contoured at 1.0 σ indicated C–S bond formation. (D) Interaction between 3CL<sup>pro</sup> and <b>18</b>. Dashed lines depict hydrogen bonds; the oxyanion hole is circled.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00628&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A 2-pyridone compound <b>18</b> was synthesized (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B, <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>), and the proton NMR of <b>18</b> in organic solvents confirmed the apparent absence of aldehyde, suggesting that it forms a δ-lactol, though it is unclear what the exact species is in aqueous buffers. Compound <b>18</b> was such a potent inhibitor of 3CL<sup>pro</sup> that its <i>K<sub>i</sub></i>* (9 nM) was a result of apparent titration of the enzyme (40 nM used in the assay). Anti-CoV-2 activity (EC<sub>50</sub> = 5 μM) in SARS-CoV-2-infected A549/ACE2 cells was also demonstrated (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_001.pdf" class="ext-link">Table S3</a>). Interestingly, <b>18</b> also inhibited human cathepsin L, which was recently shown to be essential to the penetrance of SARS-CoV-2 into mammalian cells in which it catalyzes essential cleavage of the coronaviral Spike protein.<a onclick="showRef(event, 'ref8 ref32'); return false;" href="javascript:void(0);" class="ref ref8 ref32">(8,32)</a> As a result, compound <b>18</b> has the potential to be a dual-acting inhibitor for two enzymes which are critical to the infection of human cells by SARS-CoV-2.</div><div class="NLM_p last">We also obtained a high-resolution (1.70 Å) crystal structure of SARS-CoV-2 3CL<sup>pro</sup> in complex with <b>18</b>. The well-defined electron density (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C) confirmed the formation of a hemithioacetal of <b>18</b> with active-site Cys<sub>145</sub>, and the resulting hydroxyl group of the hemithioacetal is stabilized by an oxyanion hole provided by Gly<sub>143</sub> and Cys<sub>145</sub> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>D). The P<sub>1</sub> 2-pyridone establishes essential binding interactions with 3CL<sup>pro</sup> analogous to that of the γ-lactam<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> in which the carbonyl oxygen of the 2-pyridone accepts two hydrogen bonds from His<sub>163</sub> and Ser<sub>144</sub>, while the amide nitrogen acts as a hydrogen bond donor to Glu<sub>166</sub> and Phe<sub>140</sub>. These interactions clearly demonstrate that the γ-lactam can be bioisosterically replaced by the 2-pyridone moiety, which is a potential SMAI substructure. As with cruzain, 3CL<sup>pro</sup> is apparently capable of catalyzing ring-opening of the putative masked aldehyde of <b>18</b>.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Chemistry</h3><div class="NLM_p">The synthesis of SMAIs and their analogues involved the preparation of various P<sub>1</sub> building blocks and subsequent coupling with P<sub>3</sub>-P<sub>2</sub> scaffolds (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). A variety of 5-substituted salicylaldehydes were coupled with <i>N</i>-Boc-2-phosphonoglycine trimethyl ester in Horner–Wadsworth–Emmons reactions. The formed double bond in <b><i>S1a</i></b> was reduced to afford the Boc-protected methyl ester of substituted <i>ortho</i>-tyrosine (<b><i>S1b</i></b>) as a mixture of enantiomers, which was then deprotected and reacted with the carboxylic acids of corresponding P<sub>3</sub>-P<sub>2</sub> fragments, Cbz-Phe-OH or NMePip-Phe-OH. Cbz-Phe-OH was commercially available, while NMePip-Phe-OH (<b><i>S1j</i></b>) was simply prepared in two steps including amide coupling and hydrogenolytic cleavage of the benzyl group. The resulting <b><i>S1d</i></b> and subsequent intermediates were diastereomers that could be mostly separated on a silica gel column. Because the phenol group is relatively reactive that may interfere with future reactions, a methyl group was originally used for its protection and eventually resulted in compound <b>5</b>. In our effort to remove the methyl group, we experienced unwanted side reactions because of harsh conditions such as the use of BBr<sub>3</sub>. Instead, a TBS group was employed as the protecting group. Next, the methyl ester of <b><i>S1e</i></b> was successively reduced to alcohol using NaBH<sub>4</sub> (<b><i>S1f</i></b> and <b>4</b>) and oxidized to aldehyde using Dess-Martin periodinane (<b><i>S1g</i></b>). Finally, efficient removal of TBS by TBAF exposed the phenol group toward the reaction with aldehyde, leading to <i>in situ</i> formation of the lactol ring (<b><i>S1h</i></b>). It should be noted that each SMAI was a mixture of anomers that could be observed by HPLC or NMR (see the <a href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_001.pdf" class="ext-link">Supporting Information</a>). Because the spontaneous interconversion existed in between the anomers, it was neither necessary nor possible to chromatographically isolate them.</div><figure id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/medium/jm1c00628_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>2</b>–<b>12</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00628&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(i) DBU, DCM, (ii) Pd/C, H<sub>2</sub>, MeOH, (iii) TFA, DCM, (iv) Cbz-Phe-OH or NMePip-Phe-OH (<b>S1j</b>), DIPEA, T3P, DCM, (v) TBSCl, imidazole, DCM, (vi) K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>I, DMF, (vii) NaBH<sub>4</sub>, MeOH, (viii) Dess-Martin periodinane, NaHCO<sub>3</sub>, DCM, 0 °C, (ix) TBAF, THF, 0 °C, (x) Et<sub>3</sub>N, THF, 0 °C, (xi) Pd/C, H<sub>2</sub>, MeOH, (xii) mCPBA, chloroform, (xiii) NaN<sub>3</sub>, MeOH/H<sub>2</sub>O, 60 °C, (xiv) Pd/C, H<sub>2</sub>, MeOH, (xv) NMePip-Phe-OH (<b>S1j</b>), DIPEA, T3P, DCM, (xvi) NMePip-Phe-OH (<b>S1j</b>), DIPEA, T3P, DCM, (xvii) NaBH<sub>4</sub>, MeOH, and (xviii) Dess-Martin periodinane, NaHCO<sub>3</sub>, DCM, 0 °C. *<b>S1l</b> contains two diastereomeric anti products, and only one is drawn here, so do <b>S1m</b> and <b>3.</b></p></p></figure><div class="NLM_p">The P<sub>1</sub> building block of <b>3</b> was synthesized using a different strategy. 1,4-Dihydronaphthalene was subjected to epoxidation (<b><i>S1k</i></b>) followed by nucleophilic attack by NaN<sub>3</sub> to produce <b><i>S1l</i></b>. The azide was then converted to the amino group which was coupled with NMePip-Phe-OH to yield compound <b>3</b>. Notably, <b>3</b> contains two diastereomeric <i>anti</i> products as the P<sub>1</sub> NH and OH are not on the same side of the ring. The preparation of free aldehyde <b>11</b> was similar to other SMAIs, except for that the latter required one more step for TBS removal.</div><div class="NLM_p">The derivatizations of the hydroxy group of <b>12</b> are summarized in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Acylation was achieved by reacting <b>12</b> with corresponding acid anhydrides under basic conditions (<b><i>S2a</i></b>); alkylation was performed by treating <b>12</b> with boron trifluoride etherate in the presence of corresponding alcohols (<b><i>S2b</i></b>).</div><figure id="sch2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/medium/jm1c00628_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>13–17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00628&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(i) acetic/propionic/isobutyric anhydride, Et<sub>3</sub>N, DMAP, DCM and (ii) BF<sub>3</sub>OEt<sub>2</sub>, EtOH/iPrOH.</p></p></figure><div class="NLM_p">Because <sup>13</sup>C-lableled <i>N</i>-Boc-2-phosphonoglycine trimethyl ester was not purchasable, we adopted a Ni(II) complex-based synthetic route for <sup>13</sup>C-labeled <b>12</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> A chiral auxiliary <b><i>S3a</i></b> (2-(<i>N</i>-benzylprolyl)aminobenzophenone, BPB) was synthesized and then treated with [1-<sup>13</sup>C] glycine and nickel(II) nitrate hexahydrate under strongly alkaline conditions to form the Ni(II) complex (<b><i>S3b</i></b>), which could increase the acidity of α-protons in the glycine. Next, a Mitsunobu–Tsunoda reaction using CMBP was performed to introduce the side chain onto glycine with high stereoselectivity (<b><i>S3c</i></b>).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> We employed 8-quinolinol for the decomplexation to release the <sup>13</sup>C-labeled benzylated <i>o</i>-Tyr (<b><i>S3d</i></b>). After protecting the amine with Boc (<b><i>S3e</i></b>), the carboxylic acid was converted to a Weinreb amide (<b><i>S3f</i></b>). The latter was deprotected and coupled to NMePip-Phe-OH (<b><i>S3g</i></b>) followed by reduction to aldehyde with an equimolar amount of lithium aluminum hydride (<b><i>S3h</i></b>) and removal of the benzyl-protecting group, resulting in <sup>13</sup>C-labeled <b>12</b>.</div><figure id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/medium/jm1c00628_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <sup>13</sup>C-labeled <b>12</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00628&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(i) 1-methylimidazole, MsCl, DCM, 45 °C, (ii) [1-<sup>13</sup>C] glycine, Ni(NO<sub>3</sub>)<sub>2</sub>·6H<sub>2</sub>O, KOH, MeOH, 60 °C, (iii) (2-(benzyloxy)phenyl)methanol, cyanomethylenetributylphosphorane (CMBP), toluene, 120 °C, (iv) 8-quinolinol, MeCN/H<sub>2</sub>O, 40 °C, (v) Et<sub>3</sub>N, Boc anhydride, dioxane/H<sub>2</sub>O, (vi) N,O-dimethylhydroxylamine, DIPEA, T3P, DCM, (vii) TFA, DCM; NMePip-Phe-OH, DIPEA, T3P, DCM, (viii) LAH, THF, 0 °C, and (ix) Pd/C, H<sub>2</sub>, MeOH.</p></p></figure><div class="NLM_p">Similar to <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, the 2-pyridone inhibitor <b>18</b> was also synthesized from 2-oxo-1,2-dihydro-3-pyridinecarbaldehyde (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). After hydrogenation of <b><i>S4a</i></b>, the methyl ester of <b>S4b</b> was hydrolyzed (<b><i>S4c</i></b>) and converted to Weinreb amide <b><i>S4d</i></b>. The incorporation of the Cbz-Val-Cha-scaffold resulted in <b><i>S4e</i></b> as diastereomers that could be separated on a silica gel column. It turned out that no protection was needed for the 2-pyridone/2-hydroxypyridine, so that the LAH reduction of the Weinreb amide afforded the final product <b>18</b>. Although there is no apparent aldehydic peak in NMR spectra when using CDCl<sub>3</sub> as the solvent, the two inherent equilibria (lactol/aldehyde and pyridone/hydroxypyridine) have led to greater complexity. The exact species of <b>18</b> are dependent on multiple factors including solvents, temperature, pH, and so on, as exemplified by its HPLC–MS data (see the <a href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_001.pdf" class="ext-link">Supporting Information</a>): there are several crowded peaks in HPLC, yet all of which correspond to the mass of <b>18</b> (<i>m</i>/<i>z</i> 552.29).</div><figure id="sch4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/medium/jm1c00628_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of <b>18</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00628&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(i) DBU, DCM, (ii) Pd/C, H<sub>2</sub>, MeOH, (iii) LiOH, MeOH/H<sub>2</sub>O, (iv) N,O-dimethylhydroxylamine, DIPEA, T3P, DCM, (v) TFA, DCM; Cbz-Val-Cha-OH, DIPEA, T3P, DCM, and (vi) LAH, THF, 0 °C.</p></p></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20788" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20788" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">While the aldehyde group has frequently been employed in chemical probes in drug discovery, rarely has this reactive functionality been advanced in earnest to drug discovery campaigns. However, the masking of aldehydes in drugs and clinical agents has provided a few examples of the successful “masking” of aldehydes for drug discovery. Here, we sequestered the potent free aldehyde inhibitor <b>1</b> into an intramolecular masked aldehyde by the introduction of a 2-hydroxyl group onto the P<sub>1</sub> benzyl group, which resulted in a surprisingly stable δ-lactol derivative that effected potent yet reversible inhibition of cruzain. The apparent stability of δ-lactol in examples of these SMAIs suggests that the observed potent inhibition of cruzain by these SMAIs most likely arises from cruzain-catalyzed ring-opening of the δ-lactol followed by formation of a hemithioacetal. Where evaluated, these self-masked aldehyde inhibitors inhibited axenic and infected cell cultures of trypanosomes with potency equaling or exceeding that of the parent aldehydes. Furthermore, the O-acylation of SMAIs yielded prodrugs that might possess improved metabolic stability and pharmacokinetic properties. Finally, we developed and characterized a novel SMAI of SARS-CoV-2 3CL<sup>pro</sup>, suggesting a broad applicability of the SMAI strategy to other cysteine proteases.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50718" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50718" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Information of Chemistry</h3><div class="NLM_p last">Unless otherwise noted, all starting materials, reagents, and solvents were obtained commercially and used without further purification or distillation. Reactions were conducted under an inert atmosphere (Ar or N<sub>2</sub>), and reaction progress was monitored by thin layer chromatography (TLC) or HPLC–MS. TLC experiments were performed with silica gel plates on aluminum foil (Sigma-Aldrich, cat. no. 60778). HPLC analysis was conducted on an UltiMate 3000 HPLC system coupled to MS analysis by an ISQ EM single quadrupole mass spectrometer. The typical settings for HPLC–MS were as follows. Column used: Phenomenex Luna 5 μm C18(2) 100 Å, 4.6 mm × 50 mm; mobile phase A: water containing 0.1% formic acid (v/v); mobile phase B: MeCN containing 0.1% formic acid (v/v); method: gradient elution at 10–100% B over 6 min, then isocratic elution at 100% B for 2 min; flow rate: 1 mL/min; MS parameters: HESI, vaporizer temperature 350 °C, source CID voltage 20 V, and gas flow: sheath = 40–50 psi, aux = sweep = 2.0 psi. Most compounds were purified by flash column chromatography (FCC) on silica gel (200–300 mesh) with different solvent systems. Some compounds were purified by semipreparative HPLC (Prep-HPLC) on the same UltiMate 3000 HPLC system, which was connected to a fraction collector. The typical settings for Prep-HPLC were as follows: Column used: Phenomenex Luna 5 μm C18(2) 100 Å, 21.2 mm × 250 mm; mobile phases A and B were the same as those for analytical HPLC; method: gradient elution at 10–100% B over 25 min, then isocratic elution at 100% B for 5 min; flow rate: 21.2 mL/min. <sup>1</sup>H and <sup>13</sup>C NMR spectra of compounds, except for <sup>13</sup>C-labeled compound <b>12</b>, were recorded on a Bruker AVANCE III 400 MHz using tetramethylsilane (TMS, 0.00 ppm) or residual solvent (CDCl<sub>3</sub>, 7.26 ppm; CD<sub>3</sub>OD, 3.31 ppm; (CD<sub>3</sub>)<sub>2</sub>SO, 2.50 ppm) as the internal standards. All final compounds used for testing in assays had purities that were determined to be >95% as evaluated by their NMR spectra and/or their LC–MS.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Synthetic Procedures</h3><div class="NLM_p">Detailed procedures and characterization of compounds for all reactions in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a><a class="ref internalNav" href="#sch2" aria-label="2">2</a><a class="ref internalNav" href="#sch3" aria-label="3">3</a><a class="ref internalNav" href="#sch4" aria-label="4">4</a> were as follows. Some of them were general procedures, which were described by representative compounds.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Methyl 2-((tert-butoxycarbonyl)amino)-3-(2-hydroxy-5-methylphenyl)acrylate (<b>S1a</b>, R = Me)</h4><div class="NLM_p last">To a solution of (±)-Boc-α-phosphonoglycine trimethyl ester (4.22 g, 14.2 mmol, 1.2 eq) in DCM (20 mL) was added DBU (2.12 mL, 14.2 mmol, 1.2 eq) dropwise at −10 °C, and the resulting mixture was stirred for 20 min. Then 4-methylsalicylaldehyde (1.61 g, 11.8 mmol, 1.0 eq) in DCM (10 mL) was slowly added to the mixture over 10 min. The reaction mixture was stirred at room temperature overnight. The resulting mixture was concentrated under reduced pressure, diluted with EtOAc (100 mL), and washed successively with saturated aqueous NH<sub>4</sub>Cl (20 mL), saturated aqueous NaHCO<sub>3</sub>, (20 mL), and brine (20 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The obtained crude product was purified by FCC (30–50% EtOAc in hexane, v/v) to give <b><i>S1a</i></b> (R = Me, 2.91 g, 80%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.45 (s, 9H, Boc), 2.25 (s, 3H, PhCH<sub>3</sub>), 3.83 (s, 3H, COOCH<sub>3</sub>), 6.77 (d, <i>J</i> = 8.3 Hz, 1H, olefin), 7.02 (dd, <i>J</i> = 2.2, 8.4 Hz, 1H, Ph), 7.41 (d, <i>J</i> = 2.2 Hz, 1H, Ph), 7.53 (s, 1H, Ph). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ 19.22, 27.18, 51.36, 79.97, 115.23, 120.46, 124.58, 128.22, 129.63, 131.02, 153.42, 154.76, 166.73. LC–MS: <i>t</i><sub>R</sub> = 4.93 min; C<sub>11</sub>H<sub>14</sub>NO<sub>3</sub><sup>+</sup> [M + H - Boc]<sup>+</sup>, <i>m</i>/<i>z</i> calcd 208.10, found 208.08.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Methyl 2-((tert-butoxycarbonyl)amino)-3-(2-hydroxy-5-methylphenyl)propanoate (<b>S1b</b>, R = Me)</h4><div class="NLM_p last"><b><i>S1a</i></b> (R = Me, 1.15 g, 3.74 mmol, 1.0 eq) was placed in a two-necked round bottom and charged with N<sub>2</sub> gas. 10% palladium on carbon powder (Pd/C, 110 mg, cat.) was quickly added to the flask followed by addition of MeOH (20 mL). The flask was degassed and backfilled with H<sub>2</sub> for three cycles. The reaction mixture was stirred at room temperature overnight with a balloon of H<sub>2</sub> for replenishment. The balloon was removed, and the mixture was filtered under reduced pressure. Note that the operation should be rapid, and the Pd/C powder must be kept wet to avoid catching fire and was appropriately disposed in a water-filled, cap-closed container. The filtrate was concentrated under reduced pressure and purified by FCC (30% EtOAc in hexane, then 6% MeOH in DCM) to give <b><i>S1b</i></b> (R = Me, 1.1 g, 95%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.39 (s, 9H, Boc), 2.36 (s, 3H, PhCH<sub>3</sub>), 2.79–3.02 (m, 1H, βCH<sub>2</sub>), 3.07 (m, 1H, βCH<sub>2</sub>), 3.75 (s, 3H, COOCH<sub>3</sub>), 4.43 (d, <i>J</i> = 6.2 Hz, 1H, αCH), 5.54 (d, <i>J</i> = 7.4 Hz, 1H, NH), 6.65–6.73 (m, 2H, Ph), 6.73–6.79 (m, 1H, Ph). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 20.57, 28.24, 32.84, 51.98, 54.97, 79.50, 113.30, 116.22, 119.28, 127.84, 147.51, 153.95, 155.33, 172.70. LC–MS: <i>t</i><sub>R</sub> = 4.98 min; C<sub>16</sub>H<sub>24</sub>NO<sub>5</sub><sup>+</sup> [M + H]<sup>+</sup>, <i>m</i>/<i>z</i> calcd 310.16, found 310.14.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Methyl 2-amino-3-(2-hydroxy-5-methylphenyl)propanoate TFA Salt (<b>S1c</b>, R = Me)</h4><div class="NLM_p last">To a suspension of <b><i>S1b</i></b> (R = Me, 1.1 g, 3.56 mmol, 1.0 eq) in DCM (6 mL) was added TFA (3 mL) at 0 °C, and the resulting mixture was stirred for 30 min. The mixture was then concentrated with toluene three times to remove most of the residual TFA. The obtained crude product <b><i>S1c</i></b> (R = Me) was used without further purification.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Methyl (S)-2-((S)-2-(((benzyloxy)carbonyl)amino)-3-phenylpropanamido)-3-(2-hydroxy-5-methylphenyl)propanoate (<b>S1d</b>, R = Me, R<sub>1</sub> = BnO)</h4><div class="NLM_p last">A mixed suspension of <b><i>S1c</i></b> (R = Me, ∼1.15 g, 3.56 mmol, 1.0 eq), Cbz-Phe-OH (1.07 g, 3.56 mmol, 1.0 eq), and DIPEA (2.17 mL, 12.46 mmol, 3.5 eq) in DCM (20 mL) was cooled to 0 °C followed by dropwise addition of T3P (>50% in MeCN, 3.53 mL, 5.34 mmol, 1.5 eq). The resulting mixture was stirred at room temperature for 2 h. The reaction mixture was concentrated under reduced pressure, diluted with EtOAc (75 mL), and washed successively with 5% citric acid (15 mL), saturated aqueous NaHCO<sub>3</sub> (15 mL), and brine (15 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The obtained crude product was purified by FCC (40% EtOAc in hexane) to give <b><i>S1d</i></b> (R = Me, R<sub>1</sub> = BnO, 1.11 g, 63% for two steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.30 (s, 3H, PhCH<sub>3</sub>), 2.83–3.16 (m, 4H, 2 × βCH<sub>2</sub>), 3.69 (s, 3H, COOCH<sub>3</sub>), 4.50 (s, 1H, αCH), 4.75 (s, 1H, αCH), 4.98–5.14 (m, 2H, Cbz CH<sub>2</sub>), 5.70 (s, 1H, OH), 6.68 (t, <i>J</i> = 8.8 Hz, 1H, NH), 6.91–7.10 (m, 3H, Ph), 7.22 (dd, <i>J</i> = 20.7, 26.3 Hz, 7H, Ph), 7.33 (s, 3H, Ph), 8.08 (s, 1H, NH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 20.66, 33.10, 38.37, 52.47, 53.19, 56.10, 67.24, 117.11, 124.49, 127.01, 127.88, 128.22, 128.32, 128.42, 128.53, 128.61, 129.25, 130.87, 135.98, 136.14, 153.57, 156.27, 171.72, 172.08. LC–MS: <i>t</i><sub>R</sub> = 5.39 min; C<sub>28</sub>H<sub>31</sub>N<sub>2</sub>O<sub>6</sub><sup>+</sup> [M + H]<sup>+</sup>, <i>m</i>/<i>z</i> calcd 491.22, found 491.19.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Methyl (S)-2-((S)-2-(((benzyloxy)carbonyl)amino)-3-phenylpropanamido)-3-(2-((tert-butyldimethylsilyl)oxy)-5-methylphenyl)propanoate (<b>S1e</b>, R = Me, R<sub>1</sub> = BnO, R<sub>2</sub> = TBS)</h4><div class="NLM_p last">A mixed solution of <b><i>S1d</i></b> (R = Me, R<sub>1</sub> = BnO, 990 mg, 2.02 mmol, 1.0 eq), TBSCl (609 mg, 4.04 mmol, 2.0 eq), and imidazole (412 mg, 6.06 mmol, 3.0 eq) was stirred at room temperature overnight. The reaction mixture was quenched by addition of 0.5 M HCl (10 mL) and was stirred for another 15 min. The mixture was concentrated under reduced pressure and was partitioned between EtOAc (50 mL) and water (10 mL). The organic layer was washed with saturated aqueous NaHCO<sub>3</sub> (10 mL) and brine (10 mL) and was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The obtained crude product was purified by FCC (20% EtOAc in hexane) to give <b><i>S1e</i></b> (R = Me, R<sub>1</sub> = BnO, R<sub>2</sub> = TBS, 897 mg, 73%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.16 (s, 6H, TBS Si(CH<sub>3</sub>)<sub>2</sub>), 0.93 (s, 9H, TBS C(CH<sub>3</sub>)<sub>3</sub>), 2.37 (s, 3H, PhCH<sub>3</sub>), 2.59–2.87 (m, 2H, βCH<sub>2</sub>), 2.89–3.05 (m, 2H, βCH<sub>2</sub>), 3.54 (d, <i>J</i> = 4.3 Hz, 3H, COOCH<sub>3</sub>), 4.36 (d, <i>J</i> = 22.6 Hz, 1H, αCH), 4.64 (q, <i>J</i> = 8.3 Hz, 1H, αCH), 4.95 (p, <i>J</i> = 12.1 Hz, 2H, Cbz CH<sub>2</sub>), 5.32–5.55 (m, 1H, NH), 6.56–6.65 (m, 1H, Ph), 6.83–7.02 (m, 3H, Ph), 7.05–7.25 (m, 9H, Ph). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ −3.50, 18.27, 20.53, 25.81, 32.94, 38.57, 52.20, 52.57, 56.08, 66.96, 119.79, 125.91, 126.90, 127.89, 127.95, 128.02, 128.04, 128.07, 128.14, 128.44, 128.47, 128.57, 128.71, 129.28, 129.35, 130.82, 136.25, 136.47, 152.62, 155.90, 170.76, 171.62, 172.00. LC–MS: <i>t</i><sub>R</sub> = 7.23 min; C<sub>34</sub>H<sub>45</sub>N<sub>2</sub>O<sub>6</sub>Si<sup>+</sup> [M + H]<sup>+</sup>, <i>m</i>/<i>z</i> calcd 605.30, found 605.24.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Methyl (S)-2-((S)-2-(((benzyloxy)carbonyl)amino)-3-phenylpropanamido)-3-(2-methoxyphenyl)propanoate (<b>S1e</b>, R = H, R<sub>1</sub> = BnO, R<sub>2</sub> = Me)</h4><div class="NLM_p last">To a solution of <b><i>S1d</i></b> (R = H, R<sub>1</sub> = BnO, 172 mg, 0.36 mmol, 1.0 eq) in DMF (2 mL) were successively added K<sub>2</sub>CO<sub>3</sub> (100 mg, 0.72 mmol, 2.0 eq) and iodomethane (67 μL, 1.08 mmol, 3.0 eq) at 0 °C. The resulting mixture was stirred at room temperature for 20 h during which the system should be kept securely sealed to avoid evaporation of iodomethane. The mixture was diluted with EtOAc (50 mL) and washed with water extensively (5 × 10 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The obtained crude product was purified by FCC (30% EtOAc in hexane) to give <b><i>S1e</i></b> (R = H, R<sub>1</sub> = BnO, R<sub>2</sub> = Me, 167 mg, 95%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.02 (qd, <i>J</i> = 5.7, 13.6, 16.9 Hz, 4H, 2 × βCH<sub>2</sub>), 3.61 (s, 3H, COOCH<sub>3</sub>), 3.93 (s, 3H, PhOCH<sub>3</sub>), 4.48 (s, 1H, αCH), 4.72 (s, 1H, αCH), 4.88–5.12 (m, 2H, Cbz CH<sub>2</sub>), 5.69 (d, <i>J</i> = 8.2 Hz, 1H, NH), 6.64–6.88 (m, 2H, Ph), 6.92–7.06 (m, 3H, Ph), 7.08–7.18 (m, 4H, Ph), 7.24 (d, <i>J</i> = 18.6 Hz, 5H, Ph), 7.77 (d, <i>J</i> = 43.8 Hz, 1H, NH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 32.65, 32.96, 38.40, 52.33, 52.40, 53.70, 56.04, 67.11, 115.84, 120.35, 122.73, 126.88, 126.90, 127.88, 128.16, 128.52, 128.72, 129.30, 131.30, 136.14, 154.71, 156.21, 156.23, 171.98, 172.34. LC–MS: <i>t</i><sub>R</sub> = 5.71 min; C<sub>28</sub>H<sub>31</sub>N<sub>2</sub>O<sub>6</sub><sup>+</sup> [M + H]<sup>+</sup>, <i>m</i>/<i>z</i> calcd 491.22, found 491.33.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Benzyl ((S)-1-(((S)-1-(2-((tert-butyldimethylsilyl)oxy)-5-methylphenyl)-3-hydroxypropan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate (<b>S1f</b>, R = Me, R<sub>1</sub> = BnO, R<sub>2</sub> = TBS)</h4><div class="NLM_p last">To a solution of <b><i>S1e</i></b> (R = Me, R<sub>1</sub> = BnO, R<sub>2</sub> = TBS, 897 mg, 1.48 mmol, 1.0 eq) in MeOH (10 mL) was added NaBH<sub>4</sub> (1.2 g, 31.7 mmol, >20 eq) in multiple portions every 30 min. The reaction mixture was stirred at room temperature for another 2 h and then quenched by addition of saturated aqueous NH<sub>4</sub>Cl (10 mL). The mixture was concentrated under reduced pressure and diluted with EtOAc (50 mL). The organic layer was washed with saturated aqueous NaHCO<sub>3</sub> (10 mL) and brine (10 mL) and was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The obtained crude product was purified by FCC (35% EtOAc in hexane) to give <b><i>S1f</i></b> (R = Me, R<sub>1</sub> = BnO, R<sub>2</sub> = TBS, 450 mg, 53%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.26 (s, 6H, TBS Si(CH<sub>3</sub>)<sub>2</sub>), 1.03 (s, 9H, TBS C(CH<sub>3</sub>)<sub>3</sub>), 2.40 (s, 3H, PhCH<sub>3</sub>), 2.74 (dt, <i>J</i> = 7.0, 13.1 Hz, 2H, βCH<sub>2</sub>), 2.97 (dd, <i>J</i> = 6.8, 40.5 Hz, 2H, βCH<sub>2</sub>), 3.25–3.60 (m, 2H, C<u class="uu">H</u><sub>2</sub>OH), 4.02–4.15 (m, 1H, αCH), 4.39 (s, 1H, αCH), 4.97–5.15 (m, 2H, Cbz CH<sub>2</sub>), 5.69 (dd, <i>J</i> = 7.8, 66.8 Hz, 1H, NH), 6.54 (dd, <i>J</i> = 6.8, 121.3 Hz, 1H, Ph), 6.72–6.81 (m, 1H, Ph), 7.04–7.14 (m, 2H, Ph), 7.15–7.30 (m, 6H, Ph & NH), 7.34 (q, <i>J</i> = 6.2, 7.1 Hz, 4H, Ph). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ −4.05, 18.27, 21.02, 25.87, 31.17, 39.00, 52.34, 56.69, 63.66, 67.03, 119.96, 126.28, 127.00, 127.56, 127.93, 128.03, 128.16, 128.47, 128.65, 129.29, 130.27, 131.00, 136.24, 136.53, 152.38, 155.94, 170.98, 171.35. LC–MS: <i>t</i><sub>R</sub> = 6.90 min; C<sub>33</sub>H<sub>45</sub>N<sub>2</sub>O<sub>5</sub>Si<sup>+</sup> [M + H]<sup>+</sup>, <i>m</i>/<i>z</i> calcd 577.31, found 577.37.</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Benzyl ((S)-1-(((S)-1-(2-((tert-butyldimethylsilyl)oxy)-5-methylphenyl)-3-oxopropan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate (<b>S1g</b>, R = Me, R<sub>1</sub> = BnO, R<sub>2</sub> = TBS)</h4><div class="NLM_p last">To a solution of <b><i>S1f</i></b> (R = Me, R<sub>1</sub> = BnO, R<sub>2</sub> = TBS, 151 mg, .26 mmol, 1.0 eq) in DCM (8 mL) at 0 °C were added Dess-Martin periodinane (133 mg, 0.31 mmol, 1.2 eq) and NaHCO<sub>3</sub> powder (55 mg, 0.65 mmol, 2.5 eq). The resulting mixture was stirred at 0 °C for 1 h and then quenched by addition of saturated aqueous Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> (2 mL). The reaction mixture was concentrated under reduced pressure, diluted with EtOAc (50 mL), and washed with brine (3 × 10 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The obtained crude product was purified by FCC (25% EtOAc in hexane) to give <b><i>S1g</i></b> (R = Me, R<sub>1</sub> = BnO, R<sub>2</sub> = TBS, 68 mg, 45%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.24 (d, <i>J</i> = 4.6 Hz, 6H, TBS Si(CH<sub>3</sub>)<sub>2</sub>), 1.01 (s, 9H, TBS C(CH<sub>3</sub>)<sub>3</sub>), 2.24 (s, 3H, PhCH<sub>3</sub>), 2.77–3.20 (m, 4H, 2 × βCH<sub>2</sub>), 4.51 (q, <i>J</i> = 6.7 Hz, 1H, αCH), 5.02–5.15 (m, 2H, Cbz CH<sub>2</sub>), 5.35 (s, 1H, αCH), 6.52 (d, <i>J</i> = 5.5 Hz, 1H, NH), 6.71 (d, <i>J</i> = 8.2 Hz, 1H, Ph), 6.85 (d, <i>J</i> = 2.2 Hz, 1H, Ph), 6.94 (dd, <i>J</i> = 2.3, 8.2 Hz, 1H, Ph), 7.16 (d, <i>J</i> = 7.1 Hz, 2H, Ph), 7.21–7.28 (m, 3H, Ph), 7.35 (dt, <i>J</i> = 4.7, 6.9 Hz, 5H, Ph), 9.41 (s, 1H, CHO). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ −4.14, 18.28, 20.43, 25.90, 29.92, 38.80, 56.11, 59.57, 67.01, 118.77, 125.68, 127.09, 128.01, 128.16, 128.50, 128.67, 128.91, 129.26, 130.94, 131.91, 136.13, 151.28, 170.96, 198.75. LC–MS: <i>t</i><sub>R</sub> = 6.81 min; C<sub>33</sub>H<sub>43</sub>N<sub>2</sub>O<sub>5</sub>Si<sup>+</sup> [M + H]<sup>+</sup>, <i>m</i>/<i>z</i> calcd 575.29, found 575.36.</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Benzyl ((2S)-1-(((3S)-2-hydroxy-6-methylchroman-3-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate (<b>S1h</b>, <b>7</b>, R = Me, R<sub>1</sub> = BnO, R<sub>2</sub> = TBS)</h4><div class="NLM_p last">To a solution of <b><i>S1g</i></b> (R = Me, R<sub>1</sub> = BnO, R<sub>2</sub> = TBS, 68 mg, 0.12 mmol, 1.0 eq) in THF (3 mL) was slowly added 1.0 M TBAF in THF (131 μL, 0.13 mmol, 1.1 eq) at 0 °C. The resulting mixture was stirred at 0 °C for 1 h and concentrated under reduced pressure. The residue was diluted with EtOAc (50 mL) and washed with saturated aqueous NH<sub>4</sub>Cl (10 mL) and brine (10 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The obtained crude product was purified by FCC (35% EtOAc in hexane) to give <b><i>S1h</i></b> (R = Me, R<sub>1</sub> = BnO, R<sub>2</sub> = TBS, i.e., compound <b>7</b>, 20 mg, 36%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.10–2.18 (m, 3H, PhCH<sub>3</sub>), 2.37–3.10 (m, 4H, 2 × βCH<sub>2</sub>), 4.10–4.45 (m, 2H, αCH & NH), 4.71–5.10 (m, 3H, Cbz CH<sub>2</sub> & NH), 5.53 (dd, <i>J</i> = 7.2, 51.9 Hz, 1H, αCH), 5.97–6.41 (m, 1H, lactol C(O)OH), 6.59 (td, <i>J</i> = 10.3, 31.2, 32.4 Hz, 2H, Ph), 6.78 (dd, <i>J</i> = 8.2, 18.7 Hz, 1H, Ph), 6.98–7.28 (m, 10H, Ph). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 20.46, 25.96, 39.10, 46.02, 56.24, 67.20, 91.04, 91.93, 116.68, 118.34, 119.01, 119.23, 128.04, 128.12, 128.20, 128.52, 128.67, 128.77, 129.19, 129.32, 129.64, 130.50, 130.63, 136.02, 136.26, 148.52, 156.15, 171.23. LC–MS: <i>t</i><sub>R</sub> = 5.32 min; C<sub>27</sub>H<sub>29</sub>N<sub>2</sub>O<sub>5</sub><sup>+</sup> [M + H]<sup>+</sup>, <i>m</i>/<i>z</i> calcd 461.21, found 461.27.</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Benzyl (4-methylpiperazine-1-carbonyl)-L-phenylalaninate (<b>S1i</b>)</h4><div class="NLM_p last">To a solution of 4-methylpiperazine-1-carbonyl chloride hydrochloride (1.365 g, 6.86 mmol, 1.1 eq) in THF (20 mL) at −10 °C was added Et<sub>3</sub>N (2.08 mL, 14.96 mmol, 2.4 eq) dropwise. The resulting mixture was stirred for 15 min, and then a solution of benzyl L-phenylalaninate hydrochloride (1.82 g, 6.23 mmol, 1.0 eq) was added into THF (20 mL) dropwise. The reaction mixture was stirred at room temperature overnight, quenched by addition of water (10 mL), and concentrated under reduced pressure. The residue was diluted with EtOAc (100 mL) and washed successively with saturated aqueous NH<sub>4</sub>Cl (20 mL), saturated aqueous NaHCO<sub>3</sub> (20 mL), and brine (20 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The obtained crude product was purified by FCC (5–10% MeOH in DCM) to give <b><i>S1i</i></b> (1.55 g, 60%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.31 (s, 3H, NCH<sub>3</sub>), 2.37 (t, <i>J</i> = 5.1 Hz, 4H, 2 × piperazinyl CH<sub>2</sub>), 3.14 (d, <i>J</i> = 4.2 Hz, 2H, βCH<sub>2</sub>), 3.37 (q, <i>J</i> = 4.9 Hz, 4H, 2 × piperazinyl CH<sub>2</sub>), 4.87 (d, <i>J</i> = 5.1 Hz, 2H, Cbz CH<sub>2</sub>), 5.05–5.28 (m, 2H, αCH & NH), 7.02 (dd, <i>J</i> = 2.9, 6.5 Hz, 2H, Ph), 7.20–7.27 (m, 3H, Ph), 7.30–7.42 (m, 5H, Ph). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 38.31, 43.69, 46.09, 54.32, 54.59, 67.11, 126.93, 128.44, 128.53, 128.57, 129.38, 135.26, 136.11, 156.46, 172.45. LC–MS: <i>t</i><sub>R</sub> = 3.42 min; C<sub>22</sub>H<sub>28</sub>N<sub>3</sub>O<sub>3</sub><sup>+</sup> [M + H]<sup>+</sup>, <i>m</i>/<i>z</i> calcd 382.21, found 382.2.</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (4-methylpiperazine-1-carbonyl)-L-phenylalanine (<b>S1j</b>)</h4><div class="NLM_p last">The compound was prepared from <b>S1i</b> in a similar procedure as described for <b>S1b</b>. The obtained crude product <b><i>S1j</i></b> was used without further purification.</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (1aR,7aS)-1a,2,7,7a-tetrahydronaphtho[2,3-b]oxirene (<b>S1k</b>)</h4><div class="NLM_p last">To a solution of 1,4-dihydronaphthalene (2.09 mg, 16.1 mmol, 1.0 eq) in chloroform (40 mL) was slowly added 70% <i>m</i>CPBA (4.74 g, 19.3 mmol, 1.2 eq) at 0 °C. The resulting mixture was stirred at room temperature overnight and quenched by addition of 2 M KOH (60 mL). The reaction mixture was concentrated under reduced pressure and diluted with EtOAc (100 mL). The organic layer was washed with brine (3 × 20 mL) and was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The obtained crude product was purified by FCC (10% EtOAc in hexane) to give <b><i>S1k</i></b> (2.03 g, 86%) <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.05 (d, <i>J</i> = 17.7 Hz, 2H, CH<sub>2</sub>), 3.18 (d, <i>J</i> = 16.8 Hz, 2H, CH<sub>2</sub>), 3.29–3.36 (m, 2H, 2 × epoxide CH), 6.95 (dd, <i>J</i> = 3.5, 5.6 Hz, 2H, Ph), 7.06 (dd, <i>J</i> = 3.4, 5.7 Hz, 2H, Ph). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 29.84, 51.71, 126.57, 129.33, 131.74.</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (2R,3R)-3-azido-1,2,3,4-tetrahydronaphthalen-2-ol and (2S,3S)-3-azido-1,2,3,4-tetrahydronaphthalen-2-ol (<b>S1l</b>)</h4><div class="NLM_p last">To a solution of <b><i>S1k</i></b> (2.02 g, 13.8 mmol, 1.0 eq) in a mixture of MeOH (30 mL) and H<sub>2</sub>O (10 mL) were added NaN<sub>3</sub> (1.8 g, 27.7 mmol, 2.0 eq) and NH<sub>4</sub>Cl (1.11 g, 20.8 mmol, 1.5 eq). The resulting mixture was heated to 60 °C and stirred overnight. The reaction mixture was cooled to room temperature, concentrated under reduced pressure, and diluted with EtOAc (100 mL). The organic layer was washed with brine (3 × 20 mL) and was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The obtained crude product <b><i>S1l</i></b> (2.22 g, 85%) was used without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.77–2.86 (m, 2H, CH<sub>2</sub>), 3.17 (ddd, <i>J</i> = 2.9, 5.8, 16.5 Hz, 2H, CH<sub>2</sub>), 3.66 (td, 1H, CH-N<sub>3</sub>), 3.87 (td, <i>J</i> = 5.8, 9.4 Hz, 1H, C<u class="uu">H</u>–OH), 7.04–7.09 (m, 2H, Ph), 7.09–7.16 (m, 2H, Ph). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 33.64, 36.57, 63.62, 70.47, 126.50, 126.68, 128.59, 128.99, 132.62, 133.41.</div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (2R,3R)-3-amino-1,2,3,4-tetrahydronaphthalen-2-ol and (2S,3S)-3-amino-1,2,3,4-tetrahydronaphthalen-2-ol (<b>S1m</b>)</h4><div class="NLM_p last">The title compound was prepared from <b><i>S1l</i></b> in a similar procedure as described for <b><i>S1b</i></b>. The obtained crude product <b><i>S1m</i></b> was used without further purification.</div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> N-((S)-1-(((2S,3S)-3-hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-4-methylpiperazine-1-carboxamide and N-((S)-1-(((2R,3R)-3-hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-4-methylpiperazine-1-carboxamide (<b>3</b>)</h4><div class="NLM_p last">The title compound was prepared from <b><i>S1j</i></b> and <b><i>S1m</i></b> in a similar procedure as described for <b><i>S1d</i></b>. The obtained crude product was purified by FCC (10% MeOH in DCM) to give compound <b>3</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.17 (s, 3H), 2.20 (q, J = 3.3 Hz, 3H) 2.61 (ddd, J = 6.7, 16.9, 27.1 Hz, 2H), 2.83 (dd, J = 10.2, 13.6 Hz, 1H), 2.95 (ddd, J = 4.7, 8.9, 12.8 Hz, 2H), 3.04–3.33 (m, 5H), 3.79 (td, J = 4.8, 6.8 Hz, 1H), 3.93 (p, J = 7.0 Hz, 1H), 4.33 (ddd, J = 4.6, 8.3, 10.1 Hz, 1H), 6.48 (d, J = 8.3 Hz, 1H), 7.05–7.10 (m, 3H), 7.13–7.21 (m, 1H), 7.22–7.27 (m, 3H), 7.77 (d, J = 7.8 Hz, 1H), 8.15 (s, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 32.84, 35.71, 38.13, 43.63, 45.94, 50.11, 54.62, 56.33, 67.15, 126.12, 126.24, 126.48, 128.35, 128.99, 129.38, 129.73, 134.39, 134.78, 139.14, 157.37, 163.56, 172.89.</div></div><div id="sec4_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 4-Methyl-N-((S)-1-oxo-1-(((S)-1-oxo-4-phenylbutan-2-yl)amino)-3-phenylpropan-2-yl)piperazine-1-carboxamide (<b>11</b>)</h4><div class="NLM_p last">The preparation of <b><i>S1n</i></b>, <b><i>S1o,</i></b> and <b>11</b> was similar to the procedures for <b><i>S1d, S1f,</i></b> and <b><i>S1g</i></b>, respectively. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.82 (dt, <i>J</i> = 7.6, 14.6 Hz, 1H, piperazinyl CH<sub>2</sub>), 2.09–2.17 (m, 1H, piperazinyl CH<sub>2</sub>), 2.28 (s, 3H, NCH<sub>3</sub>), 2.34 (dt, <i>J</i> = 3.8, 7.1 Hz, 4H, piperazinyl CH<sub>2</sub> & homoPhe βCH<sub>2</sub>), 2.55 (dt, <i>J</i> = 7.9, 27.5 Hz, 2H, homoPhe γCH<sub>2</sub>), 3.11 (p, <i>J</i> = 5.9, 6.5 Hz, 2H, Phe βCH<sub>2</sub>), 3.29–3.39 (m, 4H, 2 × piperazinyl CH<sub>2</sub>), 4.33 (td, <i>J</i> = 5.3, 7.5 Hz, 1H, homoPhe αCH), 4.64 (q, <i>J</i> = 7.3 Hz, 1H, Phe αCH), 5.02 (d, <i>J</i> = 7.3 Hz, 1H, NH), 6.75 (d, <i>J</i> = 7.1 Hz, 1H, NH), 7.08–7.13 (m, 2H, Ph), 7.18–7.25 (m, 5H, Ph), 7.27–7.31 (m, 3H, Ph), 9.43 (s, 1H, CHO). C<sub>25</sub>H<sub>33</sub>N<sub>4</sub>O<sub>3</sub><sup>+</sup> [M + H]<sup>+</sup>, <i>m</i>/<i>z</i> calcd 437.25, found 481.21.</div></div><div id="sec4_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (3S)-3-((S)-2-(4-methylpiperazine-1-carboxamido)-3-phenylpropanamido)chroman-2-yl acetate (<b>S2a</b>, <b>13</b>, R<sub>1</sub> = Me)</h4><div class="NLM_p last">To a solution of compound <b>12</b> (50 mg, 0.114 mmol, 1.0 eq) in DCM (3 mL) were added acetic anhydride (32 μL, 0.342 mmol, 3.0 eq), Et<sub>3</sub>N (48 μL, 0.342 mmol, 3.0 eq), and DMAP (2.8 mg, 0.023 mmol, 0.2 eq). The resulting mixture was stirred at room temperature overnight and concentrated under reduced pressure. The residue was diluted with EtOAc (50 mL) and washed successively with saturated aqueous NH<sub>4</sub>Cl (10 mL), saturated aqueous NaHCO<sub>3</sub> (10 mL), and brine (10 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The obtained crude product was purified by FCC (10% MeOH in DCM) to give <b><i>S2a</i></b> (R<sub>1</sub> = Me, i.e., compound <b>13</b>, 31 mg, 57%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.01 (d, <i>J</i> = 23.4 Hz, 3H, CH<sub>3</sub>CO), 2.29 (d, <i>J</i> = 3.5 Hz, 3H, NCH<sub>3</sub>), 2.30–2.38 (m, 4H, 2 × piperazinyl CH<sub>2</sub>), 2.69–2.97 (m, 2H, lactol βCH<sub>2</sub>), 2.98–3.15 (m, 2H, Phe βCH<sub>2</sub>), 3.25–3.41 (m, 4H, 2 × piperazinyl CH<sub>2</sub>), 4.49 (dt, <i>J</i> = 6.9, 13.8 Hz, 1H, αCH), 5.18 (dd, <i>J</i> = 7.4, 40.0 Hz, 1H, Phe αCH), 6.12 (dd, <i>J</i> = 2.5, 17.4 Hz, 1H, lactol CH), 6.31–6.54 (m, 1H, NH), 6.82–6.91 (m, 1H, Ph), 6.91–7.07 (m, 2H, Ph), 7.07–7.19 (m, 2H, Ph), 7.19 (s, 3H, Ph & NH), 7.26–7.34 (m, 2H, Ph). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 20.99, 26.61, 29.67, 38.69, 43.71, 45.99, 54.48, 56.23, 88.88, 89.33, 117.07, 119.40, 121.89, 127.09, 128.06, 128.70, 128.74, 129.15, 129.20, 136.94, 150.22, 157.02, 169.38, 171.96. LC–MS: <i>t</i><sub>R</sub> = 3.29 min; C<sub>26</sub>H<sub>33</sub>N<sub>4</sub>O<sub>5</sub><sup>+</sup> [M + H]<sup>+</sup>, <i>m</i>/<i>z</i> calcd 481.24, found 481.3.</div></div><div id="sec4_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> N-((2S)-1-(((3S)-2-ethoxychroman-3-yl)amino)-1-oxo-3-phenylpropan-2-yl)-4-methylpiperazine-1-carboxamide (<b>S2b</b>, <b>16</b>, R<sub>2</sub> = Et)</h4><div class="NLM_p last">To a solution of compound <b>12</b> (40 mg, 0.091 mmol, 1.0 eq) in EtOH (2 mL) was added BF<sub>3</sub>OEt<sub>2</sub> (300 μL, 2.43 mmol, >20 eq) dropwise at 0 °C. The resulting mixture was stirred at room temperature overnight and quenched by addition of saturated aqueous NH<sub>4</sub>Cl (2 mL). The reaction mixture was concentrated under reduced pressure and then partitioned between DCM (20 mL) and water (20 mL). The water layer was further washed with DCM (2 × 20 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The obtained crude product was purified by FCC (8% MeOH in DCM) to give <b><i>S2b</i></b> (R<sub>2</sub> = Et, i.e., compound <b>16</b>, 18.3 mg, 43%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.00 (t, 3H, OCH<sub>2</sub>C<u class="uu">H</u><sub>3</sub>), 2.16–2.36 (m, 7H, NCH<sub>3</sub> & 2 × piperazinyl CH<sub>2</sub>), 2.69 (dd, <i>J</i> = 9.2, 14.2 Hz, 1H, βCH<sub>2</sub>), 2.83–2.95 (m, 1H, βCH<sub>2</sub>), 3.10 (dt, <i>J</i> = 7.2, 13.4 Hz, 1H, Phe βCH<sub>2</sub>), 3.21 (dd, <i>J</i> = 4.0, 6.1 Hz, 1H, Phe βCH<sub>2</sub>), 3.31 (dt, <i>J</i> = 6.0, 11.1 Hz, 3H, OC<u class="uu">H</u><sub>2</sub>CH<sub>3</sub> & piperazinyl CH<sub>2</sub>), 3.58–3.76 (m, 1H, piperazinyl CH<sub>2</sub>), 4.13–4.27 (m, 1H, piperazinyl CH<sub>2</sub>), 4.41 (q, <i>J</i> = 7.3 Hz, 1H, piperazinyl CH<sub>2</sub>), 4.68 (dd, <i>J</i> = 2.3, 49.7 Hz, 1H, αCH), 4.90–5.15 (m, 1H, Phe αCH), 5.78 (dd, <i>J</i> = 8.9, 24.8 Hz, 1H, lactol CH), 6.73 (d, <i>J</i> = 8.1 Hz, 1H, Ph), 6.80 (q, <i>J</i> = 6.8, 7.4 Hz, 1H, Ph), 6.90 (d, <i>J</i> = 7.2 Hz, 1H, Ph), 7.03 (t, <i>J</i> = 7.2 Hz, 1H, Ph), 7.07–7.30 (m, 5H, Ph). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 14.94, 14.98, 27.08, 39.59, 43.72, 45.10, 46.06, 54.58, 56.30, 64.01, 96.02, 96.34, 116.79, 120.48, 121.16, 126.99, 127.67, 128.65, 128.75, 129.20, 129.33, 136.84, 137.17, 150.58, 150.70, 156.56, 156.68, 171.26, 171.66. LC–MS: <i>t</i><sub>R</sub> = 3.53 min; C<sub>26</sub>H<sub>35</sub>N<sub>4</sub>O<sub>4</sub><sup>+</sup> [M + H]<sup>+</sup>, <i>m</i>/<i>z</i> calcd 467.27, found 467.3.</div></div><div id="sec4_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (S)-N-(2-benzoylphenyl)-1-benzylpyrrolidine-2-carboxamide (<b>S3a</b>)</h4><div class="NLM_p last">To a mixed solution of benzyl-L-proline (1.03 g, 5.0 mmol, 1.0 eq) and 1-methylimidazole (877 μL, 11.0 mmol, 2.2 eq) in DCM (10 mL) was added MsCl (387 μL, 5.0 mmol, 1.0 eq) dropwise at 0 °C. The resulting mixture was stirred at room temperature for 10 min, and then was added a solution of 2-aminobenzophenone (888 mg, 4.5 mmol, 0.9 eq) in DCM (10 mL). The reaction mixture was heated to 45 °C and stirred overnight. The reaction mixture was quenched by addition of NH<sub>4</sub>Cl (15 mL) and concentrated under reduced pressure. The residue was diluted with EtOAc (75 mL) and washed with saturated aqueous NaHCO<sub>3</sub> (15 mL) and brine (15 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The obtained crude product was purified by FCC (15–25% EtOAc in hexane) to give <b><i>S3a</i></b> (1.344 g, 70%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.72–1.85 (m, 2H, Pro γCH<sub>2</sub>), 1.91–2.01 (m, 1H, Pro βCH<sub>2</sub>), 2.17–2.31 (m, 1H, Pro βCH<sub>2</sub>), 2.40 (td, <i>J</i> = 6.8, 9.5 Hz, 1H, Pro δCH<sub>2</sub>), 3.20 (ddd, <i>J</i> = 2.4, 6.4, 9.1 Hz, 1H, Pro δCH<sub>2</sub>), 3.31 (dd, <i>J</i> = 4.8, 10.1 Hz, 1H, Pro αCH), 3.58 (d, <i>J</i> = 12.9 Hz, 1H, Bn CH<sub>2</sub>), 3.91 (d, <i>J</i> = 12.9 Hz, 1H, Bn CH<sub>2</sub>), 7.07 (td, <i>J</i> = 1.1, 7.6 Hz, 1H, Ph), 7.10–7.17 (m, 3H, Ph), 7.33–7.40 (m, 2H, Ph), 7.49 (qd, <i>J</i> = 6.5, 7.9 Hz, 4H, Ph), 7.56–7.61 (m, 1H, Ph), 7.73–7.83 (m, 2H, Ph), 8.57 (dd, <i>J</i> = 1.0, 8.4 Hz, 1H, Ph), 11.50 (s, 1H, NH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 24.18, 31.03, 53.89, 59.87, 68.32, 121.53, 122.19, 125.36, 127.06, 128.16, 128.31, 129.13, 130.10, 132.45, 132.54, 133.35, 138.15, 138.59, 139.22, 174.60, 197.99. LC–MS: <i>t</i><sub>R</sub> = 3.50 min; C<sub>25</sub>H<sub>25</sub>N<sub>2</sub>O<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup>, <i>m</i>/<i>z</i> calcd 385.19, found 384.85.</div></div><div id="sec4_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (S,E)-2-(((2-(1-benzylpyrrolidine-2-carboxamido)phenyl)(phenyl)methylene)amino)acetate-1-<sup>13</sup>C in Complex with Ni(II) (<b>S3b</b>)</h4><div class="NLM_p last">To a mixed suspension of <b><i>S3a</i></b> (860 mg, 2.24 mmol, 1.0 eq), [1-<sup>13</sup>C] glycine (425 mg, 5.59 mmol, 2.5 eq), and Ni(NO<sub>3</sub>)<sub>2</sub>·6H<sub>2</sub>O (1.30 g, 4.47 mmol, 2.0 eq) in MeOH (7 mL) at 45 °C was added a solution of ground KOH (752 mg, 13.4 mmol, 6.0 eq) in MeOH (3 mL). The resulting mixture was stirred at 60 °C for 1 h (note that prolonged heating might lead to racemization).The reaction mixture was neutralized by addition of acetic acid (800 μL) and diluted with water to a volume of 50 mL. The reaction mixture was concentrated under reduced pressure and extracted with DCM (75 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The obtained crude product was purified by FCC (20–30% acetone in DCM) to give <b><i>S3b</i></b> (715 mg, 64%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.07 (dddd, <i>J</i> = 2.4, 5.6, 8.5, 15.1 Hz, 1H, Pro γCH<sub>2</sub>), 2.12–2.21 (m, 1H, Pro γCH<sub>2</sub>), 2.42 (dddd, <i>J</i> = 8.3, 9.5, 10.7, 13.4 Hz, 1H, Pro βCH<sub>2</sub>), 2.57 (dddd, <i>J</i> = 2.6, 6.3, 9.2, 14.4 Hz, 1H, Pro βCH<sub>2</sub>), 3.25–3.40 (m, 1H, Pro δCH<sub>2</sub>), 3.46 (dd, <i>J</i> = 5.4, 10.7 Hz, 1H, Pro δCH<sub>2</sub>), 3.61–3.74 (m, 3H, <i>N</i>-Bn CH<sub>2</sub> & Pro αCH), 3.77 (dd, <i>J</i> = 5.5, 20.1 Hz, 1H, Gly CH<sub>2</sub>), 4.48 (d, <i>J</i> = 12.7 Hz, 1H, Gly CH<sub>2</sub>), 6.69 (ddd, <i>J</i> = 1.2, 6.9, 8.1 Hz, 1H, Ph), 6.80 (dd, <i>J</i> = 1.7, 8.3 Hz, 1H, Ph), 6.92–7.04 (m, 1H, Ph), 7.05–7.13 (m, 1H, Ph), 7.20 (ddd, <i>J</i> = 1.7, 6.9, 8.7 Hz, 1H, Ph), 7.28–7.33 (m, 1H, Ph), 7.42 (t, <i>J</i> = 7.6 Hz, 2H, Ph), 7.52 (ddd, <i>J</i> = 3.4, 7.7, 18.9 Hz, 3H, Ph), 8.01–8.12 (m, 2H, Ph), 8.31 (dd, <i>J</i> = 1.1, 8.6 Hz, 1H, Ph). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 23.69, 30.76, 57.56, 61.57, 63.16, 69.94, 124.26, 125.16, 126.27, 128.91, 129.11, 129.34, 129.59, 131.73, 132.22, 132.77, 133.17, 133.37, 134.67, 142.62, 143.81, 177.21, 179.27. LC–MS: <i>t</i><sub>R</sub> = 3.71 min; C<sub>26</sub><sup>13</sup>CH<sub>26</sub>N<sub>3</sub>NiO<sub>3</sub><sup>+</sup> [M + H]<sup>+</sup>, <i>m</i>/<i>z</i> calcd 499.14, found 498.83.</div></div><div id="sec4_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> (S)-3-(2-(benzyloxy)phenyl)-2-(((E)-(2-((S)-1-benzylpyrrolidine-2-carboxamido)phenyl)(phenyl)methylene)amino)propanoate-1-<sup>13</sup>C in Complex with Ni(II) (<b>S3c</b>)</h4><div class="NLM_p last">A mixed slurry of <b><i>S3b</i></b> (715 mg, 1.43 mmol, 1.0 eq), (2-(benzyloxy)phenyl)methanol (613 mg, 2.86 mmol, 2.0 eq), and CMBP (750 μL, 2.86 mmol, 2.0 eq) in toluene (5 mL) was heated to 120 °C and stirred overnight. The reaction mixture was cooled to room temperature and concentrated under reduced pressure. The obtained crude product was purified by FCC (10% acetone in DCM) to give <b><i>S3c</i></b> (417 mg, 40%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.48–1.59 (m, 1H, Pro γCH<sub>2</sub>), 1.99 (ddd, <i>J</i> = 6.5, 8.4, 11.1 Hz, 1H, Pro δCH<sub>2</sub>), 2.04–2.14 (m, 1H, Pro γCH<sub>2</sub>), 2.31 (tdd, <i>J</i> = 2.9, 6.7, 9.7 Hz, 2H, Pro βCH<sub>2</sub>), 2.76 (ddd, <i>J</i> = 1.6, 4.4, 13.6 Hz, 1H, <i>o</i>-Tyr βCH<sub>2</sub>), 2.90–3.05 (m, 1H, Pro δCH<sub>2</sub>), 3.22 (ddd, <i>J</i> = 5.0, 7.2, 13.6 Hz, 1H, <i>o</i>-Tyr βCH<sub>2</sub>), 3.33 (dd, <i>J</i> = 8.0, 9.3 Hz, 1H, Pro αH), 3.44 (d, <i>J</i> = 12.6 Hz, 1H, <i>N</i>-Bn CH<sub>2</sub>), 4.18 (q, <i>J</i> = 4.4 Hz, 1H, <i>o</i>-Tyr αCH), 4.23 (d, <i>J</i> = 12.6 Hz, 1H, <i>N</i>-Bn CH<sub>2</sub>), 4.55 (d, <i>J</i> = 10.8 Hz, 1H, OBn CH<sub>2</sub>), 4.90 (d, <i>J</i> = 10.8 Hz, 1H, OBn CH<sub>2</sub>), 6.14 (dt, <i>J</i> = 1.5, 7.7 Hz, 1H, Ph), 6.41 (dd, <i>J</i> = 1.7, 8.2 Hz, 1H, Ph), 6.63 (ddd, <i>J</i> = 1.2, 6.9, 8.2 Hz, 1H, Ph), 6.83–6.94 (m, 2H, Ph), 6.96–7.22 (m, 9H, Ph), 7.28 (d, <i>J</i> = 7.6 Hz, 2H, Ph), 7.33–7.46 (m, 4H, Ph), 7.95–8.08 (m, 2H, Ph), 8.35 (dd, <i>J</i> = 1.1, 8.7 Hz, 1H, Ph). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 22.35, 25.60, 28.10, 59.19, 63.38, 68.12, 69.68, 71.86, 112.85, 122.38, 123.33, 123.36, 124.10, 127.39, 127.74, 127.80, 128.06, 128.35, 128.51, 128.73, 128.88, 129.20, 129.27, 129.61, 130.06, 130.30, 130.32, 134.10, 134.82, 137.07, 145.11, 155.82, 158.83, 170.83, 175.71. LC–MS: <i>t</i><sub>R</sub> = 4.70 min; C<sub>40</sub><sup>13</sup>CH<sub>38</sub>N<sub>3</sub>NiO<sub>4</sub><sup>+</sup> [M + H]<sup>+</sup>, <i>m</i>/<i>z</i> calcd 695.22, found 694.96.</div></div><div id="sec4_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> (S)-2-amino-3-(2-benzyloxy)phenyl)propanoic-1-<sup>13</sup>C Acid (<b>S3d</b>)</h4><div class="NLM_p last">A mixed solution of <b><i>S3c</i></b> (522 mg, 0.75 mmol, 1.0 eq) and 8-quinolinol (272 mg, 1.88 mmol, 2.5 eq) in MeCN (10 mL) and H<sub>2</sub>O (1 mL) was heated to 40 °C and stirred overnight. The reaction mixture was filtered, and the filtrate was concentrated. The residue was diluted with DCM (30 mL) and washed with water (3 × 30 mL). The organic layer containing the retrieved BPB was concentrated and saved for future use. The combined water layers were concentrated to a small volume that was subsequently purified by Prep-HPLC to give <b><i>S3d</i></b> (87 mg, 43%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.96 (ddd, <i>J</i> = 2.5, 9.4, 14.3 Hz, 1H, βCH<sub>2</sub>), 3.49 (ddd, <i>J</i> = 2.9, 4.5, 14.3 Hz, 1H, βCH<sub>2</sub>), 3.93 (dt, <i>J</i> = 4.7, 9.4 Hz, 1H, αCH), 5.20 (s, 2H, OBn CH<sub>2</sub>), 6.92 (td, <i>J</i> = 1.1, 7.4 Hz, 1H, Ph), 7.05 (d, <i>J</i> = 8.1 Hz, 1H, Ph), 7.24 (dd, <i>J</i> = 6.7, 8.2 Hz, 2H, Ph), 7.28–7.34 (m, 1H, Ph), 7.38 (dd, <i>J</i> = 6.6, 8.3 Hz, 2H, Ph), 7.45–7.53 (m, 2H, Ph). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 33.52, 55.91, 71.50, 114.97, 120.74, 124.67, 127.65, 127.97, 128.07, 128.32, 130.64, 139.00, 157.44, 173.03. LC–MS: <i>t</i><sub>R</sub> = 2.70 min; C<sub>15</sub><sup>13</sup>CH<sub>18</sub>NO<sub>3</sub><sup>+</sup> [M + H]<sup>+</sup>, <i>m</i>/<i>z</i> calcd 273.13, found 272.75.</div></div><div id="sec4_2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> (S)-3-(2-(benzyloxy)phenyl)-2-((tert-butoxycarbonyl)amino)propanoic-1-<sup>13</sup>C Acid (<b>S3e</b>)</h4><div class="NLM_p last">To a solution of <b><i>S3d</i></b> (87 mg, 0.32 mmol, 1.0 eq) in dioxane (5 mL) and H<sub>2</sub>O (5 mL) were added Et<sub>3</sub>N (134 μL, 0.96 mmol, 3.0 eq) and Boc anhydride (84 mg, 0.38 mmol, 1.2 eq) at 0 °C. The resulting mixture was stirred at room temperature for 2.5 h and then concentrated under reduced pressure. The residue was acidified by addition of 0.1 M HCl to pH 2–3 and then diluted with EtOAc (50 mL). The organic layer was washed with brine (3 × 10 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The obtained crude product <b><i>S3e</i></b> (113 mg, 94%) was used without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.28 (s, 9H, Boc), 2.74–3.06 (m, 1H, βCH<sub>2</sub>), 3.15 (d, <i>J</i> = 14.5 Hz, 1H, βCH<sub>2</sub>), 4.33–4.55 (m, 1H, αCH), 5.00 (d, <i>J</i> = 6.7 Hz, 2H, OBn CH<sub>2</sub>), 6.82 (d, <i>J</i> = 8.0 Hz, 2H, Ph), 7.04–7.15 (m, 2H, Ph), 7.21 (t, <i>J</i> = 7.3 Hz, 1H, Ph), 7.28 (d, <i>J</i> = 14.8 Hz, 2H, Ph), 7.36 (d, <i>J</i> = 7.4 Hz, 2H, Ph), 9.86 (s, 1H, COOH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 28.30, 29.71, 32.44, 54.81, 70.26, 111.95, 121.12, 127.22, 127.93, 128.46, 128.64, 131.40, 176.93. LC–MS: <i>t</i><sub>R</sub> = 4.28 min; C<sub>20</sub><sup>13</sup>CH<sub>25</sub>NNaO<sub>5</sub><sup>+</sup> [M + Na]<sup>+</sup>, <i>m</i>/<i>z</i> calcd 395.17, found 394.83; C<sub>15</sub><sup>13</sup>CH<sub>18</sub>NO<sub>3</sub><sup>+</sup> [M + H - Boc]<sup>+</sup>, <i>m</i>/<i>z</i> calcd 273.13, found 272.82.</div></div><div id="sec4_2_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Tert-Butyl (S)-(3-(2-(benzyloxy)phenyl)-1-(methoxy(methyl)amino)-1-oxopropan-2-yl-1-<sup>13</sup>C)carbamate (<b>S3f</b>)</h4><div class="NLM_p last">The title compound was prepared from <b><i>S3e</i></b> (113 mg, 0.30 mmol, 1.0 eq) and <i>N,O-</i>dimethylhydroxylamine hydrochloride (44.4 mg, 0.45 mmol, 1.5 eq) in a similar procedure as described for <b><i>S1d</i></b>. The obtained crude product was purified by FCC (25% EtOAc in hexane) to give <b><i>S3f</i></b> (136 mg, 100%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.25 (s, 9H, Boc), 2.79–2.96 (m, 2H, <i>o</i>-Tyr βCH<sub>2</sub>), 2.99 (d, <i>J</i> = 5.6 Hz, 3H, OCH<sub>3</sub>), 3.44 (s, 3H, NCH<sub>3</sub>), 4.90 (s, 1H, αCH), 4.99 (d, <i>J</i> = 4.1 Hz, 2H, OBn CH<sub>2</sub>), 5.21 (d, <i>J</i> = 8.9 Hz, 1H, NH), 6.79 (t, <i>J</i> = 7.7 Hz, 2H, Ph), 7.00–7.14 (m, 2H, Ph), 7.18–7.32 (m, 3H, Ph), 7.38 (d, <i>J</i> = 7.5 Hz, 2H, Ph). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 28.30, 29.66, 32.03, 45.85, 61.26, 70.23, 79.09, 111.68, 120.70, 125.50, 127.52, 127.87, 128.15, 128.54, 131.42, 137.08, 155.20, 157.10, 172.86. LC–MS: <i>t</i><sub>R</sub> = 4.60 min; C<sub>22</sub><sup>13</sup>CH<sub>30</sub>N<sub>2</sub>NaO<sub>5</sub><sup>+</sup> [M + Na]<sup>+</sup>, <i>m</i>/<i>z</i> calcd 438.21, found 437.81; C<sub>17</sub><sup>13</sup>CH<sub>22</sub>N<sub>2</sub>O<sub>5</sub><sup>+</sup> [M + H - Boc]<sup>+</sup>, <i>m</i>/<i>z</i> calcd 316.17, found 315.73.</div></div><div id="sec4_2_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> N-((S)-1-(((S)-3-(2-(benzyloxy)phenyl)-1-(methoxy(methyl)amino)-1-oxopropan-2-yl-1-<sup>13</sup>C)amino)-1-oxo-3-phenylpropan-2-yl)-4-methylpiperazine-1-carboxamide (<b>S3g</b>)</h4><div class="NLM_p last">The Boc group of <b><i>S3f</i></b> (136 mg, 0.33 mmol, 1.0 eq) was first deprotected in a similar procedure as described for <b><i>S1c</i></b>. Subsequently, the intermediate product was coupled to NMePip-Phe-OH (114 mg, 0.39 mmol, 1.2 eq) in a similar procedure as described for <b><i>S1d</i></b>. The obtained crude product was purified by FCC (8% MeOH in DCM) to give <b><i>S3g</i></b> (107 mg, 55%).<sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.27 (s, 3H, piperazinyl NCH<sub>3</sub>), 2.30 (dt, <i>J</i> = 3.7, 6.5 Hz, 4H, 2 × piperazinyl CH<sub>2</sub>), 2.96 (dd, <i>J</i> = 2.9, 6.3 Hz, 3H, OCH<sub>3</sub>), 3.07 (s, 4H, 2 x βCH<sub>2</sub>), 3.28 (ddd, <i>J</i> = 7.7, 13.5, 17.9 Hz, 4H, 2 × piperazinyl CH<sub>2</sub>), 3.48 (s, 3H, NCH<sub>3</sub>), 4.49 (q, <i>J</i> = 6.5 Hz, 1H, αCH), 4.99 (d, <i>J</i> = 7.0 Hz, 1H, αCH), 5.05 (s, 2H, OBn CH<sub>2</sub>), 5.19 (s, 1H, NH), 6.62 (s, 1H, NH), 6.79 (t, <i>J</i> = 7.3 Hz, 1H, Ph), 6.90 (dd, <i>J</i> = 7.3, 19.1 Hz, 2H, Ph), 7.12–7.25 (m, 6H, Ph), 7.30 (t, <i>J</i> = 7.3 Hz, 1H, Ph), 7.37 (t, <i>J</i> = 7.4 Hz, 2H, Ph), 7.46 (d, <i>J</i> = 7.2 Hz, 2H, Ph). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 32.03, 32.92, 38.74, 43.62, 46.03, 49.23, 54.53, 55.10, 61.22, 70.22, 111.82, 120.68, 125.09, 126.70, 127.57, 127.97, 128.30, 128.36, 128.59, 129.68, 131.43, 136.95, 137.02, 156.53, 156.99, 171.19, 171.76. LC–MS: <i>t</i><sub>R</sub> = 3.72 min; C<sub>32</sub><sup>13</sup>CH<sub>42</sub>N<sub>5</sub>O<sub>5</sub><sup>+</sup> [M + H]<sup>+</sup>, <i>m</i>/<i>z</i> calcd 589.32, found 589.02.</div></div><div id="sec4_2_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> N-((S)-1-(((S)-1-(2-(benzyloxy)phenyl)-3-oxopropan-2-yl-3-<sup>13</sup>C)amino)-1-oxo-3-phenylpropan-2-yl)-4-methylpiperazine-1-carboxamide (<b>S3h</b>)</h4><div class="NLM_p last">To a solution of <b><i>S3g</i></b> (107 mg, 0.182 mmol, 1.0 eq) in THF (8 mL) at −10 °C was added 2.0 M LAH in THF (218 μL, 0.218 mmol, 1.2 eq) dropwise. The resulting mixture was stirred at 0 °C for 1 h and then quenched using tiny pieces of ice. The reaction mixture was concentrated under reduced pressure and diluted with EtOAc (50 mL). The organic layer was washed successively with a saturated solution of Rochelle salt (15 mL), NaHCO<sub>3</sub> (15 mL), and brine (15 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The obtained crude product was purified by FCC (10% MeOH in DCM) to give <b><i>S3h</i></b> (81 mg, 84%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.28 (s, 3H, piperazinyl NCH<sub>3</sub>), 2.31 (t, <i>J</i> = 4.2 Hz, 4H, 2 × piperazinyl CH<sub>2</sub>), 2.95–3.13 (m, 4H, 2 × βCH<sub>2</sub>), 3.29 (dt, <i>J</i> = 5.2, 9.7 Hz, 4H, 2 × piperazinyl CH<sub>2</sub>), 4.52 (m, 2H, αCH & NH), 4.95 (d, <i>J</i> = 7.3 Hz, 1H, αCH), 5.04 (dd, <i>J</i> = 3.6, 10.5 Hz, 2H, OBn CH<sub>2</sub>), 6.82 (s, 3H, Ph & NH), 7.10–7.24 (m, 6H, Ph), 7.29–7.50 (m, 6H, Ph), 9.36 (s, 1H, CHO). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 29.66, 38.59, 43.67, 46.04, 54.52, 55.31, 59.49, 70.25, 97.62, 111.96, 121.04, 126.93, 127.55, 128.19, 128.55, 128.60, 128.73, 129.33, 129.43, 131.61, 136.52, 136.76, 156.39, 156.60, 171.89, 198.37. LC–MS: <i>t</i><sub>R</sub> = 3.76 min; C<sub>30</sub><sup>13</sup>CH<sub>36</sub>N<sub>4</sub>O<sub>4</sub><sup>+</sup> [M + H]<sup>+</sup>, <i>m</i>/<i>z</i> calcd 530.28, found 530.03.</div></div><div id="sec4_2_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> N-((2S)-1-(((3S)-2-hydroxychroman-3-yl-2-<sup>13</sup>C)amino)-1-oxo-3-phenylpropan-2-yl)-4-methylpiperazine-1-carboxamide (<b><sup>13</sup>C-labeled 12</b>)</h4><div class="NLM_p">The title compound was prepared from <b><i>S3h</i></b> (81 mg, 0.152 mmol, 1.0 eq) in a similar procedure as described for <b><i>S1b</i></b>. The obtained crude product was purified by Prep-HPLC to give <sup>13</sup>C-labeled compound <b>12</b> (45 mg, 67%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.28 (s, 1H, lactol OH), 2.45 (s, 3H, NCH<sub>3</sub>), 2.65 (p, <i>J</i> = 6.5 Hz, 4H, 2 × piperazinyl CH<sub>2</sub>), 3.03 (dt, <i>J</i> = 7.6, 21.2 Hz, 2H, <i>o</i>-Tyr βCH<sub>2</sub>), 3.40–3.60 (m, 4H, 2 x piperazinyl CH<sub>2</sub>), 4.21–4.40 (m, 1H, Phe βCH<sub>2</sub>), 4.64 (dq, <i>J</i> = 7.7, 46.1 Hz, 1H, Phe βCH<sub>2</sub>), 5.38 (dd, <i>J</i> = 30.9, 170.9 Hz, 1H, <i>o</i>-Tyr αCH), 6.16 (d, <i>J</i> = 8.0 Hz, 1H, Phe αCH), 6.50 (dd, <i>J</i> = 8.0, 141.5 Hz, 1H, lactol CH), 6.86–7.08 (m, 3H, Ph), 7.13 (dd, <i>J</i> = 3.0, 6.9 Hz, 1H, Ph), 7.20 (dt, <i>J</i> = 2.3, 6.5 Hz, 2H, Ph), 7.25 (d, <i>J</i> = 6.7 Hz, 2H, Ph), 7.71 (s, 2H, Ph & NH), 8.27 (s, 1H, NH). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>, scanned for only a few times) δ 91.69, 92.25. LC–MS: <i>t</i><sub>R</sub> = 2.77 min; C<sub>23</sub><sup>13</sup>CH<sub>31</sub>N<sub>4</sub>O<sub>4</sub><sup>+</sup> [M + H]<sup>+</sup>, <i>m</i>/<i>z</i> calcd 440.24, found 439.94.</div><div class="NLM_p last">In <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>, the preparation of <b><i>S4a</i></b> and <b><i>S4b</i></b> was similar to the procedures for <b><i>S1a</i></b> and <b><i>S1b</i></b>, respectively; the preparation of <b><i>S4d</i></b>, <b><i>S4e</i></b>, and <b><i>S4f</i></b> was similar to the procedures for <b><i>S3f</i></b>, <b><i>S3g,</i></b> and <b><i>S3h</i></b>, respectively. Therefore, only the preparation of <b><i>S4c</i></b> was described in detail as below.</div></div><div id="sec4_2_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 2-((tert-butoxycarbonyl)amino)-3-(2-oxo-1,2-dihydropyridin-3-yl)propanoic Acid (<b>S4c</b>)</h4><div class="NLM_p last">A mixed solution of <b><i>S4b</i></b> (1.18 g, 4.0 mmol, 1.0 eq) and LiOH (192 mg, 8.0 mmol, 2.0 eq) in MeOH (10 mL) and H<sub>2</sub>O (5 mL) was stirred at room temperature for 2 h. The reaction mixture was acidified by addition of 0.1 M HCl to pH 2–3 and then concentrated under reduced pressure. The residue was extracted with DCM (3 × 50 mL). The organic layers were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The obtained crude product <b><i>S4c</i></b> was used without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.39 (s, 9H, Boc), 2.86 (dd, <i>J</i> = 8.9, 14.0 Hz, 1H, βCH<sub>2</sub>), 3.11 (dd, <i>J</i> = 4.3, 13.9 Hz, 1H, βCH<sub>2</sub>), 4.42 (dd, <i>J</i> = 4.3, 8.8 Hz, 1H, αCH), 6.32 (t, <i>J</i> = 6.7 Hz, 1H, pyridine), 7.30 (dd, <i>J</i> = 2.0, 6.6 Hz, 1H, pyridine), 7.39–7.54 (m, 1H, pyridine).</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Enzyme Assays</h3><div class="NLM_p last">The preparation of cruzain and 3CL<sup>pro</sup> was described in previous publications.<a onclick="showRef(event, 'ref8 ref34'); return false;" href="javascript:void(0);" class="ref ref8 ref34">(8,34)</a> The evaluation of inhibitors was modified from our lab protocol and described briefly as follows.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> All enzyme assays were conducted in 96-well, clear bottom, black plates at 25 °C, and fluorescence emanating from product formation was measured using either a SpectraMax M2 (Molecular Devices) or a Synergy HTX (Biotek) microplate reader, with excitation at λ<sub>ex</sub> = 360 nm and emission at λ<sub>em</sub> = 460 nm. For evaluation of inhibitors that exhibited time-dependent time courses (“burst kinetics),” variable concentrations of inhibitor and a fixed concentration of substrate [typically, for cruzain: 10 μM Cbz-Phe-Arg-AMC (<i>K</i><sub>m</sub> = 0.9 μM), for 3CL<sup>pro</sup>: 40 μM ACC-SAVLQSGFRK(DNP)-NH<sub>2</sub> (<i>K</i><sub>m</sub> = 26 μM)] were first added into assay buffer [for cruzain: 50 mM MES (pH 7.5), 50 mM TAPSO, 1 mM CHAPS, 1 mM Na<sub>2</sub>EDTA, 5 mM DTT, and 10% DMSO (v/v); for 3CL<sup>pro</sup>: 20 mM Tris·HCl (pH 7.5), 150 mM NaCl, 0.1 mM EDTA-Na<sub>2</sub>, 2 mM DTT, and 10% DMSO (v/v)]. Reactions were started with addition of enzyme (typically, to a final concentration of 0.2 nM for cruzain or 40 nM for 3CL<sup>pro</sup>), and the time courses were recorded for 0.5–1 h. In a rapid dilution assay, 100X concentrations of the enzyme and inhibitor were preincubated for 1–2 h and then diluted by 100-fold into assay buffer containing standard concentrations of the substrates followed by data collection.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> <i>In Vitro</i> Cell Assays</h3><div class="NLM_p">BSF <i>T. b. brucei</i> strain SM427 was grown in HM1–9 medium that included fetal bovine serum (10%) and antibiotics (100 U/mL penicillin–streptomycin, Gibco). Inhibitors dissolved in 100% (v/v) DMSO stock solutions were added at final concentrations of 0.5–20 μM (final concentrations of DMSO were <1% (v/v)). <i>T. b. brucei</i> were seeded at ∼1 × 10<sup>6</sup> cells at 37 °C and diluted daily to maintain a log phase of growth for up to 96 h. Treated cells were typically grown for 4 days. After each dilution, the cell cultures were supplemented with inhibitor or DMSO (control) to keep concentrations constant. Cell density was determined and graphed as previously reported.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Trypanosomes were quantified using a Z2 Coulter Counter, and values of EC<sub>50</sub> were determined after 3–4 days of treatment by the interpolation method of Huber and Koella.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><div class="NLM_p"><i>T. cruzi</i> infection was evaluated in C2C12 murine cardiomyoblast cells. Three hundred and eighty four-microwell plates containing C2C12 murine cardiomyoblast cells were infected with 10<sup>3</sup> and 10<sup>4</sup> cells of <i>T. cruzi</i> (Ca-I/72), to which was added 3-fold serial dilutions of inhibitor with maximal concentrations of 40 μM followed by incubation at 37 °C for 2 days. The wells were fixed with 2% PFA in PBS and stained by 5 μg/mL of DAPI. After >30 min of incubation in a dark environment, the plates were read on an ImageXpress MicroXL microscope (Molecular Devices). The images were analyzed to quantify parasites as well host cells.</div><div class="NLM_p last">Evaluation of the anti-CoV-2 activity of compound <b>18</b> using human A549 cells transduced with the ACE2 viral receptor (A549/ACE2) was as described in our recent publication.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Evaluation of SMAI Prodrugs</h3><div class="NLM_p">Esterase from porcine liver was obtained as an ammonium sulfate suspension (Sigma-Aldrich, E2884, 10 U/μL). Compounds <b>13</b>–<b>15</b> in 100% (v/v) DMSO solutions were diluted by 10-fold into cruzain assay buffer to make 1 mL samples, each containing 2 mM compound. For the experimental sample, 4 μL of esterase suspension was added to the reaction mixtures (40 U/mL), which was immediately placed on a low-speed orbital shaker in a 37 °C incubator. In the meantime, a negative control (lacking esterase) and a blank control (buffer only) were included. Aliquots (140 μL) of the reaction mixtures were removed at 0, 15, 30, 60, 120, 180, and 300 min, and reaction mixtures were quenched by the addition of MeCN (260 μL). The resulting solution was vortexed followed by centrifugation to precipitate the protein, and the resulting compounds in the supernatant were analyzed by HPLC–MS with detection at 270 nm.</div><div class="NLM_p last">Commercially available CYPs 3A4, 2D6, and 2C9 (CypExpress; Sigma-Aldrich, MTOXCE3A4, MTOXCE3D6, and MTOXCE2C9) containing glucose-6-phosphate dehydrogenase (G6PDH) and Mg<sup>2+</sup> were used to evaluate the stability of acetal prodrugs to these oxidases. The following components were combined in 800 μL reaction mixtures: 0.5 mM <b>16</b> or <b>17</b>, 5 mM sodium glucose 6-phosphate, 2 mM NADP<sup>+</sup>, cruzain assay buffer (pH 7.5), and 2.5% DMSO (v/v). For the experimental samples, 64 mg of CypExpress P450 as a lyophilized powder was added to the reaction vial (80 mg/mL), which was gently shaken to dissolve the solid, and the mixtures were stirred at 30 °C in an incubator. Sample vials were capped loosely with aluminum foil to allow aeration as well as to reduce evaporation. Additionally, a negative control lacking CypExpress P450 and a blank control containing only buffer were included. Aliquots (65 μL) were removed from mixtures at 0, 30, 60, 120, 180, and 240 min, and reaction mixtures were quenched with the addition of MeCN (65 μL). The resulting solution was vortexed followed by centrifugation to precipitate the protein, and the resulting compounds in the supernatant were analyzed by HPLC–MS with detection at 270 nm.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 2D NMR Study</h3><div class="NLM_p last">Wilmad precision NMR tubes (541-PP-8, thin wall, 800 MHz, 5 mm × 8 inch) were used for this experiment. The total volume of sample in each tube was 660 μL, and the final concentrations of the components in the NMR buffer were as follows: 18 mM phosphate (K<sub>2</sub>HPO<sub>4</sub>/KH<sub>2</sub>PO<sub>4</sub>), 45 mM NaCl, 4.5 mM DTT, pH 7.5, and 10% DMSO-<i>d</i><sub>6</sub> (v/v). A 10 mM stock of <sup>13</sup>C-labeled <b>12</b> in DMSO-<i>d</i><sub>6</sub> was diluted into the NMR buffer to specified concentrations. A control sample contained 0.6 mM of <sup>13</sup>C-labeled <b>12</b>, and an experimental sample contained 0.4 mM of <sup>13</sup>C-labeled <b>12</b> and 0.44 mM of cruzain freshly purified by size exclusion chromatography, directly after thawing from a −80 °C stock to minimize autoproteolysis. Both samples were analyzed on a Bruker AVANCE III HD 800 MHz (18.8 Tesla) equipped with a 5 mm triple resonance cryoprobe. <sup>1</sup>H-<sup>13</sup>C HSQC NMR spectra were acquired at 25 °C with 72 scans for the enzyme-free control sample and 128 scans for the experimental sample containing cruzain. Spectral widths were obtained at 9615 and 28,179 Hz in the <sup>13</sup>C and <sup>1</sup>H dimensions, respectively. Spectra were processed using NMRpipe,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> and cross-peak intensities were analyzed using Sparky<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> and MestreNova.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Detection of Aldehyde Content Using Phenylhydrazine</h3><div class="NLM_p last">In a 96-well clear microplate, compounds <b>11</b> and <b>12</b> in DMSO solutions, or pure DMSO as a control, were diluted into the above NMR buffer without addition of DTT to make 250 μL samples, each containing 0.2 mM of compounds and 10% DMSO (v/v). Upon addition of 1 M phenylhydrazine (0.25 μL), the formation of phenylhydrazone in these wells was continuously monitored for 2 h by measuring UV absorbance at a maximal wavelength of 282 nm.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> X-ray Crystallography</h3><div class="NLM_p">The procedure of crystallization for the 3CL<sup>pro</sup>-<b>18</b> complex is based on the previous publication.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The crystals were obtained at 25 °C from 0.2 M ammonium phosphate dibasic, 17% w/v PEG3350, pH 8.0, with a protein concentration of 14 mg/mL. Soaking was performed to produce 3CL<sup>pro</sup>-<b>18</b> complex crystals. The crystals were washed three times with reservoir solution plus 0.5 mM inhibitor and 2% DMSO (Inhibitor was dissolved to 25 mM in 100% DMSO). The mixture was incubated at 25 °C for 48 h. The cryo-protectant solution contained mother liquor plus 30% glycerol, 0.5 mM inhibitor, and 2% DMSO. Cryo-protected crystals were fished for data collection.</div><div class="NLM_p last">The 3CL<sup>pro</sup>-<b>18</b> data were collected at 1.70 Å on a Rigaku R-AXIS IV++ image plate detector. Reflections were indexed, integrated, scaled, and merged to space group <i>I 1 2 1</i> using iMosflm.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The structure was solved by molecular replacement using the Phaser module of the Phenix package using a high-resolution structure of the apo SARS-CoV-2 3CL<sup>pro</sup> (PDB accession code: 6Y2E) as the search model.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43,44)</a> The atomic coordinates and geometric restraints for the inhibitor were generated in the CCP4 suite.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The inhibitor was built into the <i>F</i><sub>o</sub><i>–F</i><sub>c</sub> electron density omit maps using Coot.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Structural refinement was performed with the Real-space Refinement module of the Phenix package. Crystallographic data were summarized in <a href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_001.pdf" class="ext-link">Table S4</a>. All structural figures were generated with PyMOL (<a href="https://www.pymol.org" class="extLink">https://www.pymol.org</a>).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Molecular Modeling</h3><div class="NLM_p last">Docking studies of compound <b>2</b> binding to cruzain were carried out using the Schrödinger Suite program package. The receptor file (PDB accession code: 2OZ2) was processed using the Protein Preparation <i>Wizard</i> function, and the compound was energetically minimized by the LigPrep function. Noncovalent docking was executed and scored by the Glide module. For covalent docking, a cubic box of 18 Å<sup>3</sup> was set to encompass any simulated poses with <b>K777</b> as a reference ligand at its centroid. The SMARTS pattern for <b>2</b> was manually defined as [C;H1] = [O], and Cys<sub>25</sub> was checked as the reactive residue. The binding affinity was scored, and the best three poses were visually inspected.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Kinetic Data Analysis</h3><div class="NLM_p">All time-course data were fitted to <a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a>, wherein <i>P</i> is the fluorescence generated by formation of AMC or liberated ACC, <i>C</i> is the background constant, <i>v<sub>i</sub></i> and <i>v</i><sub>s</sub> are, respectively, initial-state and steady-state reaction rates, <i>t</i> is time, and <i>k</i><sub>obs</sub> is the observed rate of conversion of the initial inhibited rate to the final inhibited rate.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a><span class="NLM_disp-formula" id="eq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/medium/jm1c00628_m001.gif" alt="" id="_i58" /></img><span class="labelSpan">(1)</span></span></div><div class="NLM_p">Values of <i>k</i><sub>obs</sub> vs [<i>I</i>] were then replotted and fitted to <a class="ref internalNav" href="#eq2" aria-label="eq 2">eq 2</a>, wherein <i>k</i><sub>3</sub> and <i>k</i><sub>4</sub> represent the respective rates of formation and dissolution of the <b>EI*</b> complex as depicted in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A.<span class="NLM_disp-formula" id="eq2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/medium/jm1c00628_m002.gif" alt="" id="_i59" /></img><span class="labelSpan">(2)</span></span></div><div class="NLM_p">As described in the main text, the linearity of <i>k</i><sub>obs</sub> versus [<i>I</i>] of compounds <b>1</b> and <b>12</b> arises when <i>K<sub>i</sub></i> > > <i>K<sub>i</sub></i>*. Under these conditions, the concentration of inhibitor required to observe time-dependent inhibition would be much less than the value of <i>K<sub>i</sub></i> for the <b>EI</b> complex. In this case, <a class="ref internalNav" href="#eq2" aria-label="eq 2">eq 2</a> reduces to <a class="ref internalNav" href="#eq3" aria-label="eq 3">eq 3</a>, which is a linear function with a slope = <i>k</i><sub>4</sub>/<i>K<sub>i</sub></i>*<sup>app</sup> and an y-intercept = <i>k</i><sub>4</sub>. For the rapid dilution assay, [<i>I</i>] was fixed at 0.1 × <i>K<sub>i</sub></i>*<sup>app</sup> , and after dilution, <i>k</i><sub>4</sub> could be estimated as <i>k</i><sub>obs</sub>/1.1 according to <a class="ref internalNav" href="#eq3" aria-label="eq 3">eq 3</a>.<span class="NLM_disp-formula" id="eq3"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/medium/jm1c00628_m003.gif" alt="" id="_i60" /></img><span class="labelSpan">(3)</span></span></div><div class="NLM_p">Overall inhibition constants (<i>K<sub>i</sub></i>* values) were obtained by fitting <i>v</i><sub>s</sub>/<i>v</i><sub>0</sub> to <a class="ref internalNav" href="#eq4" aria-label="eq 4">eq 4</a>, wherein <i>v</i><sub>s</sub> and <i>v</i><sub>0</sub> are steady-state reaction rates in the presence and absence of the inhibitor, respectively, [<i>S</i>] and [<i>I</i>] represent the fixed concentration of the substrate and variable inhibitor, and <i>K</i><sub>m</sub> is the Michaelis constant of the substrate.<span class="NLM_disp-formula" id="eq4"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/medium/jm1c00628_m004.gif" alt="" id="_i61" /></img><span class="labelSpan">(4)</span></span></div><div class="NLM_p">As a tight-binding inhibitor, the <i>K<sub>i</sub></i>* values of <b>1</b> for cruzain and <b>18</b> for 3CL<sup>pro</sup> were obtained by fitting <i>v<sub>i</sub></i>/<i>v</i><sub>0</sub> data to <a class="ref internalNav" href="#eq5" aria-label="eq 5">eq 5</a> in which <i>v<sub>i</sub></i> and <i>v</i><sub>0</sub> are the initial rates obtained with or without the inhibitor, respectively, [<i>E</i>]<i><sub>t</sub></i>, [<i>I</i>]<i><sub>t</sub></i>, [<i>S</i>], <i>K<sub>i</sub></i>*, and <i>K</i><sub>m</sub>, are, respectively, concentrations of enzyme, inhibitor, and substrate, and <i>K<sub>i</sub></i>* and <i>K</i><sub>m</sub> are the inhibition and Michaelis constants, respectively.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a><span class="NLM_disp-formula" id="eq5"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/medium/jm1c00628_m005.gif" alt="" id="_i62" /></img><span class="labelSpan">(5)</span></span></div><div class="NLM_p">Rates of deacylation reactions of SMAI prodrugs <b>13</b>–<b>15</b> were obtained upon evaluation of the first-order loss of reagent as fitted to <a class="ref internalNav" href="#eq6" aria-label="eq 6">eq 6</a> in which <i>A</i><sub>0</sub> and <i>C</i> are the initial and final fraction of the unhydrolyzed compound, respectively, and <i>k</i> is the pseudo-first-order rate constant from which the half-life was <i>t</i><sub>1/2</sub> = ln(2)/<i>k</i>.<span class="NLM_disp-formula" id="eq6"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/medium/jm1c00628_m006.gif" alt="" id="_i63" /></img><span class="labelSpan">(6)</span></span></div><div id="sec4_10_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> PDB ID Code</h4><div class="NLM_p last">The cocrystal structure of 3CL<sup>pro</sup>-<b>18</b> is deposited in Protein Data Bank under the ID code 7M2P. Authors will release the atomic coordinates and experimental data upon article publication.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i65"><a href="/doi/suppl/10.1021/acs.jmedchem.1c00628" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15714" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15714" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.1c00628?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00628</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Kinetic parameters obtained from rapid dilution assays, details of peaks in <sup>1</sup>H-<sup>13</sup>C HSQC NMR, statistic summary of the cocrystal structure of 3CL<sup>pro</sup>-<b>18</b>, LC-MS of <sup>13</sup>C-labeled <b>12</b>, kinetic analysis of cruzain inhibition by <b>11</b> and <b>13</b>, growth curves for <i>T. b. brucei</i> BSFs, cell viability of <i>T. cruzi</i>-infected murine cardiomyoblasts, and NMR spectra of the synthesized compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Model coordinates for <b>2</b> bound to cruzain in its free aldehyde form (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_003.pdb" class="ext-link">PDB</a>) and its lactol form (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_004.pdb" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_001.pdf">jm1c00628_si_001.pdf (3.97 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_002.csv">jm1c00628_si_002.csv (1.89 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_003.pdb">jm1c00628_si_003.pdb (157.0 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_004.pdb">jm1c00628_si_004.pdb (149.06 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.1c00628" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36331" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36331" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas D. Meek</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Biophysics, Texas A&M
University, 300 Olsen Blvd, College Station, Texas 77843, United
States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-1931-8073" title="Orcid link">https://orcid.org/0000-0002-1931-8073</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#790d1d141c1c12390d18140c571c1d0c"><span class="__cf_email__" data-cfemail="cabeaea7afafa18abeaba7bfe4afaebf">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Linfeng Li</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Biophysics, Texas A&M
University, 300 Olsen Blvd, College Station, Texas 77843, United
States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0001-6185-4999" title="Orcid link">https://orcid.org/0000-0001-6185-4999</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bala C. Chenna</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Biophysics, Texas A&M
University, 300 Olsen Blvd, College Station, Texas 77843, United
States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-2660-5302" title="Orcid link">https://orcid.org/0000-0002-2660-5302</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kai S. Yang</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Texas A&M University, 580 Ross Street, College Station, Texas 77843, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-1890-4169" title="Orcid link">https://orcid.org/0000-0002-1890-4169</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Taylor R. Cole</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Biophysics, Texas A&M
University, 300 Olsen Blvd, College Station, Texas 77843, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zachary T. Goodall</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Biophysics, Texas A&M
University, 300 Olsen Blvd, College Station, Texas 77843, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Miriam Giardini</span> - <span class="hlFld-Affiliation affiliation">Skaggs
School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 9500 Gilman Dr, La Jolla, California 92093, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zahra Moghadamchargari</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Texas A&M University, 580 Ross Street, College Station, Texas 77843, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elizabeth A. Hernandez</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Biophysics, Texas A&M
University, 300 Olsen Blvd, College Station, Texas 77843, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jana Gomez</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Biophysics, Texas A&M
University, 300 Olsen Blvd, College Station, Texas 77843, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claudia M. Calvet</span> - <span class="hlFld-Affiliation affiliation">Skaggs
School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 9500 Gilman Dr, La Jolla, California 92093, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean A. Bernatchez</span> - <span class="hlFld-Affiliation affiliation">Skaggs
School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 9500 Gilman Dr, La Jolla, California 92093, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-8309-1627" title="Orcid link">https://orcid.org/0000-0002-8309-1627</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Drake M. Mellott</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Biophysics, Texas A&M
University, 300 Olsen Blvd, College Station, Texas 77843, United
States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-8043-8170" title="Orcid link">https://orcid.org/0000-0002-8043-8170</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiyun Zhu</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Biophysics, Texas A&M
University, 300 Olsen Blvd, College Station, Texas 77843, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew Rademacher</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Biophysics, Texas A&M
University, 300 Olsen Blvd, College Station, Texas 77843, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Diane Thomas</span> - <span class="hlFld-Affiliation affiliation">Skaggs
School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 9500 Gilman Dr, La Jolla, California 92093, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lauren R. Blankenship</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Texas A&M University, 580 Ross Street, College Station, Texas 77843, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aleksandra Drelich</span> - <span class="hlFld-Affiliation affiliation">Department
of Microbiology and Immunology, University
of Texas Medical Branch, 301 University Blvd, Galveston, Texas 77555, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arthur Laganowsky</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Texas A&M University, 580 Ross Street, College Station, Texas 77843, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0001-5012-5547" title="Orcid link">https://orcid.org/0000-0001-5012-5547</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chien-Te K. Tseng</span> - <span class="hlFld-Affiliation affiliation">Department
of Microbiology and Immunology, University
of Texas Medical Branch, 301 University Blvd, Galveston, Texas 77555, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wenshe R. Liu</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Biophysics, Texas A&M
University, 300 Olsen Blvd, College Station, Texas 77843, United
States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Texas A&M University, 580 Ross Street, College Station, Texas 77843, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">A. Joshua Wand</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Biophysics, Texas A&M
University, 300 Olsen Blvd, College Station, Texas 77843, United
States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0001-8341-0782" title="Orcid link">https://orcid.org/0000-0001-8341-0782</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jorge Cruz-Reyes</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Biophysics, Texas A&M
University, 300 Olsen Blvd, College Station, Texas 77843, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jair L. Siqueira-Neto</span> - <span class="hlFld-Affiliation affiliation">Skaggs
School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 9500 Gilman Dr, La Jolla, California 92093, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0001-9574-8174" title="Orcid link">https://orcid.org/0000-0001-9574-8174</a></span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i66">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21064" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21064" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Financial support for the research was provided by NIH grants R21 AI127634, R01 GM129076, and Texas A&M AgriLife Research.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">ACC</td><td class="NLM_def"><p class="first last">7-amino-4-carbamoylmethylcoumarin</p></td></tr><tr><td class="NLM_term">AMC</td><td class="NLM_def"><p class="first last">7-amino-4-methylcoumarin</p></td></tr><tr><td class="NLM_term">BSF</td><td class="NLM_def"><p class="first last">bloodstream form</p></td></tr><tr><td class="NLM_term">CES</td><td class="NLM_def"><p class="first last">carboxylesterase</p></td></tr><tr><td class="NLM_term">CHAPS</td><td class="NLM_def"><p class="first last">3-[3-(cholamidopropyl)dimethylammonio]-1-propanesulfonate</p></td></tr><tr><td class="NLM_term">CMBP</td><td class="NLM_def"><p class="first last">cyanomethylenetributylphosphorane</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">N,N-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">endoplasmic reticulum</p></td></tr><tr><td class="NLM_term">FCC</td><td class="NLM_def"><p class="first last">flash column chromatography</p></td></tr><tr><td class="NLM_term">hPhe</td><td class="NLM_def"><p class="first last">homophenylalanyl</p></td></tr><tr><td class="NLM_term">MES</td><td class="NLM_def"><p class="first last">2-(N-morpholino)ethanesulfonic acid</p></td></tr><tr><td class="NLM_term">NMePip</td><td class="NLM_def"><p class="first last">N-methlypiperazinyl</p></td></tr><tr><td class="NLM_term">SMAI</td><td class="NLM_def"><p class="first last">self-masked aldehyde inhibitor</p></td></tr><tr><td class="NLM_term">T3P</td><td class="NLM_def"><p class="first last">propylphosphonic anhydride</p></td></tr><tr><td class="NLM_term">TAPSO</td><td class="NLM_def"><p class="first last">3-[N-tris(hydroxymethyl)methylamino]-2-hydroxypropanesulfonic acid</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i68">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20715" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20715" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 48 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bedard, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semler, B. L.</span></span> <span> </span><span class="NLM_article-title">Regulation of picornavirus gene expression</span>. <i>Microbes Infect.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">702</span>– <span class="NLM_lpage">713</span>, <span class="refDoi"> DOI: 10.1016/j.micinf.2004.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1016%2Fj.micinf.2004.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=15158778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktF2qsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=702-713&author=K.+M.+Bedardauthor=B.+L.+Semler&title=Regulation+of+picornavirus+gene+expression&doi=10.1016%2Fj.micinf.2004.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of picornavirus gene expression</span></div><div class="casAuthors">Bedard, Kristin M.; Semler, Bert L.</div><div class="citationInfo"><span class="NLM_cas:title">Microbes and Infection</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">702-713</span>CODEN:
                <span class="NLM_cas:coden">MCINFS</span>;
        ISSN:<span class="NLM_cas:issn">1286-4579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Members of the Picornaviridae are pos.- strand RNA viruses that cause a variety of human diseases such as poliomyelitis, the common cold, myocarditis, and hepatitis.  Although the diseases caused by picornaviruses are diverse, the genome organization and mechanisms of gene expression are highly conserved among family members.  This review will discuss the mechanisms of viral gene expression including cap-independent translation initiation, host cell translation shut off, viral polyprotein processing, and RNA replication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcHzQce4AM9rVg90H21EOLACvtfcHk0likNbKqT3DNjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktF2qsb8%253D&md5=f2162a6027d95bfac299842da74e26c3</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.micinf.2004.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.micinf.2004.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DBedard%26aufirst%3DK.%2BM.%26aulast%3DSemler%26aufirst%3DB.%2BL.%26atitle%3DRegulation%2520of%2520picornavirus%2520gene%2520expression%26jtitle%3DMicrobes%2520Infect.%26date%3D2004%26volume%3D6%26spage%3D702%26epage%3D713%26doi%3D10.1016%2Fj.micinf.2004.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morse, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalonde, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W. R.</span></span> <span> </span><span class="NLM_article-title">Learning from the past: Possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">730</span>– <span class="NLM_lpage">738</span>, <span class="refDoi"> DOI: 10.1002/cbic.202000047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1002%2Fcbic.202000047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=32022370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjs1ans74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2020&pages=730-738&author=J.+S.+Morseauthor=T.+Lalondeauthor=S.+Xuauthor=W.+R.+Liu&title=Learning+from+the+past%3A+Possible+urgent+prevention+and+treatment+options+for+severe+acute+respiratory+infections+caused+by+2019-nCoV&doi=10.1002%2Fcbic.202000047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV</span></div><div class="casAuthors">Morse, Jared S.; Lalonde, Tyler; Xu, Shiqing; Liu, Wenshe Ray</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">730-738</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  With the current trajectory of the 2019-nCoV outbreak unknown, public health and medicinal measures will both be needed to contain spreading of the virus and to optimize patient outcomes.  Although little is known about the virus, an examn. of the genome sequence shows strong homol. with its better-studied cousin, SARS-CoV.  The spike protein used for host cell infection shows key nonsynonymous mutations that might hamper the efficacy of previously developed therapeutics but remains a viable target for the development of biologics and macrocyclic peptides.  Other key drug targets, including RNA-dependent RNA polymerase and coronavirus main proteinase (3CLpro), share a strikingly high (>95 %) homol. to SARS-CoV.  Herein, we suggest four potential drug candidates (an ACE2-based peptide, remdesivir, 3CLpro-1 and a novel vinylsulfone protease inhibitor) that could be used to treat patients suffering with the 2019-nCoV.  We also summarize previous efforts into drugging these targets and hope to help in the development of broad-spectrum anti-coronaviral agents for future epidemics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQKe18V4rt9rVg90H21EOLACvtfcHk0likNbKqT3DNjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjs1ans74%253D&md5=57c88df2259222d0a25a545493c66630</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2Fcbic.202000047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.202000047%26sid%3Dliteratum%253Aachs%26aulast%3DMorse%26aufirst%3DJ.%2BS.%26aulast%3DLalonde%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DW.%2BR.%26atitle%3DLearning%2520from%2520the%2520past%253A%2520Possible%2520urgent%2520prevention%2520and%2520treatment%2520options%2520for%2520severe%2520acute%2520respiratory%2520infections%2520caused%2520by%25202019-nCoV%26jtitle%3DChemBioChem%26date%3D2020%26volume%3D21%26spage%3D730%26epage%3D738%26doi%3D10.1002%2Fcbic.202000047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steele-Mortimer, O.</span></span> <span> </span><span class="NLM_article-title">Exploitation of the ubiquitin system by invading bacteria</span>. <i>Traffic</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">162</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1111/j.1600-0854.2010.01137.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1111%2Fj.1600-0854.2010.01137.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=20977569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlSmsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=162-169&author=O.+Steele-Mortimer&title=Exploitation+of+the+ubiquitin+system+by+invading+bacteria&doi=10.1111%2Fj.1600-0854.2010.01137.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Exploitation of the ubiquitin system by invading bacteria</span></div><div class="casAuthors">Steele-Mortimer, Olivia</div><div class="citationInfo"><span class="NLM_cas:title">Traffic (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">162-169</span>CODEN:
                <span class="NLM_cas:coden">TRAFFA</span>;
        ISSN:<span class="NLM_cas:issn">1398-9219</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  A variety of bacterial intracellular pathogens target the host cell ubiquitin system during invasion, a process that involves transient but fundamental changes in the actin cytoskeleton and plasma membrane.  These changes are induced by bacterial proteins, which can be surface assocd., secreted or injected directly into the host cell.  Here, the invasion strategies of two extensively studied intracellular bacteria, Salmonella enterica serovar Typhimurium and Listeria monocytogenes, are used to illustrate some of the diverse ways by which bacterial pathogens intersect the host cell ubiquitin pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMJbYtp7Q8fLVg90H21EOLACvtfcHk0ljIech64rRIkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlSmsr8%253D&md5=379eaeeef6ea69e421739734d02df0b9</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0854.2010.01137.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0854.2010.01137.x%26sid%3Dliteratum%253Aachs%26aulast%3DSteele-Mortimer%26aufirst%3DO.%26atitle%3DExploitation%2520of%2520the%2520ubiquitin%2520system%2520by%2520invading%2520bacteria%26jtitle%3DTraffic%26date%3D2011%26volume%3D12%26spage%3D162%26epage%3D169%26doi%3D10.1111%2Fj.1600-0854.2010.01137.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sajid, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span> <span> </span><span class="NLM_article-title">Cysteine proteases of parasitic organisms</span>. <i>Mol. Biochem. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1016/S0166-6851(01)00438-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1016%2FS0166-6851%2801%2900438-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=11849701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BD38Xht1agsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2002&pages=1-21&author=M.+Sajidauthor=J.+H.+McKerrow&title=Cysteine+proteases+of+parasitic+organisms&doi=10.1016%2FS0166-6851%2801%2900438-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cysteine proteases of parasitic organisms</span></div><div class="casAuthors">Sajid, M.; McKerrow, J. H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Biochemical Parasitology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-21</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Cysteine proteases play numerous indispensable roles in the biol. of parasitic organisms.  Aside from previously known general catabolic functions and protein processing, cysteine proteases may be key to parasite immunoevasion, excystment/encystment, exsheathing and cell and tissue invasion.  Parasite cysteine proteases are unusually immunogenic and have been exploited as serodiagnostic markers and vaccine targets.  Although host homologues exist, parasite cysteine proteases have distinct structural and biochem. properties including, pH optima and stability, the alteration in peptide loops or domain extensions, diverse substrate specificity and cellular location.  The disparate nature of parasite cysteine protease compared to the host orthologous proteins has opened opportunities for chemotherapy.  This review will highlight recent research on the 'papain-like' class of cysteine proteases, the most abundant family, and the newly discovered class of asparaginyl-endopeptidases.  Cysteine protease classification will be re-examd. in light of the diversity uncovered within parasitic organisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxpzi_yram6LVg90H21EOLACvtfcHk0ljIech64rRIkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xht1agsbo%253D&md5=6fdd0c0a83d2a50fab6adbeb158d3d96</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0166-6851%2801%2900438-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-6851%252801%252900438-8%26sid%3Dliteratum%253Aachs%26aulast%3DSajid%26aufirst%3DM.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26atitle%3DCysteine%2520proteases%2520of%2520parasitic%2520organisms%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D2002%26volume%3D120%26spage%3D1%26epage%3D21%26doi%3D10.1016%2FS0166-6851%2801%2900438-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rassi, A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rassi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcondes de Rezende, J.</span></span> <span> </span><span class="NLM_article-title">American trypanosomiasis (Chagas disease)</span>. <i>Infect. Dis. Clin. North Am.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">291</span>, <span class="refDoi"> DOI: 10.1016/j.idc.2012.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1016%2Fj.idc.2012.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=22632639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A280%3ADC%252BC38nmtlOltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=275-291&author=A.+Rassiauthor=A.+Rassiauthor=J.+Marcondes+de+Rezende&title=American+trypanosomiasis+%28Chagas+disease%29&doi=10.1016%2Fj.idc.2012.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">American trypanosomiasis (Chagas disease)</span></div><div class="casAuthors">Rassi Anis Jr; Rassi Anis; Marcondes de Rezende Joffre</div><div class="citationInfo"><span class="NLM_cas:title">Infectious disease clinics of North America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-91</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Chagas disease, also known as American trypanosomiasis, is a chronic infection caused by Trypanosoma cruzi, a protozoan parasite.  It is transmitted to human beings mainly through the feces of infected triatomine bugs.  The disease affects an estimated 8 to 10 million people in the Americas, putting them at risk of developing life-threatening cardiac and gastrointestinal complications.  This article provides a brief update on the epidemiology, clinical manifestations, diagnosis, and treatment of Chagas disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRJzahk2B7NOeRS7coPn-RtfW6udTcc2eYO392BxOd5bbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38nmtlOltA%253D%253D&md5=ef2274a813974a0cf8a7995a06ef1b71</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.idc.2012.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.idc.2012.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DRassi%26aufirst%3DA.%26aulast%3DRassi%26aufirst%3DA.%26aulast%3DMarcondes%2Bde%2BRezende%26aufirst%3DJ.%26atitle%3DAmerican%2520trypanosomiasis%2520%2528Chagas%2520disease%2529%26jtitle%3DInfect.%2520Dis.%2520Clin.%2520North%2520Am.%26date%3D2012%26volume%3D26%26spage%3D275%26epage%3D291%26doi%3D10.1016%2Fj.idc.2012.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Branquinha, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangenito, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodre, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kneipp, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">d’Avila-Levy, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, A. L. S.</span></span> <span> </span><span class="NLM_article-title">Cruzipain: An update on its potential as chemotherapy target against the human pathogen trypanosoma cruzi</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2225</span>– <span class="NLM_lpage">2235</span>, <span class="refDoi"> DOI: 10.2174/0929867322666150521091652</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.2174%2F0929867322666150521091652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=25994861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFWls7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=2225-2235&author=M.+H.+Branquinhaauthor=S.+S.+Oliveiraauthor=L.+S.+Sangenitoauthor=C.+L.+Sodreauthor=L.+F.+Kneippauthor=C.+M.+d%E2%80%99Avila-Levyauthor=A.+L.+S.+Santos&title=Cruzipain%3A+An+update+on+its+potential+as+chemotherapy+target+against+the+human+pathogen+trypanosoma+cruzi&doi=10.2174%2F0929867322666150521091652"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Cruzipain: An Update on its Potential as Chemotherapy Target against the Human Pathogen Trypanosoma cruzi</span></div><div class="casAuthors">Branquinha, M. H.; Oliveira, S. S. C.; Sangenito, L. S.; Sodre, C. L.; Kneipp, L. F.; d'Avila-Levy, C. M.; Santos, A. L. S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2225-2235</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Chagas' disease is one of the most impactful and prevalent neglected tropical diseases in the Americas, specially affecting the poor and underdeveloped areas in Latin America.  Aggravating this scenario, the medicines used in the current chemotherapy are old, toxic and present a low efficacy to treat the chronic stage of this disease.  In addn., resistant strains of Trypanosoma cruzi, the etiol. agent, are frequently reported.  So, there is an imperative requirement for novel chemotherapeutic options to treat this debilitating disease.  In this context, peptidases have emerged as potential targets and, consequently, proteolytic inhibitors have confirmed to be valuable drugs against several human pathologies.  In this line of thinking, T. cruzi produces a major multifunctional cysteine peptidase, named cruzipain, which directly and/or indirectly orchestrates several physiol. and pathol. processes, which culminate in a successful parasitic infection.  Taken together, these findings point out that cruzipain is one of the most important targets for driving a chemotherapy approach against the human pathogen T. cruzi.  The present review summarizes some of the recent advances and failures in this area, with particular emphasis on recently published studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvrikftkPpfrVg90H21EOLACvtfcHk0ljIech64rRIkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFWls7jE&md5=c152a7e35be17861d2f0cf228d42d6f4</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F0929867322666150521091652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867322666150521091652%26sid%3Dliteratum%253Aachs%26aulast%3DBranquinha%26aufirst%3DM.%2BH.%26aulast%3DOliveira%26aufirst%3DS.%2BS.%26aulast%3DSangenito%26aufirst%3DL.%2BS.%26aulast%3DSodre%26aufirst%3DC.%2BL.%26aulast%3DKneipp%26aufirst%3DL.%2BF.%26aulast%3Dd%25E2%2580%2599Avila-Levy%26aufirst%3DC.%2BM.%26aulast%3DSantos%26aufirst%3DA.%2BL.%2BS.%26atitle%3DCruzipain%253A%2520An%2520update%2520on%2520its%2520potential%2520as%2520chemotherapy%2520target%2520against%2520the%2520human%2520pathogen%2520trypanosoma%2520cruzi%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2015%26volume%3D22%26spage%3D2225%26epage%3D2235%26doi%3D10.2174%2F0929867322666150521091652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roush, W. R.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the synthesis, design and selection of cysteine protease inhibitors</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">459</span>– <span class="NLM_lpage">465</span>, <span class="refDoi"> DOI: 10.1016/S1367-5931(02)00345-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1016%2FS1367-5931%2802%2900345-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=12133721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsVyjtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2002&pages=459-465&author=A.+A.+Hernandezauthor=W.+R.+Roush&title=Recent+advances+in+the+synthesis%2C+design+and+selection+of+cysteine+protease+inhibitors&doi=10.1016%2FS1367-5931%2802%2900345-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the synthesis, design and selection of cysteine protease inhibitors</span></div><div class="casAuthors">Hernandez, Alejandro Alvarez; Roush, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">459-465</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Inhibition of cysteine proteases is emerging as an important strategy for the treatment of a variety of human diseases.  Intense efforts involving structure-based inhibitor design have been directed toward several cysteine proteases, including cathepsin K, calpain, human rhinovirus 3C protease and several parasitic cysteine protease targets.  Other successful recent efforts have involved combinatorial synthesis and screening for identification of new inhibitor templates.  Inhibition of cysteine proteases is emerging as an important strategy for the treatment of a variety of human diseases.  Successful recent efforts have included combinatorial synthesis and compd. screening for identification of new inhibitor templates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE_foTSFvfeLVg90H21EOLACvtfcHk0lgn1-DvdOTCrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsVyjtbY%253D&md5=b3a8ab70cbd42dd3f1f9fbdb0bed841b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS1367-5931%2802%2900345-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1367-5931%252802%252900345-9%26sid%3Dliteratum%253Aachs%26aulast%3DHernandez%26aufirst%3DA.%2BA.%26aulast%3DRoush%26aufirst%3DW.%2BR.%26atitle%3DRecent%2520advances%2520in%2520the%2520synthesis%252C%2520design%2520and%2520selection%2520of%2520cysteine%2520protease%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2002%26volume%3D6%26spage%3D459%26epage%3D465%26doi%3D10.1016%2FS1367-5931%2802%2900345-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mellott, D.</span>; <span class="NLM_string-name">Tseng, C. T.</span>; <span class="NLM_string-name">Drelich, A.</span>; <span class="NLM_string-name">Fajtova, P.</span>; <span class="NLM_string-name">Chenna, B. C.</span>; <span class="NLM_string-name">Kostomiris, D.</span>; <span class="NLM_string-name">Hsu, J. C.</span>; <span class="NLM_string-name">Zhu, J.</span>; <span class="NLM_string-name">Taylor, Z.</span>; <span class="NLM_string-name">Tat, V.</span>; <span class="NLM_string-name">Katzfuss, A.</span>; <span class="NLM_string-name">Li, L.</span>; <span class="NLM_string-name">Giardini, M. A.</span>; <span class="NLM_string-name">Skinner, D.</span>; <span class="NLM_string-name">Hirata, K.</span>; <span class="NLM_string-name">Beck, S.</span>; <span class="NLM_string-name">Carlin, A. F.</span>; <span class="NLM_string-name">Clark, A. E.</span>; <span class="NLM_string-name">Berreta, L.</span>; <span class="NLM_string-name">Maneval, D.</span>; <span class="NLM_string-name">Frueh, F.</span>; <span class="NLM_string-name">Hurst, B. L.</span>; <span class="NLM_string-name">Wang, H.</span>; <span class="NLM_string-name">Kocurek, K. I.</span>; <span class="NLM_string-name">Raushel, F. M.</span>; <span class="NLM_string-name">O’Donoghue, A.</span>; <span class="NLM_string-name">Siqueira-Neto, J. L.</span>; <span class="NLM_string-name">Meek, T. D.</span>; <span class="NLM_string-name">McKerrow, J. H.</span></span> <i>A cysteine protease inhibitor blocks SARS-CoV-2 infection of human and monkey cells</i>. <span class="NLM_publisher-name">bioRxiv</span> <span class="NLM_year">2020</span>, 2020.10.23.347534, <span class="refDoi"> DOI: 10.1101/2020.10.23.347534</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1101%2F2020.10.23.347534" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=D.+Mellott&author=C.+T.+Tseng&author=A.+Drelich&author=P.+Fajtova&author=B.+C.+Chenna&author=D.+Kostomiris&author=J.+C.+Hsu&author=J.+Zhu&author=Z.+Taylor&author=V.+Tat&author=A.+Katzfuss&author=L.+Li&author=M.+A.+Giardini&author=D.+Skinner&author=K.+Hirata&author=S.+Beck&author=A.+F.+Carlin&author=A.+E.+Clark&author=L.+Berreta&author=D.+Maneval&author=F.+Frueh&author=B.+L.+Hurst&author=H.+Wang&author=K.+I.+Kocurek&author=F.+M.+Raushel&author=A.+O%E2%80%99Donoghue&author=J.+L.+Siqueira-Neto&author=T.+D.+Meek&author=J.+H.+McKerrow&title=A+cysteine+protease+inhibitor+blocks+SARS-CoV-2+infection+of+human+and+monkey+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1101%2F2020.10.23.347534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1101%252F2020.10.23.347534%26sid%3Dliteratum%253Aachs%26aulast%3DMellott%26aufirst%3DD.%26btitle%3DA%2520cysteine%2520protease%2520inhibitor%2520blocks%2520SARS-CoV-2%2520infection%2520of%2520human%2520and%2520monkey%2520cells%26pub%3DbioRxiv%26date%3D2020%26doi%3D10.1101%2F2020.10.23.347534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gampe, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, V. A.</span></span> <span> </span><span class="NLM_article-title">Curse or cure? A perspective on the developability of aldehydes as active pharmaceutical ingredients</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">14357</span>– <span class="NLM_lpage">14381</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c01177</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c01177" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvVWhs7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=14357-14381&author=C.+Gampeauthor=V.+A.+Verma&title=Curse+or+cure%3F+A+perspective+on+the+developability+of+aldehydes+as+active+pharmaceutical+ingredients&doi=10.1021%2Facs.jmedchem.0c01177"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Curse or Cure? A Perspective on the Developability of Aldehydes as Active Pharmaceutical Ingredients</span></div><div class="casAuthors">Gampe, Christian; Verma, Vishal A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">14357-14381</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  There is a dichotomy between the increasing utility of aldehydes as tool mols. that bind to "undruggable" protein sites and the designation of the aldehyde functional group as a structural alert by the medicinal chem. community.  Herein we compile information about pharmacol. active aldehydes that are being used in humans.  We summarize the learnings from these data, discuss advantages and challenges assocd. with aldehydes, and derive strategies for the successful development of aldehydes within drug discovery programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppz1oqp1WGV7Vg90H21EOLACvtfcHk0lgn1-DvdOTCrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvVWhs7vE&md5=4696123fdaba8f20895bb11f2b78ff84</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c01177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c01177%26sid%3Dliteratum%253Aachs%26aulast%3DGampe%26aufirst%3DC.%26aulast%3DVerma%26aufirst%3DV.%2BA.%26atitle%3DCurse%2520or%2520cure%253F%2520A%2520perspective%2520on%2520the%2520developability%2520of%2520aldehydes%2520as%2520active%2520pharmaceutical%2520ingredients%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D14357%26epage%3D14381%26doi%3D10.1021%2Facs.jmedchem.0c01177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bandyopadhyay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span> <span> </span><span class="NLM_article-title">Targeting biomolecules with reversible covalent chemistry</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">110</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2016.08.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1016%2Fj.cbpa.2016.08.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=27599186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVOqtrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=110-116&author=A.+Bandyopadhyayauthor=J.+Gao&title=Targeting+biomolecules+with+reversible+covalent+chemistry&doi=10.1016%2Fj.cbpa.2016.08.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting biomolecules with reversible covalent chemistry</span></div><div class="casAuthors">Bandyopadhyay, Anupam; Gao, Jianmin</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">110-116</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Interaction of biomols. typically proceeds in a highly selective and reversible manner, for which covalent bond formation has been largely avoided due to the potential difficulty of dissocn.  However, employing reversible covalent warheads in drug design has given rise to covalent enzyme inhibitors that serve as powerful therapeutics, as well as mol. probes with exquisite target selectivity.  This review article summarizes the recent advances in the development of reversible covalent chem. for biol. and medicinal applications.  Specifically, we document the chem. strategies that allow for reversible modification of the three major classes of nucleophiles in biol.: thiols, alcs. and amines.  Emphasis is given to the chem. mechanisms that underlie the development of these reversible covalent reactions and their utilization in biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUElo9YTpOWrVg90H21EOLACvtfcHk0lhUI7Dfxr_PYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVOqtrrE&md5=1294e2befed2127ceec6a7e7ae0dd2f3</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2016.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2016.08.011%26sid%3Dliteratum%253Aachs%26aulast%3DBandyopadhyay%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DJ.%26atitle%3DTargeting%2520biomolecules%2520with%2520reversible%2520covalent%2520chemistry%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D34%26spage%3D110%26epage%3D116%26doi%3D10.1016%2Fj.cbpa.2016.08.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinen, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lange, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grisostomi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weston, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallai, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartsough, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMakin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilton, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldino, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span> <span> </span><span class="NLM_article-title">Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in chagas disease</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2141</span>– <span class="NLM_lpage">2156</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2004.12.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1016%2Fj.bmc.2004.12.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=15727867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsFSjtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=2141-2156&author=Y.+Choeauthor=L.+S.+Brinenauthor=M.+S.+Priceauthor=J.+C.+Engelauthor=M.+Langeauthor=C.+Grisostomiauthor=S.+G.+Westonauthor=P.+V.+Pallaiauthor=H.+Chengauthor=L.+W.+Hardyauthor=D.+S.+Hartsoughauthor=M.+McMakinauthor=R.+F.+Tiltonauthor=C.+M.+Baldinoauthor=C.+S.+Craik&title=Development+of+alpha-keto-based+inhibitors+of+cruzain%2C+a+cysteine+protease+implicated+in+chagas+disease&doi=10.1016%2Fj.bmc.2004.12.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Development of α-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease</span></div><div class="casAuthors">Choe, Youngchool; Brinen, Linda S.; Price, Mark S.; Engel, Juan C.; Lange, Meinolf; Grisostomi, Corinna; Weston, Scott G.; Pallai, Peter V.; Cheng, Hong; Hardy, Larry W.; Hartsough, David S.; McMakin, Marsha; Tilton, Robert F.; Baldino, Carmen M.; Craik, Charles S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2141-2156</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Trypanosoma cruzi, a protozoan parasite, is the causative agent of Chagas disease, a major cause of cardiovascular disease in many Latin American countries.  There is an urgent need to develop an improved therapy due to the toxicity of existing drugs and emerging drug resistance.  Cruzain, the primary cysteine protease of T. cruzi, is essential for the survival of the parasite in host cells and therefore is an important target for the development of inhibitors as potential therapeutics.  A novel series of α-ketoamide-, α-keto acid-, α-keto ester-, and aldehyde-based inhibitors of cruzain has been developed.  The inhibitors were identified by screening protease targeted small mol. libraries and systematically optimizing the P1, P2, P3, and P1' residues using specific structure-guided methods.  A total of 20 compds. displayed picomolar potency in in vitro assays and three inhibitors representing different α-keto-based inhibitor scaffolds demonstrated anti-trypanosomal activity in cell culture.  A 2.3 Å crystallog. structure of cruzain bound with one of the α-ketoester analogs is also reported.  The structure and kinetic assay data illustrate the covalent binding, reversible inhibition mechanism of the inhibitor.  Information on the compds. reported here will be useful in the development of new lead compds. as potential therapeutic agents for the treatment of Chagas disease and as biol. probes to study the role that cruzain plays in the pathol.  This study also demonstrates the validity of structure-guided approaches to focused library design and lead compd. optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOi1yF-Og77LVg90H21EOLACvtfcHk0lhUI7Dfxr_PYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsFSjtrg%253D&md5=b91651cf2c66921b1fc98e6cabd67dfe</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2004.12.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2004.12.053%26sid%3Dliteratum%253Aachs%26aulast%3DChoe%26aufirst%3DY.%26aulast%3DBrinen%26aufirst%3DL.%2BS.%26aulast%3DPrice%26aufirst%3DM.%2BS.%26aulast%3DEngel%26aufirst%3DJ.%2BC.%26aulast%3DLange%26aufirst%3DM.%26aulast%3DGrisostomi%26aufirst%3DC.%26aulast%3DWeston%26aufirst%3DS.%2BG.%26aulast%3DPallai%26aufirst%3DP.%2BV.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DHardy%26aufirst%3DL.%2BW.%26aulast%3DHartsough%26aufirst%3DD.%2BS.%26aulast%3DMcMakin%26aufirst%3DM.%26aulast%3DTilton%26aufirst%3DR.%2BF.%26aulast%3DBaldino%26aufirst%3DC.%2BM.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26atitle%3DDevelopment%2520of%2520alpha-keto-based%2520inhibitors%2520of%2520cruzain%252C%2520a%2520cysteine%2520protease%2520implicated%2520in%2520chagas%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D2141%26epage%3D2156%26doi%3D10.1016%2Fj.bmc.2004.12.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scheidt, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roush, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selzer, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, P. J.</span></span> <span> </span><span class="NLM_article-title">Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">2477</span>– <span class="NLM_lpage">2494</span>, <span class="refDoi"> DOI: 10.1016/S0968-0896(98)80022-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1016%2FS0968-0896%2898%2980022-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=9925304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADyaK1MXjvVKitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=2477-2494&author=K.+A.+Scheidtauthor=W.+R.+Roushauthor=J.+H.+McKerrowauthor=P.+M.+Selzerauthor=E.+Hansellauthor=P.+J.+Rosenthal&title=Structure-based+design%2C+synthesis+and+evaluation+of+conformationally+constrained+cysteine+protease+inhibitors&doi=10.1016%2FS0968-0896%2898%2980022-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors</span></div><div class="casAuthors">Scheidt, Karl A.; Roush, William R.; McKerrow, James H.; Selzer, Paul M.; Hansell, Elizabeth; Rosenthal, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2477-2494</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The inhibition of cysteine proteases is being studied as a strategy to combat parasitic diseases such as Chagas' disease, leishmaniasis, and malaria.  Cruzain is the major cysteine protease of Trypanosoma cruzi, the etiol. agent of Chagas' disease.  A crystal structure of cruzain, covalently inactivated by fluoromethyl ketone inhibitor, Cbz-Phe-NHCH(Me)COCH2F, was used as a template to design potential inhibitors.  Conformationally constrained γ-lactams contg. electrophilic aldehyde (I; R = H, CH2CH2Ph) and vinyl sulfone (II; R = Me, CH2CH2Ph) units were synthesized.  Constrained lactam III had IC50 value of ca. 20 nM against the Leishmania major protease and ca. 50 nM against falcipain, an important cysteine protease isolated from Plasmodium falciparum.  However, all of the conformationally constrained inhibitors were weak inhibitors of cruzain, compared to unconstrained peptide aldehyde, Cbz-Phe-NHCH(Me)CHO, and vinyl sulfone inhibitors [e.g. IV, which proved to be an excellent inhibitor of cruzain with an apparent second order inhibition rate const. (kintact/Ki) of 634,000 s-1M-1].  A significant redn. in activity was also obsd. with acyclic inhibitors, such as V and VI, which contain phenylalanine residues at the P2 position.  These data indicate that the pyrrolidinone ring, esp. the quaternary center at P2, interferes with the normal substrate binding mode with cruzain, but not with falcipain or the leishmania protease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz-tdVgayNd7Vg90H21EOLACvtfcHk0lhUI7Dfxr_PYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvVKitQ%253D%253D&md5=9c136c9397df677ac3125aa297cd86fd</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2898%2980022-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252898%252980022-9%26sid%3Dliteratum%253Aachs%26aulast%3DScheidt%26aufirst%3DK.%2BA.%26aulast%3DRoush%26aufirst%3DW.%2BR.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DSelzer%26aufirst%3DP.%2BM.%26aulast%3DHansell%26aufirst%3DE.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26atitle%3DStructure-based%2520design%252C%2520synthesis%2520and%2520evaluation%2520of%2520conformationally%2520constrained%2520cysteine%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1998%26volume%3D6%26spage%3D2477%26epage%3D2494%26doi%3D10.1016%2FS0968-0896%2898%2980022-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silva, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro, J. F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vita, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freitas-Junior, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraes, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocha, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burtoloso, A. C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenny, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leitão, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montanari, C. A.</span></span> <span> </span><span class="NLM_article-title">A comparative study of warheads for design of cysteine protease inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">5031</span>– <span class="NLM_lpage">5035</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1016%2Fj.bmcl.2017.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=29054358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1yjsL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=5031-5035&author=D.+G.+Silvaauthor=J.+F.+R.+Ribeiroauthor=D.+de+Vitaauthor=L.+Cianniauthor=C.+H.+Francoauthor=L.+H.+Freitas-Juniorauthor=C.+B.+Moraesauthor=J.+R.+Rochaauthor=A.+C.+B.+Burtolosoauthor=P.+W.+Kennyauthor=A.+Leit%C3%A3oauthor=C.+A.+Montanari&title=A+comparative+study+of+warheads+for+design+of+cysteine+protease+inhibitors&doi=10.1016%2Fj.bmcl.2017.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A comparative study of warheads for design of cysteine protease inhibitors</span></div><div class="casAuthors">Silva, Daniel G.; Ribeiro, Jean F. R.; De Vita, Daniela; Cianni, Lorenzo; Franco, Caio Haddad; Freitas-Junior, Lucio H.; Moraes, Carolina Borsoi; Rocha, Josmar R.; Burtoloso, Antonio C. B.; Kenny, Peter W.; Leitao, Andrei; Montanari, Carlos A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5031-5035</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The effects on potency of cruzain inhibition of replacing a nitrile group with alternative warheads were explored.  The oxime was almost an order of magnitude more potent than the corresponding nitrile and has the potential to provide access to the prime side of the catalytic site.  Dipeptide aldehydes and azadipeptide nitriles were found to be two orders of magnitude more potent cruzain inhibitors than the corresponding dipeptide nitriles although potency differences were modulated by substitution at P1 and P3.  Replacement of the α methylene of a dipeptide aldehyde with cyclopropane led to a loss of potency of almost three orders of magnitude.  The vinyl esters and amides that were characterized as reversible inhibitors were less potent than the corresponding nitrile by between one and two orders of magnitude.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1EsVPrEhve7Vg90H21EOLACvtfcHk0lgLEzpSJgoBPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1yjsL%252FI&md5=0e2c0c2f3bc188bd43e05c14a1b8d963</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DSilva%26aufirst%3DD.%2BG.%26aulast%3DRibeiro%26aufirst%3DJ.%2BF.%2BR.%26aulast%3Dde%2BVita%26aufirst%3DD.%26aulast%3DCianni%26aufirst%3DL.%26aulast%3DFranco%26aufirst%3DC.%2BH.%26aulast%3DFreitas-Junior%26aufirst%3DL.%2BH.%26aulast%3DMoraes%26aufirst%3DC.%2BB.%26aulast%3DRocha%26aufirst%3DJ.%2BR.%26aulast%3DBurtoloso%26aufirst%3DA.%2BC.%2BB.%26aulast%3DKenny%26aufirst%3DP.%2BW.%26aulast%3DLeit%25C3%25A3o%26aufirst%3DA.%26aulast%3DMontanari%26aufirst%3DC.%2BA.%26atitle%3DA%2520comparative%2520study%2520of%2520warheads%2520for%2520design%2520of%2520cysteine%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D5031%26epage%3D5035%26doi%3D10.1016%2Fj.bmcl.2017.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonatto, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batista, P. H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vita, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cedron, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tezuka, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Albuquerque, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraes, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lameira, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leitão, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montanari, C. A.</span></span> <span> </span><span class="NLM_article-title">On the intrinsic reactivity of highly potent trypanocidal cruzain inhibitors</span>. <i>RSC Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1275</span>– <span class="NLM_lpage">1284</span>, <span class="refDoi"> DOI: 10.1039/D0MD00097C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1039%2FD0MD00097C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=34095840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhslyjt7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=1275-1284&author=V.+Bonattoauthor=P.+H.+J.+Batistaauthor=L.+Cianniauthor=D.+de+Vitaauthor=D.+G.+Silvaauthor=R.+Cedronauthor=D.+Y.+Tezukaauthor=S.+de+Albuquerqueauthor=C.+B.+Moraesauthor=C.+H.+Francoauthor=J.+Lameiraauthor=A.+Leit%C3%A3oauthor=C.+A.+Montanari&title=On+the+intrinsic+reactivity+of+highly+potent+trypanocidal+cruzain+inhibitors&doi=10.1039%2FD0MD00097C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">On the intrinsic reactivity of highly potent trypanocidal cruzain inhibitors</span></div><div class="casAuthors">Bonatto, Vinicius; Batista, Pedro Henrique Jatai; Cianni, Lorenzo; De Vita, Daniela; Silva, Daniel G.; Cedron, Rodrigo; Tezuka, Daiane Y.; de Albuquerque, Sergio; Moraes, Carolina Borsoi; Franco, Caio Haddad; Lameira, Jeronimo; Leitao, Andrei; Montanari, Carlos A.</div><div class="citationInfo"><span class="NLM_cas:title">RSC Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1275-1284</span>CODEN:
                <span class="NLM_cas:coden">RMCSEZ</span>;
        ISSN:<span class="NLM_cas:issn">2632-8682</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The cysteine protease cruzipain is considered to be a validated target for therapeutic intervention in the treatment of Chagas disease.  Hence, peptidomimetic cruzipain inhibitors having a reactive group (known as warhead) are subject to continuous studies to discover novel antichagasic compds.  Here, we evaluated how different warheads for a set of structurally similar related compds. could inhibit the activity of cruzipain and, ultimately, their trypanocidal effect.  We first investigated in silico the intrinsic reactivity of these compds. by applying the Fukui index to correlate it with the enzymic affinity.  Then, we evaluated their potency against T. cruzi (Y and Tulahuen strains), which revealed the reversible cruzain inhibitor Neq0656 as a better trypanocidal agent (ECY.strain50 = 0.1μM; SI = 58.4) than the current drug benznidazole (ECY.strain50 = 5.1μM; SI > 19.6).  We also measured the half-life time by HPLC anal. of three lead compds. in the presence of glutathione and cysteine to exptl. assess their intrinsic reactivity.  Results clearly illustrated the reactivity trend for the warheads (azanitrile > aldehyde > nitrile), where the aldehyde displayed an intermediate intrinsic reactivity.  Therefore, the aldehyde bearing peptidomimetic compds. should be subject for in-depth evaluation in the drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXL7EU9_GhxLVg90H21EOLACvtfcHk0lgLEzpSJgoBPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhslyjt7jF&md5=feee55089bb2fe2197e64c2d3037bef5</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1039%2FD0MD00097C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FD0MD00097C%26sid%3Dliteratum%253Aachs%26aulast%3DBonatto%26aufirst%3DV.%26aulast%3DBatista%26aufirst%3DP.%2BH.%2BJ.%26aulast%3DCianni%26aufirst%3DL.%26aulast%3Dde%2BVita%26aufirst%3DD.%26aulast%3DSilva%26aufirst%3DD.%2BG.%26aulast%3DCedron%26aufirst%3DR.%26aulast%3DTezuka%26aufirst%3DD.%2BY.%26aulast%3Dde%2BAlbuquerque%26aufirst%3DS.%26aulast%3DMoraes%26aufirst%3DC.%2BB.%26aulast%3DFranco%26aufirst%3DC.%2BH.%26aulast%3DLameira%26aufirst%3DJ.%26aulast%3DLeit%25C3%25A3o%26aufirst%3DA.%26aulast%3DMontanari%26aufirst%3DC.%2BA.%26atitle%3DOn%2520the%2520intrinsic%2520reactivity%2520of%2520highly%2520potent%2520trypanocidal%2520cruzain%2520inhibitors%26jtitle%3DRSC%2520Med.%2520Chem.%26date%3D2020%26volume%3D11%26spage%3D1275%26epage%3D1284%26doi%3D10.1039%2FD0MD00097C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siraki, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shangari, N.</span></span> <span> </span><span class="NLM_article-title">Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health</span>. <i>Crit. Rev. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">609</span>– <span class="NLM_lpage">662</span>, <span class="refDoi"> DOI: 10.1080/10408440591002183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1080%2F10408440591002183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=16417045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1agtr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2005&pages=609-662&author=P.+J.+O%E2%80%99Brienauthor=A.+G.+Sirakiauthor=N.+Shangari&title=Aldehyde+sources%2C+metabolism%2C+molecular+toxicity+mechanisms%2C+and+possible+effects+on+human+health&doi=10.1080%2F10408440591002183"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health</span></div><div class="casAuthors">O'Brien, Peter; Siraki, Arno; Shangari, Nandita</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Toxicology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">609-662</span>CODEN:
                <span class="NLM_cas:coden">CRTXB2</span>;
        ISSN:<span class="NLM_cas:issn">1040-8444</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A review.  Aldehydes are org. compds. that are widespread in nature.  They can be formed endogenously by lipid peroxidn. (LPO), carbohydrate or metab. ascorbate autoxidn., amine oxidases, cytochrome P-450s, or myeloperoxidase-catalyzed metabolic activation.  This review compares the reactivity of many aldehydes towards biomols. particularly macromols.  Furthermore, it includes not only aldehydes of environmental or occupational concerns but also dietary aldehydes and aldehydes formed endogenously by intermediary metab.  Drugs that are aldehydes or form reactive aldehyde metabolites that cause side-effect toxicity are also included.  The effects of these aldehydes on biol. function, their contribution to human diseases, and the role of nucleic acid and protein carbonylation/oxidn. in mutagenicity and cytotoxicity mechanisms, resp., as well as carbonyl signal transduction and gene expression, are reviewed.  Aldehyde metabolic activation and detoxication by metabolizing enzymes are also reviewed, as well as the toxicol. and anticancer therapeutic effects of metabolizing enzyme inhibitors.  The human health risks from clin. and animal research studies are reviewed, including aldehydes as haptens in allergenic hypersensitivity diseases, respiratory allergies, and idiosyncratic drug toxicity; the potential carcinogenic risks of the carbonyl body burden; and the toxic effects of aldehydes in liver disease, embryo toxicity/teratogenicity, diabetes/hypertension, sclerosing peritonitis, cerebral ischemia/neurodegenerative diseases, and other aging-assocd. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw561xTk_YUrVg90H21EOLACvtfcHk0lh482oy2LHeBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1agtr3L&md5=b5be34c7f0253a8e988dd0e93427a399</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1080%2F10408440591002183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10408440591002183%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DP.%2BJ.%26aulast%3DSiraki%26aufirst%3DA.%2BG.%26aulast%3DShangari%26aufirst%3DN.%26atitle%3DAldehyde%2520sources%252C%2520metabolism%252C%2520molecular%2520toxicity%2520mechanisms%252C%2520and%2520possible%2520effects%2520on%2520human%2520health%26jtitle%3DCrit.%2520Rev.%2520Toxicol.%26date%3D2005%26volume%3D35%26spage%3D609%26epage%3D662%26doi%3D10.1080%2F10408440591002183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gibbons, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verissimo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araujo, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nixon, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amewu, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chadwick, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stocks, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biagini, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gut, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guedes, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cristiano, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shone, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, P. M.</span></span> <span> </span><span class="NLM_article-title">Endoperoxide carbonyl falcipain 2/3 inhibitor hybrids: Toward combination chemotherapy of malaria through a single chemical entity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">8202</span>– <span class="NLM_lpage">8206</span>, <span class="refDoi"> DOI: 10.1021/jm1009567</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1009567" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlClur7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8202-8206&author=P.+Gibbonsauthor=E.+Verissimoauthor=N.+C.+Araujoauthor=V.+Bartonauthor=G.+L.+Nixonauthor=R.+K.+Amewuauthor=J.+Chadwickauthor=P.+A.+Stocksauthor=G.+A.+Biaginiauthor=A.+Srivastavaauthor=P.+J.+Rosenthalauthor=J.+Gutauthor=R.+C.+Guedesauthor=R.+Moreiraauthor=R.+Sharmaauthor=N.+Berryauthor=M.+L.+Cristianoauthor=A.+E.+Shoneauthor=S.+A.+Wardauthor=P.+M.+O%E2%80%99Neill&title=Endoperoxide+carbonyl+falcipain+2%2F3+inhibitor+hybrids%3A+Toward+combination+chemotherapy+of+malaria+through+a+single+chemical+entity&doi=10.1021%2Fjm1009567"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Endoperoxide Carbonyl Falcipain 2/3 Inhibitor Hybrids: Toward Combination Chemotherapy of Malaria through a Single Chemical Entity</span></div><div class="casAuthors">Gibbons, Peter; Verissimo, Edite; Barton, Victoria; Nixon, Gemma L.; Amewu, Richard K.; Chadwick, James; Stocks, Paul A.; Biagini, Giancarlo A.; Srivastava, Abhishek; Rosenthal, Philip J.; Gut, Jiri; Guedes, Rita C.; Moreira, Rui; Sharma, Raman; Berry, Neil; Cristiano, M. Lurdes S.; Shone, Alison E.; Ward, Stephen A.; O'Neill, Paul M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8202-8206</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors extend their approach of combination chemotherapy through a single prodrug entity (O'Neill et al. Angew. Chem., Int. Ed. 2004, 43, 4193) by using a 1,2,4-trioxolane as a protease inhibitor carbonyl-masking group.  These mols. are designed to target the malaria parasite through two independent mechanisms of action: iron(II) decompn. releases the carbonyl protease inhibitor and potentially cytotoxic C-radical species in tandem.  Using a proposed target "heme", the authors also demonstrate heme alkylation/carbonyl inhibitor release and quant. measure endoperoxide turnover in parasitized red blood cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk03ZtQuSTGbVg90H21EOLACvtfcHk0lh482oy2LHeBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlClur7J&md5=8c93b6fdd9321a8b59a1f027dff37356</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm1009567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1009567%26sid%3Dliteratum%253Aachs%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DVerissimo%26aufirst%3DE.%26aulast%3DAraujo%26aufirst%3DN.%2BC.%26aulast%3DBarton%26aufirst%3DV.%26aulast%3DNixon%26aufirst%3DG.%2BL.%26aulast%3DAmewu%26aufirst%3DR.%2BK.%26aulast%3DChadwick%26aufirst%3DJ.%26aulast%3DStocks%26aufirst%3DP.%2BA.%26aulast%3DBiagini%26aufirst%3DG.%2BA.%26aulast%3DSrivastava%26aufirst%3DA.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DGut%26aufirst%3DJ.%26aulast%3DGuedes%26aufirst%3DR.%2BC.%26aulast%3DMoreira%26aufirst%3DR.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DBerry%26aufirst%3DN.%26aulast%3DCristiano%26aufirst%3DM.%2BL.%26aulast%3DShone%26aufirst%3DA.%2BE.%26aulast%3DWard%26aufirst%3DS.%2BA.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DP.%2BM.%26atitle%3DEndoperoxide%2520carbonyl%2520falcipain%25202%252F3%2520inhibitor%2520hybrids%253A%2520Toward%2520combination%2520chemotherapy%2520of%2520malaria%2520through%2520a%2520single%2520chemical%2520entity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8202%26epage%3D8206%26doi%3D10.1021%2Fjm1009567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schechter, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, A.</span></span> <span> </span><span class="NLM_article-title">On the size of the active site in proteases I. Papain</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1967</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">162</span>, <span class="refDoi"> DOI: 10.1016/S0006-291X(67)80055-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1016%2FS0006-291X%2867%2980055-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=6035483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADyaF2sXktVyhsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1967&pages=157-162&author=I.+Schechterauthor=A.+Berger&title=On+the+size+of+the+active+site+in+proteases+I.+Papain&doi=10.1016%2FS0006-291X%2867%2980055-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">On the size of the active site in proteases.  I.  Papain</span></div><div class="casAuthors">Schechter, Israel; Berger, Arieh</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-62</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">The action of papain on 40 diastereoisomeric peptides of alanine, ranging in length from Ala2 to Ala6, was studied to investigate the size of the active site.  The variations observed in the rates of hydrolysis lead to the conclusion that papain has a large active site which extends over ∼25 A. and can be divided into 7 "subsites," each accommodating 1 amino acid residue of the peptide substrate.  The subsites are located on both sides of the catalytic site, 4 on the one side and 3 on the other.  It is postulated that a long "groove" analogous to that found by x-ray analysis in lysozyme is present.  The substrate is believed to fit into the groove, binding to several subsites of specific geometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_kZeRVAOVyrVg90H21EOLACvtfcHk0liQA2gYcP4MYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2sXktVyhsrg%253D&md5=a58ceccdbb5cc5c021af06912835f77c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2867%2980055-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252867%252980055-X%26sid%3Dliteratum%253Aachs%26aulast%3DSchechter%26aufirst%3DI.%26aulast%3DBerger%26aufirst%3DA.%26atitle%3DOn%2520the%2520size%2520of%2520the%2520active%2520site%2520in%2520proteases%2520I.%2520Papain%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1967%26volume%3D27%26spage%3D157%26epage%3D162%26doi%3D10.1016%2FS0006-291X%2867%2980055-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuerrier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moldoveanu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, R. L.</span></span> <span> </span><span class="NLM_article-title">Calpain inhibition by alpha-ketoamide and cyclic hemiacetal inhibitors revealed by X-ray crystallography</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">7446</span>– <span class="NLM_lpage">7452</span>, <span class="refDoi"> DOI: 10.1021/bi060425j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi060425j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BD28Xkslymsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=7446-7452&author=D.+Cuerrierauthor=T.+Moldoveanuauthor=J.+Inoueauthor=P.+L.+Daviesauthor=R.+L.+Campbell&title=Calpain+inhibition+by+alpha-ketoamide+and+cyclic+hemiacetal+inhibitors+revealed+by+X-ray+crystallography&doi=10.1021%2Fbi060425j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Calpain Inhibition by α-Ketoamide and Cyclic Hemiacetal Inhibitors Revealed by X-ray Crystallography</span></div><div class="casAuthors">Cuerrier, D.; Moldoveanu, T.; Inoue, J.; Davies, P. L.; Campbell, R. L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7446-7452</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Calpains are intracellular calcium-activated cysteine proteases whose unregulated proteolysis following the loss of calcium homeostasis can lead to acute degeneration during ischemic episodes and trauma, as well as Alzheimer's disease and cataract formation.  The detn. of the crystal structure of the proteolytic core of μ-calpain (μI-II) in a calcium-bound active conformation has made structure-guided design of active site inhibitors feasible.  We present here high-resoln. crystal structures of rat μI-II complexed with two reversible calpain-specific inhibitors employing cyclic hemiacetal (SNJ-1715) and α-ketoamide (SNJ-1945) chemistries that reveal new details about the interactions of inhibitors with this enzyme.  The SNJ-1715 complex confirms that the free aldehyde is the reactive species of the cornea-permeable cyclic hemiacetal.  The α-ketoamide warhead of SNJ-1945 binds with the hydroxyl group of the tetrahedral adduct pointing toward the catalytic histidine rather than the oxyanion hole.  The μI-II-SNJ-1945 complex shows residue Glu-261 displaced from the S1' site by the inhibitor, resulting in an extended "open" conformation of the domain II gating loop and an unobstructed S1' site.  This conformation offers an addnl. template for structure-based drug design extending to the primed subsites.  An important role for the highly conserved Glu-261 is proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf1Hz8gVj2s7Vg90H21EOLACvtfcHk0liQA2gYcP4MYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xkslymsbc%253D&md5=5723cbc8b8924fff33239a63ae26a4db</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fbi060425j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi060425j%26sid%3Dliteratum%253Aachs%26aulast%3DCuerrier%26aufirst%3DD.%26aulast%3DMoldoveanu%26aufirst%3DT.%26aulast%3DInoue%26aufirst%3DJ.%26aulast%3DDavies%26aufirst%3DP.%2BL.%26aulast%3DCampbell%26aufirst%3DR.%2BL.%26atitle%3DCalpain%2520inhibition%2520by%2520alpha-ketoamide%2520and%2520cyclic%2520hemiacetal%2520inhibitors%2520revealed%2520by%2520X-ray%2520crystallography%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D7446%26epage%3D7452%26doi%3D10.1021%2Fbi060425j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, J.</span></span> <span> </span><span class="NLM_article-title">Exploration of cornea permeable calpain inhibitors as anticataract agents</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1371</span>– <span class="NLM_lpage">1379</span>, <span class="refDoi"> DOI: 10.1016/S0968-0896(02)00612-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1016%2FS0968-0896%2802%2900612-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=12628663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvFGrs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=1371-1379&author=M.+Nakamuraauthor=M.+Yamaguchiauthor=O.+Sakaiauthor=J.+Inoue&title=Exploration+of+cornea+permeable+calpain+inhibitors+as+anticataract+agents&doi=10.1016%2FS0968-0896%2802%2900612-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Exploration of cornea permeable calpain inhibitors as anticataract agents</span></div><div class="casAuthors">Nakamura, Masayuki; Yamaguchi, Masazumi; Sakai, Osamu; Inoue, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1371-1379</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">To explore cornea permeable calpain inhibitors, four compds. displaying different characteristics were designed and synthesized based on the known potent calpain inhibitor, peptidyl aldehyde SJA6017.  Two approaches were adopted; an improvement in the physicochem. properties, and conversion of the active aldehyde.  The water-sol. peptidyl aldehyde 1 contg. a pyridine ring at the P3 site showed a modest inhibition against calpains and an improvement of corneal permeability in comparison with SJA6017.  Replacement of the aldehyde of SJA6017 by an α-ketoamide provided compd. 2 that was approx. equipotent with SJA6017, but it was extremely water-insol.  However, compd. 3, in which the aldehyde was converted into a cyclic hemiacetal, proved to be a less potent calpain inhibitor than SJA6017, but demonstrated excellent transcorneal permeability.  Further modification generating the cyclic hemiacetal 4 contg. a thiourea linker between the P3 and P2 sites exhibited potent inhibitory activities, high cornea permeability and excellent efficacy in the rat lens culture cataract model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOzIjCh4ST37Vg90H21EOLACvtfcHk0libi1BONlc6QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvFGrs7w%253D&md5=c90fc9511b44489bb2fd399d1471b4a6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2802%2900612-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252802%252900612-0%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DYamaguchi%26aufirst%3DM.%26aulast%3DSakai%26aufirst%3DO.%26aulast%3DInoue%26aufirst%3DJ.%26atitle%3DExploration%2520of%2520cornea%2520permeable%2520calpain%2520inhibitors%2520as%2520anticataract%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D1371%26epage%3D1379%26doi%3D10.1016%2FS0968-0896%2802%2900612-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farady, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marion, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajid, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caffrey, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legac, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinen, L. S.</span></span> <span> </span><span class="NLM_article-title">Vinyl sulfones as antiparasitic agents and a structural basis for drug design</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">25697</span>– <span class="NLM_lpage">25703</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.014340</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1074%2Fjbc.M109.014340" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=19620707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFWhsbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=25697-25703&author=I.+D.+Kerrauthor=J.+H.+Leeauthor=C.+J.+Faradyauthor=R.+Marionauthor=M.+Rickertauthor=M.+Sajidauthor=K.+C.+Pandeyauthor=C.+R.+Caffreyauthor=J.+Legacauthor=E.+Hansellauthor=J.+H.+McKerrowauthor=C.+S.+Craikauthor=P.+J.+Rosenthalauthor=L.+S.+Brinen&title=Vinyl+sulfones+as+antiparasitic+agents+and+a+structural+basis+for+drug+design&doi=10.1074%2Fjbc.M109.014340"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Vinyl Sulfones as Antiparasitic Agents and a Structural Basis for Drug Design</span></div><div class="casAuthors">Kerr, Iain D.; Lee, Ji H.; Farady, Christopher J.; Marion, Rachael; Rickert, Mathias; Sajid, Mohammed; Pandey, Kailash C.; Caffrey, Conor R.; Legac, Jennifer; Hansell, Elizabeth; McKerrow, James H.; Craik, Charles S.; Rosenthal, Philip J.; Brinen, Linda S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">25697-25703</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Cysteine proteases of the papain superfamily are implicated in a no. of cellular processes and are important virulence factors in the pathogenesis of parasitic disease.  These enzymes have therefore emerged as promising targets for antiparasitic drugs.  We report the crystal structures of three major parasite cysteine proteases, cruzain, falcipain-3, and the first reported structure of rhodesain, in complex with a class of potent, small mol., cysteine protease inhibitors, the vinyl sulfones.  These data, in conjunction with comparative inhibition kinetics, provide insight into the mol. mechanisms that drive cysteine protease inhibition by vinyl sulfones, the binding specificity of these important proteases and the potential of vinyl sulfones as antiparasitic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolV0DUxF0YFbVg90H21EOLACvtfcHk0libi1BONlc6QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFWhsbbK&md5=c0bed13d912846fdcb4c2ba7f31954cb</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.014340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.014340%26sid%3Dliteratum%253Aachs%26aulast%3DKerr%26aufirst%3DI.%2BD.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DFarady%26aufirst%3DC.%2BJ.%26aulast%3DMarion%26aufirst%3DR.%26aulast%3DRickert%26aufirst%3DM.%26aulast%3DSajid%26aufirst%3DM.%26aulast%3DPandey%26aufirst%3DK.%2BC.%26aulast%3DCaffrey%26aufirst%3DC.%2BR.%26aulast%3DLegac%26aufirst%3DJ.%26aulast%3DHansell%26aufirst%3DE.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DBrinen%26aufirst%3DL.%2BS.%26atitle%3DVinyl%2520sulfones%2520as%2520antiparasitic%2520agents%2520and%2520a%2520structural%2520basis%2520for%2520drug%2520design%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D25697%26epage%3D25703%26doi%3D10.1074%2Fjbc.M109.014340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clementi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raimondi, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinhardt, W. P.</span></span> <span> </span><span class="NLM_article-title">Atomic screening constants from SCF functions. II. Atoms with 37 to 86 electrons</span>. <i>J. Chem. Phys</i> <span class="NLM_year" style="font-weight: bold;">1967</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1300</span>– <span class="NLM_lpage">1307</span>, <span class="refDoi"> DOI: 10.1063/1.1712084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1063%2F1.1712084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADyaF2sXkvVGisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1967&pages=1300-1307&author=E.+Clementiauthor=D.+L.+Raimondiauthor=W.+P.+Reinhardt&title=Atomic+screening+constants+from+SCF+functions.+II.+Atoms+with+37+to+86+electrons&doi=10.1063%2F1.1712084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Atomic screening constants from S.C.F. [self-con-sistent field] functions.  II.  Atoms with 37 to 86 electrons</span></div><div class="casAuthors">Clementi, Enrico; Raimondi, Donald L.; Reinhardt, W. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1300-7</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    </div><div class="casAbstract">cf. CA 59: 118f.  Minimal basis-set at. functions for the ground-state atoms from Rb (Z = 37) to Rn(Z = 86) are presented.  These functions are analyzed in order to obtain systematic data for the screening consts. and at. radii following the work initiated by Slater.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRRzONF_PmlLVg90H21EOLACvtfcHk0libi1BONlc6QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2sXkvVGisrY%253D&md5=851e8055b9d0b30737bb7d399fe6dd3c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1063%2F1.1712084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.1712084%26sid%3Dliteratum%253Aachs%26aulast%3DClementi%26aufirst%3DE.%26aulast%3DRaimondi%26aufirst%3DD.%2BL.%26aulast%3DReinhardt%26aufirst%3DW.%2BP.%26atitle%3DAtomic%2520screening%2520constants%2520from%2520SCF%2520functions.%2520II.%2520Atoms%2520with%252037%2520to%252086%2520electrons%26jtitle%3DJ.%2520Chem.%2520Phys%26date%3D1967%26volume%3D47%26spage%3D1300%26epage%3D1307%26doi%3D10.1063%2F1.1712084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clayden, J.</span>; <span class="NLM_string-name">Greeves, N.</span>; <span class="NLM_string-name">Warren, S. G.</span></span> <i>Organic chemistry</i>. Second ed.; <span class="NLM_publisher-name">Oxford University Press</span>: <span class="NLM_publisher-loc">Oxford</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+Clayden&author=N.+Greeves&author=S.+G.+Warren&title=Organic+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DClayden%26aufirst%3DJ.%26btitle%3DOrganic%2520chemistry%26pub%3DOxford%2520University%2520Press%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mackenzie, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malthouse, J. P.</span></span> <span> </span><span class="NLM_article-title"><sup>13</sup>C NMR study of the stereospecificity of the thiohemiacetals formed on inhibition of papain by specific enantiomeric aldehydes</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2293</span>– <span class="NLM_lpage">2298</span>, <span class="refDoi"> DOI: 10.1021/bi00356a066</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00356a066" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADyaL28Xkt1SrtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1986&pages=2293-2298&author=N.+E.+Mackenzieauthor=S.+K.+Grantauthor=A.+I.+Scottauthor=J.+P.+Malthouse&title=13C+NMR+study+of+the+stereospecificity+of+the+thiohemiacetals+formed+on+inhibition+of+papain+by+specific+enantiomeric+aldehydes&doi=10.1021%2Fbi00356a066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Carbon-13 NMR study of the stereospecificity of the thiohemiacetals formed on inhibition of papain by specific enantiomeric aldehydes</span></div><div class="casAuthors">Mackenzie, Neil E.; Grant, Stephan K.; Scott, A. Ian; Malthouse, J. Paul G.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2293-8</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">The inhibition of papain by N-acetyl-D- and N-acetyl-L-phenylalanyl[1-13C]glycinal was investigated by 13C NMR spectroscopy.  Both the L- and D-aldehyde enantiomers formed thiohemiacetals with papain.  The 13C-enriched C atom of the thiohemiacetals formed with the L- and D-aldehydes has chem. shifts at 74.7 and 75.1 ppm, resp.  The difference in chem. shift for the 2 inhibitor complexes is attributed to each forming a different diastereomeric papain thiohemiacetal.  With papain thiohemiacetal formation is stereospecific.  The D inhibitor is bound only 5-fold less tightly than the L inhibitor, which suggests that in both these inhibitor complexes the Ph ring of the inhibitor phenylalanine is bound at the S2 hydrophobic pocket of papain.  This is supported by computer modeling studies that show that both the N-acetyl-D- and N-acetyl-L-phenylalanine moieties can be sep. fitted into the S2 subsite with the Ph ring of phenylalanine in the S2 hydrophobic pocket.  Thus, thiohemiacetal formation at S1 (S1 and S1' are the active center amino acid binding sites) is stereospecific with both D and L inhibitors.  Computer modeling studies support this, showing that due to steric hindrance between the thiohemiacetal OH group and the backbone amide N atom of serine-24 only 1 of the 2 possible thiohemiacetal enantiomers can be formed at the S1 subsite.  The thiohemiacetals formed from both the D and L aldehyde inhibitors therefore have only 1 permitted conformation at S1.  In this conformation, the thiohemiacetal OH does not point toward the oxyanion hole but instead points away from it into the bottom of the active site cleft of papain, where there are no significant H-bonded interactions with the thiohemiacetal OH group.  It is therefore inferred that the stabilization of the oxyanion of a tetrahedral intermediate by H-bonded interactions with groups in the oxyanion hole may not be possible in papain-catalyzed reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVIJqUcmtcG7Vg90H21EOLACvtfcHk0lgS1Nf4-17Y7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28Xkt1SrtLw%253D&md5=87a90c5c8f6d472f181cc9993544ddb4</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fbi00356a066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00356a066%26sid%3Dliteratum%253Aachs%26aulast%3DMackenzie%26aufirst%3DN.%2BE.%26aulast%3DGrant%26aufirst%3DS.%2BK.%26aulast%3DScott%26aufirst%3DA.%2BI.%26aulast%3DMalthouse%26aufirst%3DJ.%2BP.%26atitle%3D13C%2520NMR%2520study%2520of%2520the%2520stereospecificity%2520of%2520the%2520thiohemiacetals%2520formed%2520on%2520inhibition%2520of%2520papain%2520by%2520specific%2520enantiomeric%2520aldehydes%26jtitle%3DBiochemistry%26date%3D1986%26volume%3D25%26spage%3D2293%26epage%3D2298%26doi%3D10.1021%2Fbi00356a066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abdulla, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackey, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajid, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grab, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span> <span> </span><span class="NLM_article-title">RNA interference of trypanosoma brucei cathepsin B and L affects disease progression in a mouse model</span>. <i>PLoS Negl. Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>2</i></span>, <span class="NLM_elocation-id">e298</span> <span class="refDoi"> DOI: 10.1371/journal.pntd.0000298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1371%2Fjournal.pntd.0000298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=18820745" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2008&author=M.+H.+Abdullaauthor=T.+O%E2%80%99Brienauthor=Z.+B.+Mackeyauthor=M.+Sajidauthor=D.+J.+Grabauthor=J.+H.+McKerrow&title=RNA+interference+of+trypanosoma+brucei+cathepsin+B+and+L+affects+disease+progression+in+a+mouse+model&doi=10.1371%2Fjournal.pntd.0000298"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0000298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0000298%26sid%3Dliteratum%253Aachs%26aulast%3DAbdulla%26aufirst%3DM.%2BH.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DT.%26aulast%3DMackey%26aufirst%3DZ.%2BB.%26aulast%3DSajid%26aufirst%3DM.%26aulast%3DGrab%26aufirst%3DD.%2BJ.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26atitle%3DRNA%2520interference%2520of%2520trypanosoma%2520brucei%2520cathepsin%2520B%2520and%2520L%2520affects%2520disease%2520progression%2520in%2520a%2520mouse%2520model%26jtitle%3DPLoS%2520Negl.%2520Trop.%2520Dis.%26date%3D2008%26volume%3D2%26doi%3D10.1371%2Fjournal.pntd.0000298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Enanga, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ariyanayagam, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, M. P.</span></span> <span> </span><span class="NLM_article-title">Activity of megazol, a trypanocidal nitroimidazole, is associated with DNA damage</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">3368</span>– <span class="NLM_lpage">3370</span>, <span class="refDoi"> DOI: 10.1128/AAC.47.10.3368-3370.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1128%2FAAC.47.10.3368-3370.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=14506061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvVWmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2003&pages=3368-3370&author=B.+Enangaauthor=M.+R.+Ariyanayagamauthor=M.+L.+Stewartauthor=M.+P.+Barrett&title=Activity+of+megazol%2C+a+trypanocidal+nitroimidazole%2C+is+associated+with+DNA+damage&doi=10.1128%2FAAC.47.10.3368-3370.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Activity of megazol, a trypanocidal nitroimidazole, is associated with DNA damage</span></div><div class="casAuthors">Enanga, Bertin; Ariyanayagam, Mark R.; Stewart, Mhairi L.; Barrett, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3368-3370</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">DNA damage assocd. with the trypanocidal activity of megazol [2-amino-5-(1-methyl-5-nitro-2-imidazolyl)-1,3,4-thiadiazole] was shown in expts. in which DNA repair-deficient RAD51-/- Trypanosoma brucei mutants were found to be hypersensitive to the drug.  Parasites resistant to megazol were selected and showed modest cross-resistance to other trypanocides, although neither drug efflux nor changes to intracellular thiols correlated with resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcSCWDmmFjwLVg90H21EOLACvtfcHk0lgS1Nf4-17Y7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvVWmtbg%253D&md5=7365cc05236781f97d01a77b69f084b1</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1128%2FAAC.47.10.3368-3370.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.47.10.3368-3370.2003%26sid%3Dliteratum%253Aachs%26aulast%3DEnanga%26aufirst%3DB.%26aulast%3DAriyanayagam%26aufirst%3DM.%2BR.%26aulast%3DStewart%26aufirst%3DM.%2BL.%26aulast%3DBarrett%26aufirst%3DM.%2BP.%26atitle%3DActivity%2520of%2520megazol%252C%2520a%2520trypanocidal%2520nitroimidazole%252C%2520is%2520associated%2520with%2520DNA%2520damage%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2003%26volume%3D47%26spage%3D3368%26epage%3D3370%26doi%3D10.1128%2FAAC.47.10.3368-3370.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christians, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benet, L. Z.</span></span> <span> </span><span class="NLM_article-title">In vitro evaluation of the disposition of a novel cysteine protease inhibitor</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1343</span>– <span class="NLM_lpage">1351</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=11038163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsFOlsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=1343-1351&author=W.+Jacobsenauthor=U.+Christiansauthor=L.+Z.+Benet&title=In+vitro+evaluation+of+the+disposition+of+a+novel+cysteine+protease+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro evaluation of the disposition of a novel cysteine protease inhibitor</span></div><div class="casAuthors">Jacobsen, Wolfgang; Christians, Uwe; Benet, Leslie Z.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1343-1351</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">K11777 (N-methyl-piperazine-Phe-homoPhe-vinylsulfone-phenyl) is a potent, irreversible cysteine protease inhibitor.  Its therapeutic targets are cruzain, a cysteine protease of the protozoan parasite Trypanosoma cruzi, and cathepsins B and L, which are assocd. with cancer progression.  The authors evaluated the metab. of K11777 by human liver microsomes, isolated cytochrome P 450 (CYP) enzymes, and flavin-contg. monooxygenase 3 (FMO3) in vitro.  K11777 was metabolized by human liver microsomes to three major metabolites: N-oxide K11777 (apparent Km = 14.0 μM and apparent Vmax = 3460 pmol · mg-1 · min-1), β-hydroxy-homoPhe K11777 (Km = 16.8 μM and Vmax = 1260 pmol · mg-1 · min-1), and N-desmethyl K11777 (Km = 18.3 μM and Vmax = 2070 pmol · mg-1 · min-1).  All three K11777 metabolites were formed by isolated CYP3A and their formation by human liver microsomes was inhibited by the CYP3A inhibitor cyclosporine (50 μM, 54-62% inhibition) and antibodies against human CYP3A4/5 (100 μg of antibodies/100 μg microsomal protein, 55-68% inhibition).  CYP2D6 metabolized K11777 to its N-desmethyl metabolite with an apparent Km (9.2 μM) lower than for CYP3A4 (25.0 μM) and human liver microsomes.  The apparent Km for N-oxide K11777 formation by cDNA-expressed FMO3 was 109 μM.  Based on the intrinsic formation clearances and the results of inhibition expts. (CYP2D6, 50 μM bufuralol; FMO3 mediated, 100 mM methionine) using human liver microsomes, it was estd. that CYP3A contributes to >80% of K11777 metabolite formation.  K11777 was a potent (IC50 = 0.06 μM) and efficacious (max. inhibition 85%) NADPH-dependent inhibitor of human CYP3A4 mediated 6'β-hydroxy lovastatin formation, suggesting that K11777 is not only a substrate but also a mechanism-based inhibitor of CYP3A4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnuA6vCCgc0bVg90H21EOLACvtfcHk0lhUrDSpjVbPAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsFOlsbw%253D&md5=d4becc1389b076d394ff43b1d7a093f9</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJacobsen%26aufirst%3DW.%26aulast%3DChristians%26aufirst%3DU.%26aulast%3DBenet%26aufirst%3DL.%2BZ.%26atitle%3DIn%2520vitro%2520evaluation%2520of%2520the%2520disposition%2520of%2520a%2520novel%2520cysteine%2520protease%2520inhibitor%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2000%26volume%3D28%26spage%3D1343%26epage%3D1351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Charrier, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durrant, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Studley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, P.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of novel prodrugs of caspase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">485</span>– <span class="NLM_lpage">488</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.10.102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1016%2Fj.bmcl.2011.10.102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=22104150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVymuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=485-488&author=J.+D.+Charrierauthor=S.+J.+Durrantauthor=J.+Studleyauthor=L.+Lawesauthor=P.+Weber&title=Synthesis+and+evaluation+of+novel+prodrugs+of+caspase+inhibitors&doi=10.1016%2Fj.bmcl.2011.10.102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of novel prodrugs of caspase inhibitors</span></div><div class="casAuthors">Charrier, Jean-Damien; Durrant, Steven J.; Studley, John; Lawes, Linda; Weber, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">485-488</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel type of caspase inhibitor prodrug that improves systemic exposure after oral administration in rats has been designed.  Such a prodrug, based on a 6,6a-dihydrofuro[3,2-d]oxazol-5(3aH)-one motif, has the advantage of rapidly liberating the active inhibitor without producing any cleavage byproduct.  Prodrugs are synthesized in a high yielding one-step transformation from emricasan, VX166, and (S)-2-C10H7CONHCH(CH2CO2H)COCH2F with high diastereomeric excess.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0Ed6GTXp617Vg90H21EOLACvtfcHk0lhUrDSpjVbPAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVymuw%253D%253D&md5=b6665ecc9ec4d146cbd5233048e11ba4</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.10.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.10.102%26sid%3Dliteratum%253Aachs%26aulast%3DCharrier%26aufirst%3DJ.%2BD.%26aulast%3DDurrant%26aufirst%3DS.%2BJ.%26aulast%3DStudley%26aufirst%3DJ.%26aulast%3DLawes%26aufirst%3DL.%26aulast%3DWeber%26aufirst%3DP.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520novel%2520prodrugs%2520of%2520caspase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D485%26epage%3D488%26doi%3D10.1016%2Fj.bmcl.2011.10.102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span> <span> </span><span class="NLM_article-title">Human carboxylesterases: A comprehensive review</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">699</span>– <span class="NLM_lpage">712</span>, <span class="refDoi"> DOI: 10.1016/j.apsb.2018.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1016%2Fj.apsb.2018.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=30245959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A280%3ADC%252BB3czhvVOjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=699-712&author=D.+Wangauthor=L.+Zouauthor=Q.+Jinauthor=J.+Houauthor=G.+Geauthor=L.+Yang&title=Human+carboxylesterases%3A+A+comprehensive+review&doi=10.1016%2Fj.apsb.2018.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Human carboxylesterases: a comprehensive review</span></div><div class="casAuthors">Wang Dandan; Zou Liwei; Jin Qiang; Ge Guangbo; Yang Ling; Hou Jie</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmaceutica Sinica. B</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">699-712</span>
        ISSN:<span class="NLM_cas:issn">2211-3835</span>.
    </div><div class="casAbstract">Mammalian carboxylesterases (CEs) are key enzymes from the serine hydrolase superfamily.  In the human body, two predominant carboxylesterases (CES1 and CES2) have been identified and extensively studied over the past decade.  These two enzymes play crucial roles in the metabolism of a wide variety of endogenous esters, ester-containing drugs and environmental toxicants.  The key roles of CES in both human health and xenobiotic metabolism arouse great interest in the discovery of potent CES modulators to regulate endobiotic metabolism or to improve the efficacy of ester drugs.  This review covers the structural and catalytic features of CES, tissue distributions, biological functions, genetic polymorphisms, substrate specificities and inhibitor properties of CES1 and CES2, as well as the significance and recent progress on the discovery of CES modulators.  The information presented here will help pharmacologists explore the relevance of CES to human diseases or to assign the contribution of certain CES in xenobiotic metabolism.  It will also facilitate medicinal chemistry efforts to design prodrugs activated by a given CES isoform, or to develop potent and selective modulators of CES for potential biomedical applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRHzNUaecqdULHHuJhbyicZfW6udTcc2ebRyA0Ox0_QULntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3czhvVOjug%253D%253D&md5=4c0b70b0208577496c8e0270af5eda8e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2018.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2018.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DD.%26aulast%3DZou%26aufirst%3DL.%26aulast%3DJin%26aufirst%3DQ.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DGe%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DL.%26atitle%3DHuman%2520carboxylesterases%253A%2520A%2520comprehensive%2520review%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2018%26volume%3D8%26spage%3D699%26epage%3D712%26doi%3D10.1016%2Fj.apsb.2018.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zanger, U. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwab, M.</span></span> <span> </span><span class="NLM_article-title">Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">103</span>– <span class="NLM_lpage">141</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2012.12.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1016%2Fj.pharmthera.2012.12.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=23333322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BC3sXislykt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2013&pages=103-141&author=U.+M.+Zangerauthor=M.+Schwab&title=Cytochrome+P450+enzymes+in+drug+metabolism%3A+Regulation+of+gene+expression%2C+enzyme+activities%2C+and+impact+of+genetic+variation&doi=10.1016%2Fj.pharmthera.2012.12.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation</span></div><div class="casAuthors">Zanger, Ulrich M.; Schwab, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">103-141</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Cytochromes P 450 (CYP) are a major source of variability in drug pharmacokinetics and response.  Of 57 putatively functional human CYPs only about a dozen enzymes, belonging to the CYP1, 2, and 3 families, are responsible for the biotransformation of most foreign substances including 70-80% of all drugs in clin. use.  The highest expressed forms in liver are CYPs 3A4, 2C9, 2C8, 2E1, and 1A2, while 2A6, 2D6, 2B6, 2C19 and 3A5 are less abundant and CYPs 2J2, 1A1, and 1B1 are mainly expressed extrahepatically.  Expression of each CYP is influenced by a unique combination of mechanisms and factors including genetic polymorphisms, induction by xenobiotics, regulation by cytokines, hormones and during disease states, as well as sex, age, and others.  Multiallelic genetic polymorphisms, which strongly depend on ethnicity, play a major role for the function of CYPs 2D6, 2C19, 2C9, 2B6, 3A5 and 2A6, and lead to distinct pharmacogenetic phenotypes termed as poor, intermediate, extensive, and ultrarapid metabolizers.  For these CYPs, the evidence for clin. significance regarding adverse drug reactions (ADRs), drug efficacy and dose requirement is rapidly growing.  Polymorphisms in CYPs 1A1, 1A2, 2C8, 2E1, 2J2, and 3A4 are generally less predictive, but new data on CYP3A4 show that predictive variants exist and that addnl. variants in regulatory genes or in NADPH:cytochrome P 450 oxidoreductase (POR) can have an influence.  Here we review the recent progress on drug metab. activity profiles, interindividual variability and regulation of expression, and the functional and clin. impact of genetic variation in drug metabolizing P450s.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyfuepoWIAkLVg90H21EOLACvtfcHk0liDPRZFzC3CEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXislykt7w%253D&md5=474dd89d1aae3c9d57ff2d33f176602e</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2012.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2012.12.007%26sid%3Dliteratum%253Aachs%26aulast%3DZanger%26aufirst%3DU.%2BM.%26aulast%3DSchwab%26aufirst%3DM.%26atitle%3DCytochrome%2520P450%2520enzymes%2520in%2520drug%2520metabolism%253A%2520Regulation%2520of%2520gene%2520expression%252C%2520enzyme%2520activities%252C%2520and%2520impact%2520of%2520genetic%2520variation%26jtitle%3DPharmacol.%2520Ther.%26date%3D2013%26volume%3D138%26spage%3D103%26epage%3D141%26doi%3D10.1016%2Fj.pharmthera.2012.12.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, G. F.</span></span> <span> </span><span class="NLM_article-title">Both boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">4417</span>, <span class="refDoi"> DOI: 10.1038/s41467-020-18233-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1038%2Fs41467-020-18233-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=32887884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvVSmsr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=4417&author=L.+Fuauthor=F.+Yeauthor=Y.+Fengauthor=F.+Yuauthor=Q.+Wangauthor=Y.+Wuauthor=C.+Zhaoauthor=H.+Sunauthor=B.+Huangauthor=P.+Niuauthor=H.+Songauthor=Y.+Shiauthor=X.+Liauthor=W.+Tanauthor=J.+Qiauthor=G.+F.+Gao&title=Both+boceprevir+and+GC376+efficaciously+inhibit+SARS-CoV-2+by+targeting+its+main+protease&doi=10.1038%2Fs41467-020-18233-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease</span></div><div class="casAuthors">Fu, Lifeng; Ye, Fei; Feng, Yong; Yu, Feng; Wang, Qisheng; Wu, Yan; Zhao, Cheng; Sun, Huan; Huang, Baoying; Niu, Peihua; Song, Hao; Shi, Yi; Li, Xuebing; Tan, Wenjie; Qi, Jianxun; Gao, George Fu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4417</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: COVID-19 was declared a pandemic on March 11 by WHO, due to its great threat to global public health.  The coronavirus main protease (Mpro, also called 3CLpro) is essential for processing and maturation of the viral polyprotein, therefore recognized as an attractive drug target.  Here we show that a clin. approved anti-HCV drug, Boceprevir, and a pre-clin. inhibitor against feline infectious peritonitis (corona) virus (FIPV), GC376, both efficaciously inhibit SARS-CoV-2 in Vero cells by targeting Mpro.  Moreover, combined application of GC376 with Remdesivir, a nucleotide analog that inhibits viral RNA dependent RNA polymerase (RdRp), results in sterilizing additive effect.  Further structural anal. reveals binding of both inhibitors to the catalytically active side of SARS-CoV-2 protease Mpro as main mechanism of inhibition.  Our findings may provide crit. information for the optimization and design of more potent inhibitors against the emerging SARS-CoV-2 virus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt43KcNqLbkLVg90H21EOLACvtfcHk0liDPRZFzC3CEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvVSmsr3F&md5=273b11d16241499f15103885be398b23</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fs41467-020-18233-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-020-18233-x%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DL.%26aulast%3DYe%26aufirst%3DF.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DNiu%26aufirst%3DP.%26aulast%3DSong%26aufirst%3DH.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DTan%26aufirst%3DW.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DG.%2BF.%26atitle%3DBoth%2520boceprevir%2520and%2520GC376%2520efficaciously%2520inhibit%2520SARS-CoV-2%2520by%2520targeting%2520its%2520main%2520protease%26jtitle%3DNat.%2520Commun.%26date%3D2020%26volume%3D11%26spage%3D4417%26doi%3D10.1038%2Fs41467-020-18233-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frank, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritzky, A. R.</span></span> <span> </span><span class="NLM_article-title">Tautomeric pyridines. Part xv. Pyridone–hydroxypyridine equilibria in solvents of differing polarity</span>. <i>J. Chem. Soc., Perkin Trans. 2</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_fpage">1428</span>– <span class="NLM_lpage">1431</span>, <span class="refDoi"> DOI: 10.1039/P29760001428</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1039%2FP29760001428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADyaE2sXntFCntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1976&pages=1428-1431&author=J.+Frankauthor=A.+R.+Katritzky&title=Tautomeric+pyridines.+Part+xv.+Pyridone%E2%80%93hydroxypyridine+equilibria+in+solvents+of+differing+polarity&doi=10.1039%2FP29760001428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Tautomeric pyridines.  Part XV.  Pyridone-hydroxypyridine equilibriums in solvents of differing polarity</span></div><div class="casAuthors">Frank, Judit; Katritzky, Alan R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society, Perkin Transactions 2:  Physical Organic Chemistry (1972-1999)</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1428-31</span>CODEN:
                <span class="NLM_cas:coden">JCPKBH</span>;
        ISSN:<span class="NLM_cas:issn">0300-9580</span>.
    </div><div class="casAbstract">Tautomeric equil. of the pyridone-hydroxypyridine type were studied for 2- and 4-pyridone, 2,6-di-tert-butyl-4-pyridone, 4-quinolone, and 3-decyl-2,8-dimethyl-4-quinolone.  The proportion of pyridone form, dominant for H2O solns., falls approx. linearly with the solvent polarity as measured by Z (Reichardt, C., 1965).  In cyclohexane soln., comparable amts. of both forms are present.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA0cm3aXpoWbVg90H21EOLACvtfcHk0lgCHaqSmChgFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXntFCntw%253D%253D&md5=5261cabc31051791483045fc8717af20</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1039%2FP29760001428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FP29760001428%26sid%3Dliteratum%253Aachs%26aulast%3DFrank%26aufirst%3DJ.%26aulast%3DKatritzky%26aufirst%3DA.%2BR.%26atitle%3DTautomeric%2520pyridines.%2520Part%2520xv.%2520Pyridone%25E2%2580%2593hydroxypyridine%2520equilibria%2520in%2520solvents%2520of%2520differing%2520polarity%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25202%26date%3D1976%26spage%3D1428%26epage%3D1431%26doi%3D10.1039%2FP29760001428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, M.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.-K.</span></span> <span> </span><span class="NLM_article-title">Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development</span>. <i>Sig. Transduct. Target Ther.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">134</span>, <span class="refDoi"> DOI: 10.1038/s41392-021-00558-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1038%2Fs41392-021-00558-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=33774649" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2021&pages=134&author=M.-M.+Zhaoauthor=W.-L.+Yangauthor=F.-Y.+Yangauthor=L.+Zhangauthor=W.+Huangauthor=W.+Houauthor=C.+Fanauthor=R.+Jinauthor=Y.+Fengauthor=Y.+Wangauthor=J.-K.+Yang&title=Cathepsin+L+plays+a+key+role+in+SARS-CoV-2+infection+in+humans+and+humanized+mice+and+is+a+promising+target+for+new+drug+development&doi=10.1038%2Fs41392-021-00558-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fs41392-021-00558-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41392-021-00558-8%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DM.-M.%26aulast%3DYang%26aufirst%3DW.-L.%26aulast%3DYang%26aufirst%3DF.-Y.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DHou%26aufirst%3DW.%26aulast%3DFan%26aufirst%3DC.%26aulast%3DJin%26aufirst%3DR.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DJ.-K.%26atitle%3DCathepsin%2520L%2520plays%2520a%2520key%2520role%2520in%2520SARS-CoV-2%2520infection%2520in%2520humans%2520and%2520humanized%2520mice%2520and%2520is%2520a%2520promising%2520target%2520for%2520new%2520drug%2520development%26jtitle%3DSig.%2520Transduct.%2520Target%2520Ther.%26date%3D2021%26volume%3D6%26spage%3D134%26doi%3D10.1038%2Fs41392-021-00558-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Noisier, A. F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brimble, M. A.</span></span> <span> </span><span class="NLM_article-title">Novel preparation of chiral α-amino acids using the Mitsunobu–Tsunoda reaction</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">7744</span>– <span class="NLM_lpage">7746</span>, <span class="refDoi"> DOI: 10.1039/c3cc44717k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1039%2Fc3cc44717k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=23877629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1elsL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=7744-7746&author=A.+F.+M.+Noisierauthor=C.+S.+Harrisauthor=M.+A.+Brimble&title=Novel+preparation+of+chiral+%CE%B1-amino+acids+using+the+Mitsunobu%E2%80%93Tsunoda+reaction&doi=10.1039%2Fc3cc44717k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Novel preparation of chiral α-amino acids using the Mitsunobu-Tsunoda reaction</span></div><div class="casAuthors">Noisier, Anais F. M.; Harris, Craig S.; Brimble, Margaret A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">70</span>),
    <span class="NLM_cas:pages">7744-7746</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">An efficient synthesis of racemic or optically active α-amino acids by modified-Mitsunobu alkylation of a racemic or chiral glycine template from alcs. was developed.  Libraries of amino acids were prepd. in moderate to good yield with good to high enantioselectivity.  This simple method widens the scope for prepn. of structurally diverse amino acids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6DZLXXLhtLrVg90H21EOLACvtfcHk0lgCHaqSmChgFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1elsL3L&md5=e688a08962a4099aa986d3baa5f8e200</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1039%2Fc3cc44717k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3cc44717k%26sid%3Dliteratum%253Aachs%26aulast%3DNoisier%26aufirst%3DA.%2BF.%2BM.%26aulast%3DHarris%26aufirst%3DC.%2BS.%26aulast%3DBrimble%26aufirst%3DM.%2BA.%26atitle%3DNovel%2520preparation%2520of%2520chiral%2520%25CE%25B1-amino%2520acids%2520using%2520the%2520Mitsunobu%25E2%2580%2593Tsunoda%2520reaction%26jtitle%3DChem.%2520Commun.%26date%3D2013%26volume%3D49%26spage%3D7744%26epage%3D7746%26doi%3D10.1039%2Fc3cc44717k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, T. D.</span></span> <span> </span><span class="NLM_article-title">Catalytic mechanism of cruzain from <i>Trypanosoma cruzi</i> as determined from solvent kinetic isotope effects of steady-state and pre-steady-state kinetics</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">3176</span>– <span class="NLM_lpage">3190</span>, <span class="refDoi"> DOI: 10.1021/acs.biochem.7b01250</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.7b01250" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotV2nsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=3176-3190&author=X.+Zhaiauthor=T.+D.+Meek&title=Catalytic+mechanism+of+cruzain+from+Trypanosoma+cruzi+as+determined+from+solvent+kinetic+isotope+effects+of+steady-state+and+pre-steady-state+kinetics&doi=10.1021%2Facs.biochem.7b01250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Catalytic Mechanism of Cruzain from Trypanosoma cruzi As Determined from Solvent Kinetic Isotope Effects of Steady-State and Pre-Steady-State Kinetics</span></div><div class="casAuthors">Zhai, Xiang; Meek, Thomas D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3176-3190</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cruzain, an important drug target for Chagas disease, is a member of Clan CA of the cysteine proteases.  Understanding the catalytic mechanism of cruzain is vital to the design of new inhibitors.  To this end, we have performed pH-rate profiles for substrates and affinity agents, and have detd. solvent kinetic isotope effects in pre-steady-state and steady-state modes using three substrates: Cbz-Phe-Arg-AMC, Cbz-Arg-Arg-AMC and Cbz-Arg-Ala-AMC.  The pH-rate profile of kcat/Km for Cbz-Arg-Arg-AMC indicated groups of pK1 = 6.6 (unprotonated) and pK2 ∼ 9.6 (protonated) required for catalysis.  The temp. dependence of the group of pK = 6.2 - 6.6 exhibited a values of ΔHion = 8.4 kcal/mol, typical of histidine.  The pH-rate profile of inactivation by iodoacetamide confirmed that the catalytic cysteine possesses a pKa of 9.8.  Normal solvent kinetic isotope effects were obsd. for both D2Okcat = 1.6 - 2.1 and D2Okcat/Km = 1.1 - 1.4 for all three substrates.  Pre-steady-state kinetics revealed exponential bursts of AMC prodn. for Cbz-Phe-Arg-AMC and Cbz-Arg-Arg-AMC, but not for Cbz-Arg-Ala-AMC.  The overall solvent isotope effect on kcat is attributable to the solvent isotope effect on the deacylation step.  Our results suggest that cruzain is unique among papain-like cysteine proteases in that the catalytic cysteine and histidine are neutral in charge in the free enzyme.  The generation of the active thiolate of the catalytic cysteine is likely proceeded (and possibly triggered) by a ligand-induced conformational change, which could bring the catalytic dyad to close proximity in order to effect proton transfer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGNPkhmnRHYbVg90H21EOLACvtfcHk0lgjjKJRhjcL7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotV2nsw%253D%253D&md5=c9905e633b50aab71fe3450428aa4c84</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.7b01250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.7b01250%26sid%3Dliteratum%253Aachs%26aulast%3DZhai%26aufirst%3DX.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26atitle%3DCatalytic%2520mechanism%2520of%2520cruzain%2520from%2520Trypanosoma%2520cruzi%2520as%2520determined%2520from%2520solvent%2520kinetic%2520isotope%2520effects%2520of%2520steady-state%2520and%2520pre-steady-state%2520kinetics%26jtitle%3DBiochemistry%26date%3D2018%26volume%3D57%26spage%3D3176%26epage%3D3190%26doi%3D10.1021%2Facs.biochem.7b01250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chenna, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellott, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siqueira-Neto, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvet Alvarez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernatchez, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desormeaux, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez Hernandez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruz-Reyes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, T. D.</span></span> <span> </span><span class="NLM_article-title">Peptidomimetic vinyl heterocyclic inhibitors of cruzain effect antitrypanosomal activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">3298</span>– <span class="NLM_lpage">3316</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b02078</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b02078" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BB3cXktlOhurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=3298-3316&author=B.+C.+Chennaauthor=L.+Liauthor=D.+M.+Mellottauthor=X.+Zhaiauthor=J.+L.+Siqueira-Netoauthor=C.+Calvet+Alvarezauthor=J.+A.+Bernatchezauthor=E.+Desormeauxauthor=E.+Alvarez+Hernandezauthor=J.+Gomezauthor=J.+H.+McKerrowauthor=J.+Cruz-Reyesauthor=T.+D.+Meek&title=Peptidomimetic+vinyl+heterocyclic+inhibitors+of+cruzain+effect+antitrypanosomal+activity&doi=10.1021%2Facs.jmedchem.9b02078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Peptidomimetic vinyl heterocyclic inhibitors of cruzain effect antitrypanosomal activity</span></div><div class="casAuthors">Chenna, Bala C.; Li, Linfeng; Mellott, Drake M.; Zhai, Xiang; Siqueira-Neto, Jair L.; Calvet Alvarez, Claudia; Bernatchez, Jean A.; Desormeaux, Emily; Alvarez Hernandez, Elizabeth; Gomez, Jana; McKerrow, James H.; Cruz-Reyes, Jorge; Meek, Thomas D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3298-3316</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cruzain, an essential cysteine protease of the parasitic protozoan, Trypanosoma cruzi, is an important drug target for Chagas disease.  We describe here a new series of reversible but time-dependent inhibitors of cruzain, composed of a dipeptide scaffold appended to vinyl heterocycles meant to provide replacements for the irreversible reactive "warheads" of vinyl sulfone inactivators of cruzain.  Peptidomimetic vinyl heterocyclic inhibitors (PVHIs) contg. Cbz-Phe-Phe/homoPhe scaffolds with vinyl-2-pyrimidine, vinyl-2-pyridine, and vinyl-2-(N-methyl)-pyridine groups conferred reversible, time-dependent inhibition of cruzain (Ki* = 0.1-0.4μM).  These cruzain inhibitors exhibited moderate to excellent selectivity vs. human cathepsins B, L, and S and showed no apparent toxicity to human cells but were effective in cell cultures of Trypanosoma brucei brucei (EC50 = 1-15μM) and eliminated T. cruzi in infected murine cardiomyoblasts (EC50 = 5-8μM).  PVHIs represent a new class of cruzain inhibitors that could progress to viable candidate compds. to treat Chagas disease and human sleeping sickness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCRV5dvomK1LVg90H21EOLACvtfcHk0lgjjKJRhjcL7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXktlOhurc%253D&md5=4115cfac549b94207be86837b81d32dc</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b02078%26sid%3Dliteratum%253Aachs%26aulast%3DChenna%26aufirst%3DB.%2BC.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DMellott%26aufirst%3DD.%2BM.%26aulast%3DZhai%26aufirst%3DX.%26aulast%3DSiqueira-Neto%26aufirst%3DJ.%2BL.%26aulast%3DCalvet%2BAlvarez%26aufirst%3DC.%26aulast%3DBernatchez%26aufirst%3DJ.%2BA.%26aulast%3DDesormeaux%26aufirst%3DE.%26aulast%3DAlvarez%2BHernandez%26aufirst%3DE.%26aulast%3DGomez%26aufirst%3DJ.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DCruz-Reyes%26aufirst%3DJ.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26atitle%3DPeptidomimetic%2520vinyl%2520heterocyclic%2520inhibitors%2520of%2520cruzain%2520effect%2520antitrypanosomal%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D3298%26epage%3D3316%26doi%3D10.1021%2Facs.jmedchem.9b02078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drew, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Englund, P. T.</span></span> <span> </span><span class="NLM_article-title">Inhibition of <i>Trypanosoma brucei</i> gene expression by RNA interference using an integratable vector with opposing T7 promoters</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">40174</span>– <span class="NLM_lpage">40179</span>, <span class="refDoi"> DOI: 10.1074/jbc.M008405200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1074%2Fjbc.M008405200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=11013266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsFemsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=40174-40179&author=Z.+Wangauthor=J.+C.+Morrisauthor=M.+E.+Drewauthor=P.+T.+Englund&title=Inhibition+of+Trypanosoma+brucei+gene+expression+by+RNA+interference+using+an+integratable+vector+with+opposing+T7+promoters&doi=10.1074%2Fjbc.M008405200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Trypanosoma brucei gene expression by RNA interference using an integratable vector with opposing T7 promoters</span></div><div class="casAuthors">Wang, Zefeng; Morris, James C.; Drew, Mark E.; Englund, Paul T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">40174-40179</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">RNA interference is a powerful method for inhibition of gene expression in Trypanosoma brucei.  Here we describe a vector (pZJM) for in vivo tetracycline-inducible synthesis of double-stranded RNA (dsRNA) in stably transformed cells.  The dsRNA is synthesized from opposing T7 promoters.  We tested the vector with genes involved in processes such as kinetoplast DNA replication, mitochondrial mRNA synthesis, glycosyl phosphatidylinositol biosynthesis, glycosome biogenesis, and polyamine biosynthesis.  In most cases the induction of dsRNA caused specific and dramatic loss of the appropriate mRNA, and in many cases there was growth inhibition or cell death.  One striking phenotype was the loss of kinetoplast DNA after interference with expression of a topoisomerase II.  The gene being analyzed by this procedure need not even be fully sequenced.  In fact, many of the genes we tested were derived from partial sequences in the T. brucei genome data base that were identified by homol. with known proteins.  It takes as little as 3 wk from identification of a gene sequence in the data base to the appearance of a phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTXMR58EDtiLVg90H21EOLACvtfcHk0ljhvmYhcDdjLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsFemsw%253D%253D&md5=9126412d958c757a3d748eb655fa99be</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M008405200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M008405200%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DDrew%26aufirst%3DM.%2BE.%26aulast%3DEnglund%26aufirst%3DP.%2BT.%26atitle%3DInhibition%2520of%2520Trypanosoma%2520brucei%2520gene%2520expression%2520by%2520RNA%2520interference%2520using%2520an%2520integratable%2520vector%2520with%2520opposing%2520T7%2520promoters%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D40174%26epage%3D40179%26doi%3D10.1074%2Fjbc.M008405200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huber, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koella, J. C.</span></span> <span> </span><span class="NLM_article-title">A comparison of three methods of estimating EC<sub>50</sub> in studies of drug resistance of malaria parasites</span>. <i>Acta Trop.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">257</span>– <span class="NLM_lpage">261</span>, <span class="refDoi"> DOI: 10.1016/0001-706X(93)90083-N</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1016%2F0001-706X%2893%2990083-N" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=8147282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A280%3ADyaK2c7pslSktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1993&pages=257-261&author=W.+Huberauthor=J.+C.+Koella&title=A+comparison+of+three+methods+of+estimating+EC50+in+studies+of+drug+resistance+of+malaria+parasites&doi=10.1016%2F0001-706X%2893%2990083-N"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites</span></div><div class="casAuthors">Huber W; Koella J C</div><div class="citationInfo"><span class="NLM_cas:title">Acta tropica</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">257-61</span>
        ISSN:<span class="NLM_cas:issn">0001-706X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCnHrDefzn2skU0YCbOU3EfW6udTcc2eb23NSwNYKjX7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c7pslSktQ%253D%253D&md5=4d08dce20a9b83bc996d3ab05dab73e4</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2F0001-706X%2893%2990083-N&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0001-706X%252893%252990083-N%26sid%3Dliteratum%253Aachs%26aulast%3DHuber%26aufirst%3DW.%26aulast%3DKoella%26aufirst%3DJ.%2BC.%26atitle%3DA%2520comparison%2520of%2520three%2520methods%2520of%2520estimating%2520EC50%2520in%2520studies%2520of%2520drug%2520resistance%2520of%2520malaria%2520parasites%26jtitle%3DActa%2520Trop.%26date%3D1993%26volume%3D55%26spage%3D257%26epage%3D261%26doi%3D10.1016%2F0001-706X%2893%2990083-N" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Delaglio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grzesiek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuister, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeifer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bax, A.</span></span> <span> </span><span class="NLM_article-title">NMRpipe: A multidimensional spectral processing system based on Unix pipes</span>. <i>J. Biomol. NMR</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">293</span>, <span class="refDoi"> DOI: 10.1007/BF00197809</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1007%2FBF00197809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=8520220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADyaK2MXhtVSmurfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1995&pages=277-293&author=F.+Delaglioauthor=S.+Grzesiekauthor=G.+W.+Vuisterauthor=G.+Zhuauthor=J.+Pfeiferauthor=A.+Bax&title=NMRpipe%3A+A+multidimensional+spectral+processing+system+based+on+Unix+pipes&doi=10.1007%2FBF00197809"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">NMRPipe: a multidimensional spectral processing system based on UNIX pipes</span></div><div class="casAuthors">Delaglio, Frank; Grzesiek, Stephan; Vuister, Geerten W.; Zhu, Guang; Pfeifer, John; Bax, Ad</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular NMR</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">277-93</span>CODEN:
                <span class="NLM_cas:coden">JBNME9</span>;
        ISSN:<span class="NLM_cas:issn">0925-2738</span>.
    
            (<span class="NLM_cas:orgname">ESCOM</span>)
        </div><div class="casAbstract">The NMRPipe system is a UNIX software environment of processing, graphics, and anal. tools designed to meet current routine and research-oriented multidimensional processing requirements, and to anticipate and accommodate future demands and developments.  The system is based on UNIX pipes, which allow programs running simultaneously to exchange streams of data under user control.  In an NMRPipe processing scheme, a stream of spectral data flows through a pipeline of processing programs, each of which performs one component of the overall scheme, such as Fourier transformation or linear prediction.  Complete multidimensional processing schemes are constructed as simple UNIX shell scripts.  The processing modules themselves maintain and exploit accurate records of data sizes, detection modes, and calibration information in all dimensions, so that schemes can be constructed without the need to explicitly define or anticipate data sizes or storage details of real and imaginary channels during processing.  The asynchronous pipeline scheme provides other substantial advantages, including high flexibility, favorable processing speeds, choice of both all-in-memory and disk-bound processing, easy adaptation to different data formats, simpler software development and maintenance, and the ability to distribute processing tasks on multi-CPU computers and computer networks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSIUdXrdcEgbVg90H21EOLACvtfcHk0ljhvmYhcDdjLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXhtVSmurfK&md5=a670fca5b164083e2178fafd2fb951ff</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2FBF00197809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00197809%26sid%3Dliteratum%253Aachs%26aulast%3DDelaglio%26aufirst%3DF.%26aulast%3DGrzesiek%26aufirst%3DS.%26aulast%3DVuister%26aufirst%3DG.%2BW.%26aulast%3DZhu%26aufirst%3DG.%26aulast%3DPfeifer%26aufirst%3DJ.%26aulast%3DBax%26aufirst%3DA.%26atitle%3DNMRpipe%253A%2520A%2520multidimensional%2520spectral%2520processing%2520system%2520based%2520on%2520Unix%2520pipes%26jtitle%3DJ.%2520Biomol.%2520NMR%26date%3D1995%26volume%3D6%26spage%3D277%26epage%3D293%26doi%3D10.1007%2FBF00197809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markley, J. L.</span></span> <span> </span><span class="NLM_article-title">NMRFAM-SPARKY: Enhanced software for biomolecular NMR spectroscopy</span>. <i>Bioinformatics</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1325</span>– <span class="NLM_lpage">1327</span>, <span class="refDoi"> DOI: 10.1093/bioinformatics/btu830</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1093%2Fbioinformatics%2Fbtu830" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=25505092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A280%3ADC%252BC2MznslWjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2015&pages=1325-1327&author=W.+Leeauthor=M.+Tonelliauthor=J.+L.+Markley&title=NMRFAM-SPARKY%3A+Enhanced+software+for+biomolecular+NMR+spectroscopy&doi=10.1093%2Fbioinformatics%2Fbtu830"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">NMRFAM-SPARKY: enhanced software for biomolecular NMR spectroscopy</span></div><div class="casAuthors">Lee Woonghee; Tonelli Marco; Markley John L</div><div class="citationInfo"><span class="NLM_cas:title">Bioinformatics (Oxford, England)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1325-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">UNLABELLED:  SPARKY (Goddard and Kneller, SPARKY 3) remains the most popular software program for NMR data analysis, despite the fact that development of the package by its originators ceased in 2001.  We have taken over the development of this package and describe NMRFAM-SPARKY, which implements new functions reflecting advances in the biomolecular NMR field.  NMRFAM-SPARKY has been repackaged with current versions of Python and Tcl/Tk, which support new tools for NMR peak simulation and graphical assignment determination.  These tools, along with chemical shift predictions from the PACSY database, greatly accelerate protein side chain assignments.  NMRFAM-SPARKY supports automated data format interconversion for interfacing with a variety of web servers including, PECAN , PINE, TALOS-N, CS-Rosetta, SHIFTX2 and PONDEROSA-C/S.  AVAILABILITY AND IMPLEMENTATION:  The software package, along with binary and source codes, if desired, can be downloaded freely from http://pine.nmrfam.wisc.edu/download_packages.html.  Instruction manuals and video tutorials can be found at http://www.nmrfam.wisc.edu/nmrfam-sparky-distribution.htm.  CONTACT:  <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="d2a5babeb7b792bcbfa0b4b3bffca5bba1b1fcb7b6a7">[email protected]</a> or <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="462b27342d2a233f06282b3420272b68312f352568232233">[email protected]</a>  SUPPLEMENTARY INFORMATION:  Supplementary data are available at Bioinformatics online.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSXhk7kdjQcojAyhZbj3lKdfW6udTcc2ea71hEaaVE4ILntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MznslWjug%253D%253D&md5=6bcf1b3b73f8d80fff0698e6b56e183e</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1093%2Fbioinformatics%2Fbtu830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbioinformatics%252Fbtu830%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DW.%26aulast%3DTonelli%26aufirst%3DM.%26aulast%3DMarkley%26aufirst%3DJ.%2BL.%26atitle%3DNMRFAM-SPARKY%253A%2520Enhanced%2520software%2520for%2520biomolecular%2520NMR%2520spectroscopy%26jtitle%3DBioinformatics%26date%3D2015%26volume%3D31%26spage%3D1325%26epage%3D1327%26doi%3D10.1093%2Fbioinformatics%2Fbtu830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Willcott, M. R.</span></span> <span> </span><span class="NLM_article-title">Mestre Nova</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">13180</span>– <span class="NLM_lpage">13180</span>, <span class="refDoi"> DOI: 10.1021/ja906709t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja906709t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVKksLzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=13180-13180&author=M.+R.+Willcott&title=Mestre+Nova&doi=10.1021%2Fja906709t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">MestRe Nova</span></div><div class="casAuthors">Willcott, Mark Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">13180</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTWkkT-BofpbVg90H21EOLACvtfcHk0ljb4P55YD8lZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVKksLzN&md5=f3bc685169d5eee2f710a04d40340a89</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fja906709t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja906709t%26sid%3Dliteratum%253Aachs%26aulast%3DWillcott%26aufirst%3DM.%2BR.%26atitle%3DMestre%2520Nova%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D13180%26epage%3D13180%26doi%3D10.1021%2Fja906709t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alugubelli, Y. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vatansever, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drelich, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sankaran, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, Z. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blankenship, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kratch, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayatshahi, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fierke, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W. R.</span></span> <span> </span><span class="NLM_article-title">A quick route to multiple highly potent SARS-CoV-2 Main protease inhibitors</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">942</span>– <span class="NLM_lpage">948</span>, <span class="refDoi"> DOI: 10.1002/cmdc.202000924</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1002%2Fcmdc.202000924" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=33283984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisFeltrnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2021&pages=942-948&author=K.+S.+Yangauthor=X.+R.+Maauthor=Y.+Maauthor=Y.+R.+Alugubelliauthor=D.+A.+Scottauthor=E.+C.+Vatanseverauthor=A.+K.+Drelichauthor=B.+Sankaranauthor=Z.+Z.+Gengauthor=L.+R.+Blankenshipauthor=H.+E.+Wardauthor=Y.+J.+Shengauthor=J.+C.+Hsuauthor=K.+C.+Kratchauthor=B.+Zhaoauthor=H.+S.+Hayatshahiauthor=J.+Liuauthor=P.+Liauthor=C.+A.+Fierkeauthor=C.+K.+Tsengauthor=S.+Xuauthor=W.+R.+Liu&title=A+quick+route+to+multiple+highly+potent+SARS-CoV-2+Main+protease+inhibitors&doi=10.1002%2Fcmdc.202000924"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A quick route to multiple highly potent SARS-CoV-2 main protease inhibitors</span></div><div class="casAuthors">Yang, Kai S.; Ma, Xinyu R.; Ma, Yuying; Alugubelli, Yugendar R.; Scott, Danielle A.; Vatansever, Erol C.; Drelich, Aleksandra K.; Sankaran, Banumathi; Geng, Zhi Z.; Blankenship, Lauren R.; Ward, Hannah E.; Sheng, Yan J.; Hsu, Jason C.; Kratch, Kaci C.; Zhao, Baoyu; Hayatshahi, Hamed S.; Liu, Jin; Li, Pingwei; Fierke, Carol A.; Tseng, Chien-Te K.; Xu, Shiqing; Liu, Wenshe Ray</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">942-948</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The COVID-19 pathogen, SARS-CoV-2, requires its main protease (SC2MPro) to digest two of its translated long polypeptides to form a no. of mature proteins that are essential for viral replication and pathogenesis.  Inhibition of this vital proteolytic process is effective in preventing the virus from replicating in infected cells and therefore provides a potential COVID-19 treatment option.  Guided by previous medicinal chem. studies about SARS-CoV-1 main protease (SC1MPro), we have designed and synthesized a series of SC2MPro inhibitors that contain β-(S-2-oxopyrrolidin-3-yl)-alaninal (Opal) for the formation of a reversible covalent bond with the SC2MPro active-site cysteine C145.  All inhibitors display high potency with Ki values at or below 100 nM.  The most potent compd., MPI3, has as a Ki value of 8.3 nM.  Crystallog. analyses of SC2MPro bound to seven inhibitors indicated both formation of a covalent bond with C145 and structural rearrangement from the apoenzyme to accommodate the inhibitors.  Virus inhibition assays revealed that several inhibitors have high potency in inhibiting the SARS-CoV-2-induced cytopathogenic effect in both Vero E6 and A549/ACE2 cells.  Two inhibitors, MPI5 and MPI8, completely prevented the SARS-CoV-2-induced cytopathogenic effect in Vero E6 cells at 2.5-5μM and A549/ACE2 cells at 0.16-0.31μM.  Their virus inhibition potency is much higher than that of some existing mols. that are under preclin. and clin. investigations for the treatment of COVID-19.  Our study indicates that there is a large chem. space that needs to be explored for the development of SC2MPro inhibitors with ultra-high antiviral potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRlIuItljsvLVg90H21EOLACvtfcHk0lh7cJGs63d8ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisFeltrnM&md5=bccda05c82b6358d5d0e38d0e0ebe757</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.202000924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.202000924%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DK.%2BS.%26aulast%3DMa%26aufirst%3DX.%2BR.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DAlugubelli%26aufirst%3DY.%2BR.%26aulast%3DScott%26aufirst%3DD.%2BA.%26aulast%3DVatansever%26aufirst%3DE.%2BC.%26aulast%3DDrelich%26aufirst%3DA.%2BK.%26aulast%3DSankaran%26aufirst%3DB.%26aulast%3DGeng%26aufirst%3DZ.%2BZ.%26aulast%3DBlankenship%26aufirst%3DL.%2BR.%26aulast%3DWard%26aufirst%3DH.%2BE.%26aulast%3DSheng%26aufirst%3DY.%2BJ.%26aulast%3DHsu%26aufirst%3DJ.%2BC.%26aulast%3DKratch%26aufirst%3DK.%2BC.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DHayatshahi%26aufirst%3DH.%2BS.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DFierke%26aufirst%3DC.%2BA.%26aulast%3DTseng%26aufirst%3DC.%2BK.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DW.%2BR.%26atitle%3DA%2520quick%2520route%2520to%2520multiple%2520highly%2520potent%2520SARS-CoV-2%2520Main%2520protease%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2021%26volume%3D16%26spage%3D942%26epage%3D948%26doi%3D10.1002%2Fcmdc.202000924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keegan, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krissinel, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, A. G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNicholas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannu, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potterton, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K. S.</span></span> <span> </span><span class="NLM_article-title">Overview of the CCP4 suite and current developments</span>. <i>Acta Crystallogr. D</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1107/S0907444910045749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=21460441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=235-242&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+W.+Leslieauthor=A.+McCoyauthor=S.+J.+McNicholasauthor=G.+N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+suite+and+current+developments&doi=10.1107%2FS0907444910045749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0lh7cJGs63d8ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520suite%2520and%2520current%2520developments%26jtitle%3DActa%2520Crystallogr.%2520D%26date%3D2011%26volume%3D67%26spage%3D235%26epage%3D242%26doi%3D10.1107%2FS0907444910045749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curth, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drosten, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauerhering, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilgenfeld, R.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of SARS-CoV-2 Main protease provides a basis for design of improved α-ketoamide inhibitors</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>368</i></span>,  <span class="NLM_fpage">409</span>– <span class="NLM_lpage">412</span>, <span class="refDoi"> DOI: 10.1126/science.abb3405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1126%2Fscience.abb3405" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=32198291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnslKrtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2020&pages=409-412&author=L.+Zhangauthor=D.+Linauthor=X.+Sunauthor=U.+Curthauthor=C.+Drostenauthor=L.+Sauerheringauthor=S.+Beckerauthor=K.+Roxauthor=R.+Hilgenfeld&title=Crystal+structure+of+SARS-CoV-2+Main+protease+provides+a+basis+for+design+of+improved+%CE%B1-ketoamide+inhibitors&doi=10.1126%2Fscience.abb3405"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors</span></div><div class="casAuthors">Zhang, Linlin; Lin, Daizong; Sun, Xinyuanyuan; Curth, Ute; Drosten, Christian; Sauerhering, Lucie; Becker, Stephan; Rox, Katharina; Hilgenfeld, Rolf</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">6489</span>),
    <span class="NLM_cas:pages">409-412</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">1095-9203</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is a global health emergency.  An attractive drug target among coronaviruses is the main protease (Mpro, also called 3CLpro) because of its essential role in processing the polyproteins that are translated from the viral RNA.  We report the x-ray structures of the unliganded SARS-CoV-2 Mpro and its complex with an α-ketoamide inhibitor.  This was derived from a previously designed inhibitor but with the P3-P2 amide bond incorporated into a pyridone ring to enhance the half-life of the compd. in plasma.  On the basis of the unliganded structure, we developed the lead compd. into a potent inhibitor of the SARS-CoV-2 Mpro.  The pharmacokinetic characterization of the optimized inhibitor reveals a pronounced lung tropism and suitability for administration by the inhalative route.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT531N47m4BbVg90H21EOLACvtfcHk0lh7cJGs63d8ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnslKrtL8%253D&md5=9ac417c20f54c3327f9de9088b512d52</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1126%2Fscience.abb3405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.abb3405%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DCurth%26aufirst%3DU.%26aulast%3DDrosten%26aufirst%3DC.%26aulast%3DSauerhering%26aufirst%3DL.%26aulast%3DBecker%26aufirst%3DS.%26aulast%3DRox%26aufirst%3DK.%26aulast%3DHilgenfeld%26aufirst%3DR.%26atitle%3DCrystal%2520structure%2520of%2520SARS-CoV-2%2520Main%2520protease%2520provides%2520a%2520basis%2520for%2520design%2520of%2520improved%2520%25CE%25B1-ketoamide%2520inhibitors%26jtitle%3DScience%26date%3D2020%26volume%3D368%26spage%3D409%26epage%3D412%26doi%3D10.1126%2Fscience.abb3405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afonine, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunkóczi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echols, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, L.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oeffner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, P. H.</span></span> <span> </span><span class="NLM_article-title">PHENIX: A comprehensive python-based system for macromolecular structure solution</span>. <i>Acta Crystallogr. D</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunk%C3%B3cziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.-W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+A+comprehensive+python-based+system+for+macromolecular+structure+solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0lj6W4VIVY6gxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunk%25C3%25B3czi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.-W.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520A%2520comprehensive%2520python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%2520D%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr. D</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lj6W4VIVY6gxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%2520D%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, C. T.</span></span> <span> </span><span class="NLM_article-title">The behavior and significance of slow-binding enzyme inhibitors</span>. <i>Adv. Enzymol. Relat. Areas Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">201</span>– <span class="NLM_lpage">301</span>, <span class="refDoi"> DOI: 10.1002/9780470123072.ch5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1002%2F9780470123072.ch5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=3281418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADyaL1MXhtlSrtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1988&pages=201-301&author=J.+F.+Morrisonauthor=C.+T.+Walsh&title=The+behavior+and+significance+of+slow-binding+enzyme+inhibitors&doi=10.1002%2F9780470123072.ch5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The behavior and significance of slow-binding enzyme inhibitors</span></div><div class="casAuthors">Morrison, John F.; Walsh, Christopher T.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Enzymology and Related Areas of Molecular Biology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">201-301</span>CODEN:
                <span class="NLM_cas:coden">AERAAD</span>;
        ISSN:<span class="NLM_cas:issn">0065-258X</span>.
    </div><div class="casAbstract">A review with 112 refs. on the anal. and properties of slow-binding enzyme inhibitors.  The topics discussed include formation of complexes of enzymes and slow-binding inhibitors, slow-binding inhibitors as drugs, characteristics and anal. of progress curves for slow-binding inhibitors, and specific cases of slow-binding inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1MoW3TRk0ubVg90H21EOLACvtfcHk0lj6W4VIVY6gxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhtlSrtbk%253D&md5=6c0d34ce86e49cd63c44b30d7fefa016</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2F9780470123072.ch5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F9780470123072.ch5%26sid%3Dliteratum%253Aachs%26aulast%3DMorrison%26aufirst%3DJ.%2BF.%26aulast%3DWalsh%26aufirst%3DC.%2BT.%26atitle%3DThe%2520behavior%2520and%2520significance%2520of%2520slow-binding%2520enzyme%2520inhibitors%26jtitle%3DAdv.%2520Enzymol.%2520Relat.%2520Areas%2520Mol.%2520Biol.%26date%3D1988%26volume%3D61%26spage%3D201%26epage%3D301%26doi%3D10.1002%2F9780470123072.ch5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span> <span> </span><span class="NLM_article-title">Tight binding inhibitors</span>. In  <i>Enzymes: A practical introduction to structure, mechanism, and data analysis</i>, <span class="NLM_publisher-loc">VCH</span>: <span class="NLM_publisher-name">New York</span>, <span class="NLM_year">2000</span>;  <span class="NLM_fpage">305</span>– <span class="NLM_lpage">317</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1002%2F0471220639.ch9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=305-317&author=R.+A.+Copeland&title=Enzymes%3A+A+practical+introduction+to+structure%2C+mechanism%2C+and+data+analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2F0471220639.ch9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0471220639.ch9%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26atitle%3DTight%2520binding%2520inhibitors%26btitle%3DEnzymes%253A%2520A%2520practical%2520introduction%2520to%2520structure%252C%2520mechanism%252C%2520and%2520data%2520analysis%26pub%3DNew%2520York%26date%3D2000%26spage%3D305%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinen, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roush, W. R.</span></span> <span> </span><span class="NLM_article-title"><i>In vitro</i> and <i>in vivo</i> studies of the trypanocidal properties of WRR-483 against <i>Trypanosoma cruzi</i></span>. <i>PLoS Negl. Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e825</span> <span class="refDoi"> DOI: 10.1371/journal.pntd.0000825</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1371%2Fjournal.pntd.0000825" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=20856868" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2010&author=Y.+T.+Chenauthor=L.+S.+Brinenauthor=I.+D.+Kerrauthor=E.+Hansellauthor=P.+S.+Doyleauthor=J.+H.+McKerrowauthor=W.+R.+Roush&title=In+vitro+and+in+vivo+studies+of+the+trypanocidal+properties+of+WRR-483+against+Trypanosoma+cruzi&doi=10.1371%2Fjournal.pntd.0000825"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0000825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0000825%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%2BT.%26aulast%3DBrinen%26aufirst%3DL.%2BS.%26aulast%3DKerr%26aufirst%3DI.%2BD.%26aulast%3DHansell%26aufirst%3DE.%26aulast%3DDoyle%26aufirst%3DP.%2BS.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DRoush%26aufirst%3DW.%2BR.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520studies%2520of%2520the%2520trypanocidal%2520properties%2520of%2520WRR-483%2520against%2520Trypanosoma%2520cruzi%26jtitle%3DPLoS%2520Negl.%2520Trop.%2520Dis.%26date%3D2010%26volume%3D4%26doi%3D10.1371%2Fjournal.pntd.0000825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/medium/jm1c00628_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00628&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/medium/jm1c00628_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Inactivator and inhibitors of cysteine proteases. (A) Structure of <b>K777</b> and its mechanism of covalent inactivation of cysteine proteases. (B) 1,2,4-trioxolane inhibitor <b>PG4b</b> undergoes Fe(II)-catalyzed fragmentation to elaborate aldehyde <b>PG3b,</b> a potent inhibitor of falcipain, and a radical byproduct. (C) γ-lactol inhibitor <b>MN3</b> is a masked aldehyde of <b>SJA0617</b>. It exhibits higher transcorneal permeability and releases the free aldehyde to inhibit μ-calpain.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00628&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/medium/jm1c00628_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Rationale for the design of SMAIs. (A) In compound <b>2</b>, the aldehyde group is expected to be masked by the 2′-phenol group via spontaneous formation of a lactol. It is anticipated that the SMAI will undergo enzyme-catalyzed opening of the lactol ring and subsequently form the hemithioacetal adduct with Cys<sub>25</sub>. The scheme describes a two-step inhibition mechanism in which rapid formation of an <b>EI</b> complex precedes isomerization to <b>EI*</b>, which slowly converts back to <b>EI</b>. (B) Lactol form of <b>2</b> (green) noncovalently docked to cruzain. (C) Opened form of <b>2</b> covalently docked to form a hemithioacetal with Cys<sub>25</sub>. Both structures are superimposed with a covalently bound <b>K777</b> (white) from the crystal structure (PDB ID: 2OZ2).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Colored dashed lines represent corresponding cruzain–inhibitor interactions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00628&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/medium/jm1c00628_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Kinetic analysis of inhibition of cruzain by <b>1</b>, <b>2,</b> and <b>12</b>. (A–C) Time courses of cruzain inhibition by <b>1, 2</b>, and <b>12</b>. Insets for (A) and (C): the <i>k</i><sub>obs</sub> values were obtained by fitting progress curves to <a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a>. Replot of <i>k</i><sub>obs</sub> vs [<i>I</i>] with the line drawn through data points from fitting to <a class="ref internalNav" href="#eq3" aria-label="eq 3">eq 3</a>. <b>1</b>: <i>k</i><sub>4</sub> = (7.6 ± 0.6) × 10<sup>–4</sup> s<sup>–1</sup>; <b>12</b>: <i>k</i><sub>4</sub> = (1.8 ± 0.7) × 10<sup>–4</sup> s<sup>–1</sup>. Inset for (B): the steady-state rates with (<i>v</i><sub>s</sub>) and without inhibitor (<i>v</i><sub>0</sub>) were obtained at <i>t</i> ≥ 20 min. Plot of <i>v</i><sub>s</sub>/<i>v</i><sub>0</sub> vs [<b>2</b>] with the line drawn through data points from fitting to <a class="ref internalNav" href="#eq4" aria-label="eq 4">eq 4</a>. (D) Proposed mechanism of phenoxy-assisted conversion of <b>EI*</b> back to <b>EI</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00628&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/medium/jm1c00628_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Rapid dilution assay for SMAIs. (A) Dilution scheme for testing the reversibility of a SMAI. Upon 100-fold dilution, the inhibitor concentration decreases from 10-fold > <i>K<sub>i</sub></i>*<sup>app</sup> (91% inhibition) to 10-fold < <i>K<sub>i</sub></i>*<sup>app</sup> (9% inhibition). (B, C) Cruzain activity rapidly recovered from inhibition by <b>2</b> and <b>6</b>–<b>10</b>. (D–F) Cruzain activity recovery showed a significant lag for <b>1</b>, <b>11</b>, and <b>12</b>. All curves were fitted to <a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a> to provide <i>k</i><sub>obs</sub> values as listed in <a href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_001.pdf" class="ext-link">Table S1</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00628&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/medium/jm1c00628_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Studies on the chemical mechanism of SMAI binding to cruzain. (A) Expansion of the superposed <sup>1</sup>H-<sup>13</sup>C HSQC NMR spectra of <sup>13</sup>C-labeled compound <b>12</b> with (blue) and without (red) an approximately equimolar concentration of cruzain, which were obtained at 800 MHz (<sup>1</sup>H) at 25 °C. (B) Time course of phenylhydrazone formation by treating 0.2 mM <b>11</b> (aldehyde) or <b>12</b> (lactol) with 1 mM phenylhydrazine, with a control sample containing DMSO. Data for the curve with compound <b>11</b> were fitted to Abs<sub>282 nm</sub> = <i>a</i>[1–exp.(−<i>k</i><sub>obs</sub><i>t</i>)] + <i>C</i> from which a = 0.279 ± 0.002, <i>k</i><sub>obs</sub> = (2.61 ± 0.05) × 10<sup>–4</sup> s<sup>–1</sup>, and <i>C</i> = 2.63, while fitting the other data to this expression led to negligible values of <i>k</i><sub>obs</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00628&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/medium/jm1c00628_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Development and assessment of SMAI prodrugs. (A) Pralnacasan is a SMAI prodrug for VRT-18858, an inhibitor for caspase-1. (B) Proposed metabolic routes of O-derivatized SMAIs to <b>12</b>. (C) Time course of remaining <b>13</b>–<b>15</b> in reactions with or without addition of porcine esterase. (D) High-performance liquid chromatography (HPLC) traces of compound <b>15</b> in buffer (control). (E) HPLC traces of <b>15</b> treated with esterase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00628&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/medium/jm1c00628_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound <b>18</b> is a potential SMAI for SARS-CoV-2 3CL<sup>pro</sup>. (A) 2-Pyridone is a surrogate for the P<sub>1</sub> γ-lactam. (B) Structure and activity of compound <b>18</b>. (C) Surface representation of the 3CL<sup>pro</sup>-<b>18</b> complex (PDB ID: 7M2P). The 2<i>F</i><sub>o</sub>–<i>F</i><sub>c</sub> electron density map contoured at 1.0 σ indicated C–S bond formation. (D) Interaction between 3CL<sup>pro</sup> and <b>18</b>. Dashed lines depict hydrogen bonds; the oxyanion hole is circled.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00628&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/medium/jm1c00628_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>2</b>–<b>12</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00628&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(i) DBU, DCM, (ii) Pd/C, H<sub>2</sub>, MeOH, (iii) TFA, DCM, (iv) Cbz-Phe-OH or NMePip-Phe-OH (<b>S1j</b>), DIPEA, T3P, DCM, (v) TBSCl, imidazole, DCM, (vi) K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>I, DMF, (vii) NaBH<sub>4</sub>, MeOH, (viii) Dess-Martin periodinane, NaHCO<sub>3</sub>, DCM, 0 °C, (ix) TBAF, THF, 0 °C, (x) Et<sub>3</sub>N, THF, 0 °C, (xi) Pd/C, H<sub>2</sub>, MeOH, (xii) mCPBA, chloroform, (xiii) NaN<sub>3</sub>, MeOH/H<sub>2</sub>O, 60 °C, (xiv) Pd/C, H<sub>2</sub>, MeOH, (xv) NMePip-Phe-OH (<b>S1j</b>), DIPEA, T3P, DCM, (xvi) NMePip-Phe-OH (<b>S1j</b>), DIPEA, T3P, DCM, (xvii) NaBH<sub>4</sub>, MeOH, and (xviii) Dess-Martin periodinane, NaHCO<sub>3</sub>, DCM, 0 °C. *<b>S1l</b> contains two diastereomeric anti products, and only one is drawn here, so do <b>S1m</b> and <b>3.</b></p></p></figure><figure data-id="sch2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/medium/jm1c00628_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>13–17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00628&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(i) acetic/propionic/isobutyric anhydride, Et<sub>3</sub>N, DMAP, DCM and (ii) BF<sub>3</sub>OEt<sub>2</sub>, EtOH/iPrOH.</p></p></figure><figure data-id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/medium/jm1c00628_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <sup>13</sup>C-labeled <b>12</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00628&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(i) 1-methylimidazole, MsCl, DCM, 45 °C, (ii) [1-<sup>13</sup>C] glycine, Ni(NO<sub>3</sub>)<sub>2</sub>·6H<sub>2</sub>O, KOH, MeOH, 60 °C, (iii) (2-(benzyloxy)phenyl)methanol, cyanomethylenetributylphosphorane (CMBP), toluene, 120 °C, (iv) 8-quinolinol, MeCN/H<sub>2</sub>O, 40 °C, (v) Et<sub>3</sub>N, Boc anhydride, dioxane/H<sub>2</sub>O, (vi) N,O-dimethylhydroxylamine, DIPEA, T3P, DCM, (vii) TFA, DCM; NMePip-Phe-OH, DIPEA, T3P, DCM, (viii) LAH, THF, 0 °C, and (ix) Pd/C, H<sub>2</sub>, MeOH.</p></p></figure><figure data-id="sch4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/medium/jm1c00628_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of <b>18</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.1c00628/20210721/images/large/jm1c00628_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00628&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(i) DBU, DCM, (ii) Pd/C, H<sub>2</sub>, MeOH, (iii) LiOH, MeOH/H<sub>2</sub>O, (iv) N,O-dimethylhydroxylamine, DIPEA, T3P, DCM, (v) TFA, DCM; Cbz-Val-Cha-OH, DIPEA, T3P, DCM, and (vi) LAH, THF, 0 °C.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i68">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55368" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55368" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 48 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bedard, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semler, B. L.</span></span> <span> </span><span class="NLM_article-title">Regulation of picornavirus gene expression</span>. <i>Microbes Infect.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">702</span>– <span class="NLM_lpage">713</span>, <span class="refDoi"> DOI: 10.1016/j.micinf.2004.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1016%2Fj.micinf.2004.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=15158778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktF2qsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=702-713&author=K.+M.+Bedardauthor=B.+L.+Semler&title=Regulation+of+picornavirus+gene+expression&doi=10.1016%2Fj.micinf.2004.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of picornavirus gene expression</span></div><div class="casAuthors">Bedard, Kristin M.; Semler, Bert L.</div><div class="citationInfo"><span class="NLM_cas:title">Microbes and Infection</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">702-713</span>CODEN:
                <span class="NLM_cas:coden">MCINFS</span>;
        ISSN:<span class="NLM_cas:issn">1286-4579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Members of the Picornaviridae are pos.- strand RNA viruses that cause a variety of human diseases such as poliomyelitis, the common cold, myocarditis, and hepatitis.  Although the diseases caused by picornaviruses are diverse, the genome organization and mechanisms of gene expression are highly conserved among family members.  This review will discuss the mechanisms of viral gene expression including cap-independent translation initiation, host cell translation shut off, viral polyprotein processing, and RNA replication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcHzQce4AM9rVg90H21EOLACvtfcHk0liHmV1JsuG90Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktF2qsb8%253D&md5=f2162a6027d95bfac299842da74e26c3</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.micinf.2004.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.micinf.2004.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DBedard%26aufirst%3DK.%2BM.%26aulast%3DSemler%26aufirst%3DB.%2BL.%26atitle%3DRegulation%2520of%2520picornavirus%2520gene%2520expression%26jtitle%3DMicrobes%2520Infect.%26date%3D2004%26volume%3D6%26spage%3D702%26epage%3D713%26doi%3D10.1016%2Fj.micinf.2004.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morse, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalonde, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W. R.</span></span> <span> </span><span class="NLM_article-title">Learning from the past: Possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">730</span>– <span class="NLM_lpage">738</span>, <span class="refDoi"> DOI: 10.1002/cbic.202000047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1002%2Fcbic.202000047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=32022370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjs1ans74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2020&pages=730-738&author=J.+S.+Morseauthor=T.+Lalondeauthor=S.+Xuauthor=W.+R.+Liu&title=Learning+from+the+past%3A+Possible+urgent+prevention+and+treatment+options+for+severe+acute+respiratory+infections+caused+by+2019-nCoV&doi=10.1002%2Fcbic.202000047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV</span></div><div class="casAuthors">Morse, Jared S.; Lalonde, Tyler; Xu, Shiqing; Liu, Wenshe Ray</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">730-738</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  With the current trajectory of the 2019-nCoV outbreak unknown, public health and medicinal measures will both be needed to contain spreading of the virus and to optimize patient outcomes.  Although little is known about the virus, an examn. of the genome sequence shows strong homol. with its better-studied cousin, SARS-CoV.  The spike protein used for host cell infection shows key nonsynonymous mutations that might hamper the efficacy of previously developed therapeutics but remains a viable target for the development of biologics and macrocyclic peptides.  Other key drug targets, including RNA-dependent RNA polymerase and coronavirus main proteinase (3CLpro), share a strikingly high (>95 %) homol. to SARS-CoV.  Herein, we suggest four potential drug candidates (an ACE2-based peptide, remdesivir, 3CLpro-1 and a novel vinylsulfone protease inhibitor) that could be used to treat patients suffering with the 2019-nCoV.  We also summarize previous efforts into drugging these targets and hope to help in the development of broad-spectrum anti-coronaviral agents for future epidemics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQKe18V4rt9rVg90H21EOLACvtfcHk0lhWlmUTf10LlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjs1ans74%253D&md5=57c88df2259222d0a25a545493c66630</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2Fcbic.202000047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.202000047%26sid%3Dliteratum%253Aachs%26aulast%3DMorse%26aufirst%3DJ.%2BS.%26aulast%3DLalonde%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DW.%2BR.%26atitle%3DLearning%2520from%2520the%2520past%253A%2520Possible%2520urgent%2520prevention%2520and%2520treatment%2520options%2520for%2520severe%2520acute%2520respiratory%2520infections%2520caused%2520by%25202019-nCoV%26jtitle%3DChemBioChem%26date%3D2020%26volume%3D21%26spage%3D730%26epage%3D738%26doi%3D10.1002%2Fcbic.202000047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steele-Mortimer, O.</span></span> <span> </span><span class="NLM_article-title">Exploitation of the ubiquitin system by invading bacteria</span>. <i>Traffic</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">162</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1111/j.1600-0854.2010.01137.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1111%2Fj.1600-0854.2010.01137.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=20977569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlSmsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=162-169&author=O.+Steele-Mortimer&title=Exploitation+of+the+ubiquitin+system+by+invading+bacteria&doi=10.1111%2Fj.1600-0854.2010.01137.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Exploitation of the ubiquitin system by invading bacteria</span></div><div class="casAuthors">Steele-Mortimer, Olivia</div><div class="citationInfo"><span class="NLM_cas:title">Traffic (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">162-169</span>CODEN:
                <span class="NLM_cas:coden">TRAFFA</span>;
        ISSN:<span class="NLM_cas:issn">1398-9219</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  A variety of bacterial intracellular pathogens target the host cell ubiquitin system during invasion, a process that involves transient but fundamental changes in the actin cytoskeleton and plasma membrane.  These changes are induced by bacterial proteins, which can be surface assocd., secreted or injected directly into the host cell.  Here, the invasion strategies of two extensively studied intracellular bacteria, Salmonella enterica serovar Typhimurium and Listeria monocytogenes, are used to illustrate some of the diverse ways by which bacterial pathogens intersect the host cell ubiquitin pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMJbYtp7Q8fLVg90H21EOLACvtfcHk0lhWlmUTf10LlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlSmsr8%253D&md5=379eaeeef6ea69e421739734d02df0b9</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0854.2010.01137.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0854.2010.01137.x%26sid%3Dliteratum%253Aachs%26aulast%3DSteele-Mortimer%26aufirst%3DO.%26atitle%3DExploitation%2520of%2520the%2520ubiquitin%2520system%2520by%2520invading%2520bacteria%26jtitle%3DTraffic%26date%3D2011%26volume%3D12%26spage%3D162%26epage%3D169%26doi%3D10.1111%2Fj.1600-0854.2010.01137.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sajid, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span> <span> </span><span class="NLM_article-title">Cysteine proteases of parasitic organisms</span>. <i>Mol. Biochem. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1016/S0166-6851(01)00438-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1016%2FS0166-6851%2801%2900438-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=11849701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BD38Xht1agsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2002&pages=1-21&author=M.+Sajidauthor=J.+H.+McKerrow&title=Cysteine+proteases+of+parasitic+organisms&doi=10.1016%2FS0166-6851%2801%2900438-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cysteine proteases of parasitic organisms</span></div><div class="casAuthors">Sajid, M.; McKerrow, J. H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Biochemical Parasitology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-21</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Cysteine proteases play numerous indispensable roles in the biol. of parasitic organisms.  Aside from previously known general catabolic functions and protein processing, cysteine proteases may be key to parasite immunoevasion, excystment/encystment, exsheathing and cell and tissue invasion.  Parasite cysteine proteases are unusually immunogenic and have been exploited as serodiagnostic markers and vaccine targets.  Although host homologues exist, parasite cysteine proteases have distinct structural and biochem. properties including, pH optima and stability, the alteration in peptide loops or domain extensions, diverse substrate specificity and cellular location.  The disparate nature of parasite cysteine protease compared to the host orthologous proteins has opened opportunities for chemotherapy.  This review will highlight recent research on the 'papain-like' class of cysteine proteases, the most abundant family, and the newly discovered class of asparaginyl-endopeptidases.  Cysteine protease classification will be re-examd. in light of the diversity uncovered within parasitic organisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxpzi_yram6LVg90H21EOLACvtfcHk0lhWlmUTf10LlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xht1agsbo%253D&md5=6fdd0c0a83d2a50fab6adbeb158d3d96</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0166-6851%2801%2900438-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-6851%252801%252900438-8%26sid%3Dliteratum%253Aachs%26aulast%3DSajid%26aufirst%3DM.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26atitle%3DCysteine%2520proteases%2520of%2520parasitic%2520organisms%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D2002%26volume%3D120%26spage%3D1%26epage%3D21%26doi%3D10.1016%2FS0166-6851%2801%2900438-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rassi, A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rassi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcondes de Rezende, J.</span></span> <span> </span><span class="NLM_article-title">American trypanosomiasis (Chagas disease)</span>. <i>Infect. Dis. Clin. North Am.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">291</span>, <span class="refDoi"> DOI: 10.1016/j.idc.2012.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1016%2Fj.idc.2012.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=22632639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A280%3ADC%252BC38nmtlOltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=275-291&author=A.+Rassiauthor=A.+Rassiauthor=J.+Marcondes+de+Rezende&title=American+trypanosomiasis+%28Chagas+disease%29&doi=10.1016%2Fj.idc.2012.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">American trypanosomiasis (Chagas disease)</span></div><div class="casAuthors">Rassi Anis Jr; Rassi Anis; Marcondes de Rezende Joffre</div><div class="citationInfo"><span class="NLM_cas:title">Infectious disease clinics of North America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-91</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Chagas disease, also known as American trypanosomiasis, is a chronic infection caused by Trypanosoma cruzi, a protozoan parasite.  It is transmitted to human beings mainly through the feces of infected triatomine bugs.  The disease affects an estimated 8 to 10 million people in the Americas, putting them at risk of developing life-threatening cardiac and gastrointestinal complications.  This article provides a brief update on the epidemiology, clinical manifestations, diagnosis, and treatment of Chagas disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRJzahk2B7NOeRS7coPn-RtfW6udTcc2eZDylTwJuIe2Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38nmtlOltA%253D%253D&md5=ef2274a813974a0cf8a7995a06ef1b71</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.idc.2012.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.idc.2012.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DRassi%26aufirst%3DA.%26aulast%3DRassi%26aufirst%3DA.%26aulast%3DMarcondes%2Bde%2BRezende%26aufirst%3DJ.%26atitle%3DAmerican%2520trypanosomiasis%2520%2528Chagas%2520disease%2529%26jtitle%3DInfect.%2520Dis.%2520Clin.%2520North%2520Am.%26date%3D2012%26volume%3D26%26spage%3D275%26epage%3D291%26doi%3D10.1016%2Fj.idc.2012.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Branquinha, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangenito, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodre, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kneipp, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">d’Avila-Levy, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, A. L. S.</span></span> <span> </span><span class="NLM_article-title">Cruzipain: An update on its potential as chemotherapy target against the human pathogen trypanosoma cruzi</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2225</span>– <span class="NLM_lpage">2235</span>, <span class="refDoi"> DOI: 10.2174/0929867322666150521091652</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.2174%2F0929867322666150521091652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=25994861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFWls7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=2225-2235&author=M.+H.+Branquinhaauthor=S.+S.+Oliveiraauthor=L.+S.+Sangenitoauthor=C.+L.+Sodreauthor=L.+F.+Kneippauthor=C.+M.+d%E2%80%99Avila-Levyauthor=A.+L.+S.+Santos&title=Cruzipain%3A+An+update+on+its+potential+as+chemotherapy+target+against+the+human+pathogen+trypanosoma+cruzi&doi=10.2174%2F0929867322666150521091652"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Cruzipain: An Update on its Potential as Chemotherapy Target against the Human Pathogen Trypanosoma cruzi</span></div><div class="casAuthors">Branquinha, M. H.; Oliveira, S. S. C.; Sangenito, L. S.; Sodre, C. L.; Kneipp, L. F.; d'Avila-Levy, C. M.; Santos, A. L. S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2225-2235</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Chagas' disease is one of the most impactful and prevalent neglected tropical diseases in the Americas, specially affecting the poor and underdeveloped areas in Latin America.  Aggravating this scenario, the medicines used in the current chemotherapy are old, toxic and present a low efficacy to treat the chronic stage of this disease.  In addn., resistant strains of Trypanosoma cruzi, the etiol. agent, are frequently reported.  So, there is an imperative requirement for novel chemotherapeutic options to treat this debilitating disease.  In this context, peptidases have emerged as potential targets and, consequently, proteolytic inhibitors have confirmed to be valuable drugs against several human pathologies.  In this line of thinking, T. cruzi produces a major multifunctional cysteine peptidase, named cruzipain, which directly and/or indirectly orchestrates several physiol. and pathol. processes, which culminate in a successful parasitic infection.  Taken together, these findings point out that cruzipain is one of the most important targets for driving a chemotherapy approach against the human pathogen T. cruzi.  The present review summarizes some of the recent advances and failures in this area, with particular emphasis on recently published studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvrikftkPpfrVg90H21EOLACvtfcHk0lghVWo4ZERF4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFWls7jE&md5=c152a7e35be17861d2f0cf228d42d6f4</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F0929867322666150521091652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867322666150521091652%26sid%3Dliteratum%253Aachs%26aulast%3DBranquinha%26aufirst%3DM.%2BH.%26aulast%3DOliveira%26aufirst%3DS.%2BS.%26aulast%3DSangenito%26aufirst%3DL.%2BS.%26aulast%3DSodre%26aufirst%3DC.%2BL.%26aulast%3DKneipp%26aufirst%3DL.%2BF.%26aulast%3Dd%25E2%2580%2599Avila-Levy%26aufirst%3DC.%2BM.%26aulast%3DSantos%26aufirst%3DA.%2BL.%2BS.%26atitle%3DCruzipain%253A%2520An%2520update%2520on%2520its%2520potential%2520as%2520chemotherapy%2520target%2520against%2520the%2520human%2520pathogen%2520trypanosoma%2520cruzi%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2015%26volume%3D22%26spage%3D2225%26epage%3D2235%26doi%3D10.2174%2F0929867322666150521091652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roush, W. R.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the synthesis, design and selection of cysteine protease inhibitors</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">459</span>– <span class="NLM_lpage">465</span>, <span class="refDoi"> DOI: 10.1016/S1367-5931(02)00345-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1016%2FS1367-5931%2802%2900345-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=12133721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsVyjtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2002&pages=459-465&author=A.+A.+Hernandezauthor=W.+R.+Roush&title=Recent+advances+in+the+synthesis%2C+design+and+selection+of+cysteine+protease+inhibitors&doi=10.1016%2FS1367-5931%2802%2900345-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the synthesis, design and selection of cysteine protease inhibitors</span></div><div class="casAuthors">Hernandez, Alejandro Alvarez; Roush, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">459-465</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Inhibition of cysteine proteases is emerging as an important strategy for the treatment of a variety of human diseases.  Intense efforts involving structure-based inhibitor design have been directed toward several cysteine proteases, including cathepsin K, calpain, human rhinovirus 3C protease and several parasitic cysteine protease targets.  Other successful recent efforts have involved combinatorial synthesis and screening for identification of new inhibitor templates.  Inhibition of cysteine proteases is emerging as an important strategy for the treatment of a variety of human diseases.  Successful recent efforts have included combinatorial synthesis and compd. screening for identification of new inhibitor templates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE_foTSFvfeLVg90H21EOLACvtfcHk0lgolvDrAEHibA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsVyjtbY%253D&md5=b3a8ab70cbd42dd3f1f9fbdb0bed841b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS1367-5931%2802%2900345-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1367-5931%252802%252900345-9%26sid%3Dliteratum%253Aachs%26aulast%3DHernandez%26aufirst%3DA.%2BA.%26aulast%3DRoush%26aufirst%3DW.%2BR.%26atitle%3DRecent%2520advances%2520in%2520the%2520synthesis%252C%2520design%2520and%2520selection%2520of%2520cysteine%2520protease%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2002%26volume%3D6%26spage%3D459%26epage%3D465%26doi%3D10.1016%2FS1367-5931%2802%2900345-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mellott, D.</span>; <span class="NLM_string-name">Tseng, C. T.</span>; <span class="NLM_string-name">Drelich, A.</span>; <span class="NLM_string-name">Fajtova, P.</span>; <span class="NLM_string-name">Chenna, B. C.</span>; <span class="NLM_string-name">Kostomiris, D.</span>; <span class="NLM_string-name">Hsu, J. C.</span>; <span class="NLM_string-name">Zhu, J.</span>; <span class="NLM_string-name">Taylor, Z.</span>; <span class="NLM_string-name">Tat, V.</span>; <span class="NLM_string-name">Katzfuss, A.</span>; <span class="NLM_string-name">Li, L.</span>; <span class="NLM_string-name">Giardini, M. A.</span>; <span class="NLM_string-name">Skinner, D.</span>; <span class="NLM_string-name">Hirata, K.</span>; <span class="NLM_string-name">Beck, S.</span>; <span class="NLM_string-name">Carlin, A. F.</span>; <span class="NLM_string-name">Clark, A. E.</span>; <span class="NLM_string-name">Berreta, L.</span>; <span class="NLM_string-name">Maneval, D.</span>; <span class="NLM_string-name">Frueh, F.</span>; <span class="NLM_string-name">Hurst, B. L.</span>; <span class="NLM_string-name">Wang, H.</span>; <span class="NLM_string-name">Kocurek, K. I.</span>; <span class="NLM_string-name">Raushel, F. M.</span>; <span class="NLM_string-name">O’Donoghue, A.</span>; <span class="NLM_string-name">Siqueira-Neto, J. L.</span>; <span class="NLM_string-name">Meek, T. D.</span>; <span class="NLM_string-name">McKerrow, J. H.</span></span> <i>A cysteine protease inhibitor blocks SARS-CoV-2 infection of human and monkey cells</i>. <span class="NLM_publisher-name">bioRxiv</span> <span class="NLM_year">2020</span>, 2020.10.23.347534, <span class="refDoi"> DOI: 10.1101/2020.10.23.347534</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1101%2F2020.10.23.347534" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=D.+Mellott&author=C.+T.+Tseng&author=A.+Drelich&author=P.+Fajtova&author=B.+C.+Chenna&author=D.+Kostomiris&author=J.+C.+Hsu&author=J.+Zhu&author=Z.+Taylor&author=V.+Tat&author=A.+Katzfuss&author=L.+Li&author=M.+A.+Giardini&author=D.+Skinner&author=K.+Hirata&author=S.+Beck&author=A.+F.+Carlin&author=A.+E.+Clark&author=L.+Berreta&author=D.+Maneval&author=F.+Frueh&author=B.+L.+Hurst&author=H.+Wang&author=K.+I.+Kocurek&author=F.+M.+Raushel&author=A.+O%E2%80%99Donoghue&author=J.+L.+Siqueira-Neto&author=T.+D.+Meek&author=J.+H.+McKerrow&title=A+cysteine+protease+inhibitor+blocks+SARS-CoV-2+infection+of+human+and+monkey+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1101%2F2020.10.23.347534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1101%252F2020.10.23.347534%26sid%3Dliteratum%253Aachs%26aulast%3DMellott%26aufirst%3DD.%26btitle%3DA%2520cysteine%2520protease%2520inhibitor%2520blocks%2520SARS-CoV-2%2520infection%2520of%2520human%2520and%2520monkey%2520cells%26pub%3DbioRxiv%26date%3D2020%26doi%3D10.1101%2F2020.10.23.347534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gampe, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, V. A.</span></span> <span> </span><span class="NLM_article-title">Curse or cure? A perspective on the developability of aldehydes as active pharmaceutical ingredients</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">14357</span>– <span class="NLM_lpage">14381</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c01177</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c01177" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvVWhs7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=14357-14381&author=C.+Gampeauthor=V.+A.+Verma&title=Curse+or+cure%3F+A+perspective+on+the+developability+of+aldehydes+as+active+pharmaceutical+ingredients&doi=10.1021%2Facs.jmedchem.0c01177"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Curse or Cure? A Perspective on the Developability of Aldehydes as Active Pharmaceutical Ingredients</span></div><div class="casAuthors">Gampe, Christian; Verma, Vishal A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">14357-14381</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  There is a dichotomy between the increasing utility of aldehydes as tool mols. that bind to "undruggable" protein sites and the designation of the aldehyde functional group as a structural alert by the medicinal chem. community.  Herein we compile information about pharmacol. active aldehydes that are being used in humans.  We summarize the learnings from these data, discuss advantages and challenges assocd. with aldehydes, and derive strategies for the successful development of aldehydes within drug discovery programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppz1oqp1WGV7Vg90H21EOLACvtfcHk0lgolvDrAEHibA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvVWhs7vE&md5=4696123fdaba8f20895bb11f2b78ff84</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c01177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c01177%26sid%3Dliteratum%253Aachs%26aulast%3DGampe%26aufirst%3DC.%26aulast%3DVerma%26aufirst%3DV.%2BA.%26atitle%3DCurse%2520or%2520cure%253F%2520A%2520perspective%2520on%2520the%2520developability%2520of%2520aldehydes%2520as%2520active%2520pharmaceutical%2520ingredients%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D14357%26epage%3D14381%26doi%3D10.1021%2Facs.jmedchem.0c01177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bandyopadhyay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span> <span> </span><span class="NLM_article-title">Targeting biomolecules with reversible covalent chemistry</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">110</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2016.08.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1016%2Fj.cbpa.2016.08.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=27599186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVOqtrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=110-116&author=A.+Bandyopadhyayauthor=J.+Gao&title=Targeting+biomolecules+with+reversible+covalent+chemistry&doi=10.1016%2Fj.cbpa.2016.08.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting biomolecules with reversible covalent chemistry</span></div><div class="casAuthors">Bandyopadhyay, Anupam; Gao, Jianmin</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">110-116</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Interaction of biomols. typically proceeds in a highly selective and reversible manner, for which covalent bond formation has been largely avoided due to the potential difficulty of dissocn.  However, employing reversible covalent warheads in drug design has given rise to covalent enzyme inhibitors that serve as powerful therapeutics, as well as mol. probes with exquisite target selectivity.  This review article summarizes the recent advances in the development of reversible covalent chem. for biol. and medicinal applications.  Specifically, we document the chem. strategies that allow for reversible modification of the three major classes of nucleophiles in biol.: thiols, alcs. and amines.  Emphasis is given to the chem. mechanisms that underlie the development of these reversible covalent reactions and their utilization in biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUElo9YTpOWrVg90H21EOLACvtfcHk0lg9VggTU-2-Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVOqtrrE&md5=1294e2befed2127ceec6a7e7ae0dd2f3</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2016.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2016.08.011%26sid%3Dliteratum%253Aachs%26aulast%3DBandyopadhyay%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DJ.%26atitle%3DTargeting%2520biomolecules%2520with%2520reversible%2520covalent%2520chemistry%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D34%26spage%3D110%26epage%3D116%26doi%3D10.1016%2Fj.cbpa.2016.08.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinen, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lange, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grisostomi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weston, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallai, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartsough, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMakin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilton, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldino, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span> <span> </span><span class="NLM_article-title">Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in chagas disease</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2141</span>– <span class="NLM_lpage">2156</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2004.12.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1016%2Fj.bmc.2004.12.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=15727867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsFSjtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=2141-2156&author=Y.+Choeauthor=L.+S.+Brinenauthor=M.+S.+Priceauthor=J.+C.+Engelauthor=M.+Langeauthor=C.+Grisostomiauthor=S.+G.+Westonauthor=P.+V.+Pallaiauthor=H.+Chengauthor=L.+W.+Hardyauthor=D.+S.+Hartsoughauthor=M.+McMakinauthor=R.+F.+Tiltonauthor=C.+M.+Baldinoauthor=C.+S.+Craik&title=Development+of+alpha-keto-based+inhibitors+of+cruzain%2C+a+cysteine+protease+implicated+in+chagas+disease&doi=10.1016%2Fj.bmc.2004.12.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Development of α-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease</span></div><div class="casAuthors">Choe, Youngchool; Brinen, Linda S.; Price, Mark S.; Engel, Juan C.; Lange, Meinolf; Grisostomi, Corinna; Weston, Scott G.; Pallai, Peter V.; Cheng, Hong; Hardy, Larry W.; Hartsough, David S.; McMakin, Marsha; Tilton, Robert F.; Baldino, Carmen M.; Craik, Charles S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2141-2156</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Trypanosoma cruzi, a protozoan parasite, is the causative agent of Chagas disease, a major cause of cardiovascular disease in many Latin American countries.  There is an urgent need to develop an improved therapy due to the toxicity of existing drugs and emerging drug resistance.  Cruzain, the primary cysteine protease of T. cruzi, is essential for the survival of the parasite in host cells and therefore is an important target for the development of inhibitors as potential therapeutics.  A novel series of α-ketoamide-, α-keto acid-, α-keto ester-, and aldehyde-based inhibitors of cruzain has been developed.  The inhibitors were identified by screening protease targeted small mol. libraries and systematically optimizing the P1, P2, P3, and P1' residues using specific structure-guided methods.  A total of 20 compds. displayed picomolar potency in in vitro assays and three inhibitors representing different α-keto-based inhibitor scaffolds demonstrated anti-trypanosomal activity in cell culture.  A 2.3 Å crystallog. structure of cruzain bound with one of the α-ketoester analogs is also reported.  The structure and kinetic assay data illustrate the covalent binding, reversible inhibition mechanism of the inhibitor.  Information on the compds. reported here will be useful in the development of new lead compds. as potential therapeutic agents for the treatment of Chagas disease and as biol. probes to study the role that cruzain plays in the pathol.  This study also demonstrates the validity of structure-guided approaches to focused library design and lead compd. optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOi1yF-Og77LVg90H21EOLACvtfcHk0lg9VggTU-2-Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsFSjtrg%253D&md5=b91651cf2c66921b1fc98e6cabd67dfe</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2004.12.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2004.12.053%26sid%3Dliteratum%253Aachs%26aulast%3DChoe%26aufirst%3DY.%26aulast%3DBrinen%26aufirst%3DL.%2BS.%26aulast%3DPrice%26aufirst%3DM.%2BS.%26aulast%3DEngel%26aufirst%3DJ.%2BC.%26aulast%3DLange%26aufirst%3DM.%26aulast%3DGrisostomi%26aufirst%3DC.%26aulast%3DWeston%26aufirst%3DS.%2BG.%26aulast%3DPallai%26aufirst%3DP.%2BV.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DHardy%26aufirst%3DL.%2BW.%26aulast%3DHartsough%26aufirst%3DD.%2BS.%26aulast%3DMcMakin%26aufirst%3DM.%26aulast%3DTilton%26aufirst%3DR.%2BF.%26aulast%3DBaldino%26aufirst%3DC.%2BM.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26atitle%3DDevelopment%2520of%2520alpha-keto-based%2520inhibitors%2520of%2520cruzain%252C%2520a%2520cysteine%2520protease%2520implicated%2520in%2520chagas%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D2141%26epage%3D2156%26doi%3D10.1016%2Fj.bmc.2004.12.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scheidt, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roush, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selzer, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, P. J.</span></span> <span> </span><span class="NLM_article-title">Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">2477</span>– <span class="NLM_lpage">2494</span>, <span class="refDoi"> DOI: 10.1016/S0968-0896(98)80022-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1016%2FS0968-0896%2898%2980022-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=9925304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADyaK1MXjvVKitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=2477-2494&author=K.+A.+Scheidtauthor=W.+R.+Roushauthor=J.+H.+McKerrowauthor=P.+M.+Selzerauthor=E.+Hansellauthor=P.+J.+Rosenthal&title=Structure-based+design%2C+synthesis+and+evaluation+of+conformationally+constrained+cysteine+protease+inhibitors&doi=10.1016%2FS0968-0896%2898%2980022-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors</span></div><div class="casAuthors">Scheidt, Karl A.; Roush, William R.; McKerrow, James H.; Selzer, Paul M.; Hansell, Elizabeth; Rosenthal, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2477-2494</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The inhibition of cysteine proteases is being studied as a strategy to combat parasitic diseases such as Chagas' disease, leishmaniasis, and malaria.  Cruzain is the major cysteine protease of Trypanosoma cruzi, the etiol. agent of Chagas' disease.  A crystal structure of cruzain, covalently inactivated by fluoromethyl ketone inhibitor, Cbz-Phe-NHCH(Me)COCH2F, was used as a template to design potential inhibitors.  Conformationally constrained γ-lactams contg. electrophilic aldehyde (I; R = H, CH2CH2Ph) and vinyl sulfone (II; R = Me, CH2CH2Ph) units were synthesized.  Constrained lactam III had IC50 value of ca. 20 nM against the Leishmania major protease and ca. 50 nM against falcipain, an important cysteine protease isolated from Plasmodium falciparum.  However, all of the conformationally constrained inhibitors were weak inhibitors of cruzain, compared to unconstrained peptide aldehyde, Cbz-Phe-NHCH(Me)CHO, and vinyl sulfone inhibitors [e.g. IV, which proved to be an excellent inhibitor of cruzain with an apparent second order inhibition rate const. (kintact/Ki) of 634,000 s-1M-1].  A significant redn. in activity was also obsd. with acyclic inhibitors, such as V and VI, which contain phenylalanine residues at the P2 position.  These data indicate that the pyrrolidinone ring, esp. the quaternary center at P2, interferes with the normal substrate binding mode with cruzain, but not with falcipain or the leishmania protease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz-tdVgayNd7Vg90H21EOLACvtfcHk0ljckAIra78l-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvVKitQ%253D%253D&md5=9c136c9397df677ac3125aa297cd86fd</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2898%2980022-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252898%252980022-9%26sid%3Dliteratum%253Aachs%26aulast%3DScheidt%26aufirst%3DK.%2BA.%26aulast%3DRoush%26aufirst%3DW.%2BR.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DSelzer%26aufirst%3DP.%2BM.%26aulast%3DHansell%26aufirst%3DE.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26atitle%3DStructure-based%2520design%252C%2520synthesis%2520and%2520evaluation%2520of%2520conformationally%2520constrained%2520cysteine%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1998%26volume%3D6%26spage%3D2477%26epage%3D2494%26doi%3D10.1016%2FS0968-0896%2898%2980022-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silva, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro, J. F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vita, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freitas-Junior, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraes, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocha, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burtoloso, A. C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenny, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leitão, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montanari, C. A.</span></span> <span> </span><span class="NLM_article-title">A comparative study of warheads for design of cysteine protease inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">5031</span>– <span class="NLM_lpage">5035</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1016%2Fj.bmcl.2017.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=29054358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1yjsL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=5031-5035&author=D.+G.+Silvaauthor=J.+F.+R.+Ribeiroauthor=D.+de+Vitaauthor=L.+Cianniauthor=C.+H.+Francoauthor=L.+H.+Freitas-Juniorauthor=C.+B.+Moraesauthor=J.+R.+Rochaauthor=A.+C.+B.+Burtolosoauthor=P.+W.+Kennyauthor=A.+Leit%C3%A3oauthor=C.+A.+Montanari&title=A+comparative+study+of+warheads+for+design+of+cysteine+protease+inhibitors&doi=10.1016%2Fj.bmcl.2017.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A comparative study of warheads for design of cysteine protease inhibitors</span></div><div class="casAuthors">Silva, Daniel G.; Ribeiro, Jean F. R.; De Vita, Daniela; Cianni, Lorenzo; Franco, Caio Haddad; Freitas-Junior, Lucio H.; Moraes, Carolina Borsoi; Rocha, Josmar R.; Burtoloso, Antonio C. B.; Kenny, Peter W.; Leitao, Andrei; Montanari, Carlos A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5031-5035</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The effects on potency of cruzain inhibition of replacing a nitrile group with alternative warheads were explored.  The oxime was almost an order of magnitude more potent than the corresponding nitrile and has the potential to provide access to the prime side of the catalytic site.  Dipeptide aldehydes and azadipeptide nitriles were found to be two orders of magnitude more potent cruzain inhibitors than the corresponding dipeptide nitriles although potency differences were modulated by substitution at P1 and P3.  Replacement of the α methylene of a dipeptide aldehyde with cyclopropane led to a loss of potency of almost three orders of magnitude.  The vinyl esters and amides that were characterized as reversible inhibitors were less potent than the corresponding nitrile by between one and two orders of magnitude.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1EsVPrEhve7Vg90H21EOLACvtfcHk0ljckAIra78l-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1yjsL%252FI&md5=0e2c0c2f3bc188bd43e05c14a1b8d963</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DSilva%26aufirst%3DD.%2BG.%26aulast%3DRibeiro%26aufirst%3DJ.%2BF.%2BR.%26aulast%3Dde%2BVita%26aufirst%3DD.%26aulast%3DCianni%26aufirst%3DL.%26aulast%3DFranco%26aufirst%3DC.%2BH.%26aulast%3DFreitas-Junior%26aufirst%3DL.%2BH.%26aulast%3DMoraes%26aufirst%3DC.%2BB.%26aulast%3DRocha%26aufirst%3DJ.%2BR.%26aulast%3DBurtoloso%26aufirst%3DA.%2BC.%2BB.%26aulast%3DKenny%26aufirst%3DP.%2BW.%26aulast%3DLeit%25C3%25A3o%26aufirst%3DA.%26aulast%3DMontanari%26aufirst%3DC.%2BA.%26atitle%3DA%2520comparative%2520study%2520of%2520warheads%2520for%2520design%2520of%2520cysteine%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D5031%26epage%3D5035%26doi%3D10.1016%2Fj.bmcl.2017.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonatto, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batista, P. H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vita, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cedron, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tezuka, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Albuquerque, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraes, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lameira, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leitão, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montanari, C. A.</span></span> <span> </span><span class="NLM_article-title">On the intrinsic reactivity of highly potent trypanocidal cruzain inhibitors</span>. <i>RSC Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1275</span>– <span class="NLM_lpage">1284</span>, <span class="refDoi"> DOI: 10.1039/D0MD00097C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1039%2FD0MD00097C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=34095840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhslyjt7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=1275-1284&author=V.+Bonattoauthor=P.+H.+J.+Batistaauthor=L.+Cianniauthor=D.+de+Vitaauthor=D.+G.+Silvaauthor=R.+Cedronauthor=D.+Y.+Tezukaauthor=S.+de+Albuquerqueauthor=C.+B.+Moraesauthor=C.+H.+Francoauthor=J.+Lameiraauthor=A.+Leit%C3%A3oauthor=C.+A.+Montanari&title=On+the+intrinsic+reactivity+of+highly+potent+trypanocidal+cruzain+inhibitors&doi=10.1039%2FD0MD00097C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">On the intrinsic reactivity of highly potent trypanocidal cruzain inhibitors</span></div><div class="casAuthors">Bonatto, Vinicius; Batista, Pedro Henrique Jatai; Cianni, Lorenzo; De Vita, Daniela; Silva, Daniel G.; Cedron, Rodrigo; Tezuka, Daiane Y.; de Albuquerque, Sergio; Moraes, Carolina Borsoi; Franco, Caio Haddad; Lameira, Jeronimo; Leitao, Andrei; Montanari, Carlos A.</div><div class="citationInfo"><span class="NLM_cas:title">RSC Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1275-1284</span>CODEN:
                <span class="NLM_cas:coden">RMCSEZ</span>;
        ISSN:<span class="NLM_cas:issn">2632-8682</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The cysteine protease cruzipain is considered to be a validated target for therapeutic intervention in the treatment of Chagas disease.  Hence, peptidomimetic cruzipain inhibitors having a reactive group (known as warhead) are subject to continuous studies to discover novel antichagasic compds.  Here, we evaluated how different warheads for a set of structurally similar related compds. could inhibit the activity of cruzipain and, ultimately, their trypanocidal effect.  We first investigated in silico the intrinsic reactivity of these compds. by applying the Fukui index to correlate it with the enzymic affinity.  Then, we evaluated their potency against T. cruzi (Y and Tulahuen strains), which revealed the reversible cruzain inhibitor Neq0656 as a better trypanocidal agent (ECY.strain50 = 0.1μM; SI = 58.4) than the current drug benznidazole (ECY.strain50 = 5.1μM; SI > 19.6).  We also measured the half-life time by HPLC anal. of three lead compds. in the presence of glutathione and cysteine to exptl. assess their intrinsic reactivity.  Results clearly illustrated the reactivity trend for the warheads (azanitrile > aldehyde > nitrile), where the aldehyde displayed an intermediate intrinsic reactivity.  Therefore, the aldehyde bearing peptidomimetic compds. should be subject for in-depth evaluation in the drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXL7EU9_GhxLVg90H21EOLACvtfcHk0ljckAIra78l-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhslyjt7jF&md5=feee55089bb2fe2197e64c2d3037bef5</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1039%2FD0MD00097C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FD0MD00097C%26sid%3Dliteratum%253Aachs%26aulast%3DBonatto%26aufirst%3DV.%26aulast%3DBatista%26aufirst%3DP.%2BH.%2BJ.%26aulast%3DCianni%26aufirst%3DL.%26aulast%3Dde%2BVita%26aufirst%3DD.%26aulast%3DSilva%26aufirst%3DD.%2BG.%26aulast%3DCedron%26aufirst%3DR.%26aulast%3DTezuka%26aufirst%3DD.%2BY.%26aulast%3Dde%2BAlbuquerque%26aufirst%3DS.%26aulast%3DMoraes%26aufirst%3DC.%2BB.%26aulast%3DFranco%26aufirst%3DC.%2BH.%26aulast%3DLameira%26aufirst%3DJ.%26aulast%3DLeit%25C3%25A3o%26aufirst%3DA.%26aulast%3DMontanari%26aufirst%3DC.%2BA.%26atitle%3DOn%2520the%2520intrinsic%2520reactivity%2520of%2520highly%2520potent%2520trypanocidal%2520cruzain%2520inhibitors%26jtitle%3DRSC%2520Med.%2520Chem.%26date%3D2020%26volume%3D11%26spage%3D1275%26epage%3D1284%26doi%3D10.1039%2FD0MD00097C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siraki, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shangari, N.</span></span> <span> </span><span class="NLM_article-title">Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health</span>. <i>Crit. Rev. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">609</span>– <span class="NLM_lpage">662</span>, <span class="refDoi"> DOI: 10.1080/10408440591002183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1080%2F10408440591002183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=16417045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1agtr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2005&pages=609-662&author=P.+J.+O%E2%80%99Brienauthor=A.+G.+Sirakiauthor=N.+Shangari&title=Aldehyde+sources%2C+metabolism%2C+molecular+toxicity+mechanisms%2C+and+possible+effects+on+human+health&doi=10.1080%2F10408440591002183"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health</span></div><div class="casAuthors">O'Brien, Peter; Siraki, Arno; Shangari, Nandita</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Toxicology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">609-662</span>CODEN:
                <span class="NLM_cas:coden">CRTXB2</span>;
        ISSN:<span class="NLM_cas:issn">1040-8444</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A review.  Aldehydes are org. compds. that are widespread in nature.  They can be formed endogenously by lipid peroxidn. (LPO), carbohydrate or metab. ascorbate autoxidn., amine oxidases, cytochrome P-450s, or myeloperoxidase-catalyzed metabolic activation.  This review compares the reactivity of many aldehydes towards biomols. particularly macromols.  Furthermore, it includes not only aldehydes of environmental or occupational concerns but also dietary aldehydes and aldehydes formed endogenously by intermediary metab.  Drugs that are aldehydes or form reactive aldehyde metabolites that cause side-effect toxicity are also included.  The effects of these aldehydes on biol. function, their contribution to human diseases, and the role of nucleic acid and protein carbonylation/oxidn. in mutagenicity and cytotoxicity mechanisms, resp., as well as carbonyl signal transduction and gene expression, are reviewed.  Aldehyde metabolic activation and detoxication by metabolizing enzymes are also reviewed, as well as the toxicol. and anticancer therapeutic effects of metabolizing enzyme inhibitors.  The human health risks from clin. and animal research studies are reviewed, including aldehydes as haptens in allergenic hypersensitivity diseases, respiratory allergies, and idiosyncratic drug toxicity; the potential carcinogenic risks of the carbonyl body burden; and the toxic effects of aldehydes in liver disease, embryo toxicity/teratogenicity, diabetes/hypertension, sclerosing peritonitis, cerebral ischemia/neurodegenerative diseases, and other aging-assocd. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw561xTk_YUrVg90H21EOLACvtfcHk0lgM2GgGA0f9sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1agtr3L&md5=b5be34c7f0253a8e988dd0e93427a399</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1080%2F10408440591002183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10408440591002183%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DP.%2BJ.%26aulast%3DSiraki%26aufirst%3DA.%2BG.%26aulast%3DShangari%26aufirst%3DN.%26atitle%3DAldehyde%2520sources%252C%2520metabolism%252C%2520molecular%2520toxicity%2520mechanisms%252C%2520and%2520possible%2520effects%2520on%2520human%2520health%26jtitle%3DCrit.%2520Rev.%2520Toxicol.%26date%3D2005%26volume%3D35%26spage%3D609%26epage%3D662%26doi%3D10.1080%2F10408440591002183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gibbons, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verissimo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araujo, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nixon, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amewu, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chadwick, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stocks, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biagini, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gut, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guedes, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cristiano, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shone, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, P. M.</span></span> <span> </span><span class="NLM_article-title">Endoperoxide carbonyl falcipain 2/3 inhibitor hybrids: Toward combination chemotherapy of malaria through a single chemical entity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">8202</span>– <span class="NLM_lpage">8206</span>, <span class="refDoi"> DOI: 10.1021/jm1009567</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1009567" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlClur7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8202-8206&author=P.+Gibbonsauthor=E.+Verissimoauthor=N.+C.+Araujoauthor=V.+Bartonauthor=G.+L.+Nixonauthor=R.+K.+Amewuauthor=J.+Chadwickauthor=P.+A.+Stocksauthor=G.+A.+Biaginiauthor=A.+Srivastavaauthor=P.+J.+Rosenthalauthor=J.+Gutauthor=R.+C.+Guedesauthor=R.+Moreiraauthor=R.+Sharmaauthor=N.+Berryauthor=M.+L.+Cristianoauthor=A.+E.+Shoneauthor=S.+A.+Wardauthor=P.+M.+O%E2%80%99Neill&title=Endoperoxide+carbonyl+falcipain+2%2F3+inhibitor+hybrids%3A+Toward+combination+chemotherapy+of+malaria+through+a+single+chemical+entity&doi=10.1021%2Fjm1009567"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Endoperoxide Carbonyl Falcipain 2/3 Inhibitor Hybrids: Toward Combination Chemotherapy of Malaria through a Single Chemical Entity</span></div><div class="casAuthors">Gibbons, Peter; Verissimo, Edite; Barton, Victoria; Nixon, Gemma L.; Amewu, Richard K.; Chadwick, James; Stocks, Paul A.; Biagini, Giancarlo A.; Srivastava, Abhishek; Rosenthal, Philip J.; Gut, Jiri; Guedes, Rita C.; Moreira, Rui; Sharma, Raman; Berry, Neil; Cristiano, M. Lurdes S.; Shone, Alison E.; Ward, Stephen A.; O'Neill, Paul M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8202-8206</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors extend their approach of combination chemotherapy through a single prodrug entity (O'Neill et al. Angew. Chem., Int. Ed. 2004, 43, 4193) by using a 1,2,4-trioxolane as a protease inhibitor carbonyl-masking group.  These mols. are designed to target the malaria parasite through two independent mechanisms of action: iron(II) decompn. releases the carbonyl protease inhibitor and potentially cytotoxic C-radical species in tandem.  Using a proposed target "heme", the authors also demonstrate heme alkylation/carbonyl inhibitor release and quant. measure endoperoxide turnover in parasitized red blood cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk03ZtQuSTGbVg90H21EOLACvtfcHk0lgM2GgGA0f9sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlClur7J&md5=8c93b6fdd9321a8b59a1f027dff37356</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm1009567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1009567%26sid%3Dliteratum%253Aachs%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DVerissimo%26aufirst%3DE.%26aulast%3DAraujo%26aufirst%3DN.%2BC.%26aulast%3DBarton%26aufirst%3DV.%26aulast%3DNixon%26aufirst%3DG.%2BL.%26aulast%3DAmewu%26aufirst%3DR.%2BK.%26aulast%3DChadwick%26aufirst%3DJ.%26aulast%3DStocks%26aufirst%3DP.%2BA.%26aulast%3DBiagini%26aufirst%3DG.%2BA.%26aulast%3DSrivastava%26aufirst%3DA.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DGut%26aufirst%3DJ.%26aulast%3DGuedes%26aufirst%3DR.%2BC.%26aulast%3DMoreira%26aufirst%3DR.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DBerry%26aufirst%3DN.%26aulast%3DCristiano%26aufirst%3DM.%2BL.%26aulast%3DShone%26aufirst%3DA.%2BE.%26aulast%3DWard%26aufirst%3DS.%2BA.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DP.%2BM.%26atitle%3DEndoperoxide%2520carbonyl%2520falcipain%25202%252F3%2520inhibitor%2520hybrids%253A%2520Toward%2520combination%2520chemotherapy%2520of%2520malaria%2520through%2520a%2520single%2520chemical%2520entity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8202%26epage%3D8206%26doi%3D10.1021%2Fjm1009567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schechter, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, A.</span></span> <span> </span><span class="NLM_article-title">On the size of the active site in proteases I. Papain</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1967</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">162</span>, <span class="refDoi"> DOI: 10.1016/S0006-291X(67)80055-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1016%2FS0006-291X%2867%2980055-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=6035483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADyaF2sXktVyhsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1967&pages=157-162&author=I.+Schechterauthor=A.+Berger&title=On+the+size+of+the+active+site+in+proteases+I.+Papain&doi=10.1016%2FS0006-291X%2867%2980055-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">On the size of the active site in proteases.  I.  Papain</span></div><div class="casAuthors">Schechter, Israel; Berger, Arieh</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-62</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">The action of papain on 40 diastereoisomeric peptides of alanine, ranging in length from Ala2 to Ala6, was studied to investigate the size of the active site.  The variations observed in the rates of hydrolysis lead to the conclusion that papain has a large active site which extends over ∼25 A. and can be divided into 7 "subsites," each accommodating 1 amino acid residue of the peptide substrate.  The subsites are located on both sides of the catalytic site, 4 on the one side and 3 on the other.  It is postulated that a long "groove" analogous to that found by x-ray analysis in lysozyme is present.  The substrate is believed to fit into the groove, binding to several subsites of specific geometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_kZeRVAOVyrVg90H21EOLACvtfcHk0lgM2GgGA0f9sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2sXktVyhsrg%253D&md5=a58ceccdbb5cc5c021af06912835f77c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2867%2980055-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252867%252980055-X%26sid%3Dliteratum%253Aachs%26aulast%3DSchechter%26aufirst%3DI.%26aulast%3DBerger%26aufirst%3DA.%26atitle%3DOn%2520the%2520size%2520of%2520the%2520active%2520site%2520in%2520proteases%2520I.%2520Papain%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1967%26volume%3D27%26spage%3D157%26epage%3D162%26doi%3D10.1016%2FS0006-291X%2867%2980055-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuerrier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moldoveanu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, R. L.</span></span> <span> </span><span class="NLM_article-title">Calpain inhibition by alpha-ketoamide and cyclic hemiacetal inhibitors revealed by X-ray crystallography</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">7446</span>– <span class="NLM_lpage">7452</span>, <span class="refDoi"> DOI: 10.1021/bi060425j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi060425j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BD28Xkslymsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=7446-7452&author=D.+Cuerrierauthor=T.+Moldoveanuauthor=J.+Inoueauthor=P.+L.+Daviesauthor=R.+L.+Campbell&title=Calpain+inhibition+by+alpha-ketoamide+and+cyclic+hemiacetal+inhibitors+revealed+by+X-ray+crystallography&doi=10.1021%2Fbi060425j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Calpain Inhibition by α-Ketoamide and Cyclic Hemiacetal Inhibitors Revealed by X-ray Crystallography</span></div><div class="casAuthors">Cuerrier, D.; Moldoveanu, T.; Inoue, J.; Davies, P. L.; Campbell, R. L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7446-7452</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Calpains are intracellular calcium-activated cysteine proteases whose unregulated proteolysis following the loss of calcium homeostasis can lead to acute degeneration during ischemic episodes and trauma, as well as Alzheimer's disease and cataract formation.  The detn. of the crystal structure of the proteolytic core of μ-calpain (μI-II) in a calcium-bound active conformation has made structure-guided design of active site inhibitors feasible.  We present here high-resoln. crystal structures of rat μI-II complexed with two reversible calpain-specific inhibitors employing cyclic hemiacetal (SNJ-1715) and α-ketoamide (SNJ-1945) chemistries that reveal new details about the interactions of inhibitors with this enzyme.  The SNJ-1715 complex confirms that the free aldehyde is the reactive species of the cornea-permeable cyclic hemiacetal.  The α-ketoamide warhead of SNJ-1945 binds with the hydroxyl group of the tetrahedral adduct pointing toward the catalytic histidine rather than the oxyanion hole.  The μI-II-SNJ-1945 complex shows residue Glu-261 displaced from the S1' site by the inhibitor, resulting in an extended "open" conformation of the domain II gating loop and an unobstructed S1' site.  This conformation offers an addnl. template for structure-based drug design extending to the primed subsites.  An important role for the highly conserved Glu-261 is proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf1Hz8gVj2s7Vg90H21EOLACvtfcHk0lj6TXWBDlHd4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xkslymsbc%253D&md5=5723cbc8b8924fff33239a63ae26a4db</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fbi060425j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi060425j%26sid%3Dliteratum%253Aachs%26aulast%3DCuerrier%26aufirst%3DD.%26aulast%3DMoldoveanu%26aufirst%3DT.%26aulast%3DInoue%26aufirst%3DJ.%26aulast%3DDavies%26aufirst%3DP.%2BL.%26aulast%3DCampbell%26aufirst%3DR.%2BL.%26atitle%3DCalpain%2520inhibition%2520by%2520alpha-ketoamide%2520and%2520cyclic%2520hemiacetal%2520inhibitors%2520revealed%2520by%2520X-ray%2520crystallography%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D7446%26epage%3D7452%26doi%3D10.1021%2Fbi060425j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, J.</span></span> <span> </span><span class="NLM_article-title">Exploration of cornea permeable calpain inhibitors as anticataract agents</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1371</span>– <span class="NLM_lpage">1379</span>, <span class="refDoi"> DOI: 10.1016/S0968-0896(02)00612-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1016%2FS0968-0896%2802%2900612-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=12628663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvFGrs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=1371-1379&author=M.+Nakamuraauthor=M.+Yamaguchiauthor=O.+Sakaiauthor=J.+Inoue&title=Exploration+of+cornea+permeable+calpain+inhibitors+as+anticataract+agents&doi=10.1016%2FS0968-0896%2802%2900612-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Exploration of cornea permeable calpain inhibitors as anticataract agents</span></div><div class="casAuthors">Nakamura, Masayuki; Yamaguchi, Masazumi; Sakai, Osamu; Inoue, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1371-1379</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">To explore cornea permeable calpain inhibitors, four compds. displaying different characteristics were designed and synthesized based on the known potent calpain inhibitor, peptidyl aldehyde SJA6017.  Two approaches were adopted; an improvement in the physicochem. properties, and conversion of the active aldehyde.  The water-sol. peptidyl aldehyde 1 contg. a pyridine ring at the P3 site showed a modest inhibition against calpains and an improvement of corneal permeability in comparison with SJA6017.  Replacement of the aldehyde of SJA6017 by an α-ketoamide provided compd. 2 that was approx. equipotent with SJA6017, but it was extremely water-insol.  However, compd. 3, in which the aldehyde was converted into a cyclic hemiacetal, proved to be a less potent calpain inhibitor than SJA6017, but demonstrated excellent transcorneal permeability.  Further modification generating the cyclic hemiacetal 4 contg. a thiourea linker between the P3 and P2 sites exhibited potent inhibitory activities, high cornea permeability and excellent efficacy in the rat lens culture cataract model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOzIjCh4ST37Vg90H21EOLACvtfcHk0lgEA-mkxUBnVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvFGrs7w%253D&md5=c90fc9511b44489bb2fd399d1471b4a6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2802%2900612-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252802%252900612-0%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DYamaguchi%26aufirst%3DM.%26aulast%3DSakai%26aufirst%3DO.%26aulast%3DInoue%26aufirst%3DJ.%26atitle%3DExploration%2520of%2520cornea%2520permeable%2520calpain%2520inhibitors%2520as%2520anticataract%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D1371%26epage%3D1379%26doi%3D10.1016%2FS0968-0896%2802%2900612-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farady, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marion, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajid, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caffrey, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legac, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinen, L. S.</span></span> <span> </span><span class="NLM_article-title">Vinyl sulfones as antiparasitic agents and a structural basis for drug design</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">25697</span>– <span class="NLM_lpage">25703</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.014340</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1074%2Fjbc.M109.014340" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=19620707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFWhsbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=25697-25703&author=I.+D.+Kerrauthor=J.+H.+Leeauthor=C.+J.+Faradyauthor=R.+Marionauthor=M.+Rickertauthor=M.+Sajidauthor=K.+C.+Pandeyauthor=C.+R.+Caffreyauthor=J.+Legacauthor=E.+Hansellauthor=J.+H.+McKerrowauthor=C.+S.+Craikauthor=P.+J.+Rosenthalauthor=L.+S.+Brinen&title=Vinyl+sulfones+as+antiparasitic+agents+and+a+structural+basis+for+drug+design&doi=10.1074%2Fjbc.M109.014340"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Vinyl Sulfones as Antiparasitic Agents and a Structural Basis for Drug Design</span></div><div class="casAuthors">Kerr, Iain D.; Lee, Ji H.; Farady, Christopher J.; Marion, Rachael; Rickert, Mathias; Sajid, Mohammed; Pandey, Kailash C.; Caffrey, Conor R.; Legac, Jennifer; Hansell, Elizabeth; McKerrow, James H.; Craik, Charles S.; Rosenthal, Philip J.; Brinen, Linda S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">25697-25703</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Cysteine proteases of the papain superfamily are implicated in a no. of cellular processes and are important virulence factors in the pathogenesis of parasitic disease.  These enzymes have therefore emerged as promising targets for antiparasitic drugs.  We report the crystal structures of three major parasite cysteine proteases, cruzain, falcipain-3, and the first reported structure of rhodesain, in complex with a class of potent, small mol., cysteine protease inhibitors, the vinyl sulfones.  These data, in conjunction with comparative inhibition kinetics, provide insight into the mol. mechanisms that drive cysteine protease inhibition by vinyl sulfones, the binding specificity of these important proteases and the potential of vinyl sulfones as antiparasitic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolV0DUxF0YFbVg90H21EOLACvtfcHk0lgEA-mkxUBnVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFWhsbbK&md5=c0bed13d912846fdcb4c2ba7f31954cb</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.014340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.014340%26sid%3Dliteratum%253Aachs%26aulast%3DKerr%26aufirst%3DI.%2BD.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DFarady%26aufirst%3DC.%2BJ.%26aulast%3DMarion%26aufirst%3DR.%26aulast%3DRickert%26aufirst%3DM.%26aulast%3DSajid%26aufirst%3DM.%26aulast%3DPandey%26aufirst%3DK.%2BC.%26aulast%3DCaffrey%26aufirst%3DC.%2BR.%26aulast%3DLegac%26aufirst%3DJ.%26aulast%3DHansell%26aufirst%3DE.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DBrinen%26aufirst%3DL.%2BS.%26atitle%3DVinyl%2520sulfones%2520as%2520antiparasitic%2520agents%2520and%2520a%2520structural%2520basis%2520for%2520drug%2520design%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D25697%26epage%3D25703%26doi%3D10.1074%2Fjbc.M109.014340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clementi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raimondi, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinhardt, W. P.</span></span> <span> </span><span class="NLM_article-title">Atomic screening constants from SCF functions. II. Atoms with 37 to 86 electrons</span>. <i>J. Chem. Phys</i> <span class="NLM_year" style="font-weight: bold;">1967</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1300</span>– <span class="NLM_lpage">1307</span>, <span class="refDoi"> DOI: 10.1063/1.1712084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1063%2F1.1712084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADyaF2sXkvVGisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1967&pages=1300-1307&author=E.+Clementiauthor=D.+L.+Raimondiauthor=W.+P.+Reinhardt&title=Atomic+screening+constants+from+SCF+functions.+II.+Atoms+with+37+to+86+electrons&doi=10.1063%2F1.1712084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Atomic screening constants from S.C.F. [self-con-sistent field] functions.  II.  Atoms with 37 to 86 electrons</span></div><div class="casAuthors">Clementi, Enrico; Raimondi, Donald L.; Reinhardt, W. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1300-7</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    </div><div class="casAbstract">cf. CA 59: 118f.  Minimal basis-set at. functions for the ground-state atoms from Rb (Z = 37) to Rn(Z = 86) are presented.  These functions are analyzed in order to obtain systematic data for the screening consts. and at. radii following the work initiated by Slater.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRRzONF_PmlLVg90H21EOLACvtfcHk0lh6v5MmNdpZBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2sXkvVGisrY%253D&md5=851e8055b9d0b30737bb7d399fe6dd3c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1063%2F1.1712084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.1712084%26sid%3Dliteratum%253Aachs%26aulast%3DClementi%26aufirst%3DE.%26aulast%3DRaimondi%26aufirst%3DD.%2BL.%26aulast%3DReinhardt%26aufirst%3DW.%2BP.%26atitle%3DAtomic%2520screening%2520constants%2520from%2520SCF%2520functions.%2520II.%2520Atoms%2520with%252037%2520to%252086%2520electrons%26jtitle%3DJ.%2520Chem.%2520Phys%26date%3D1967%26volume%3D47%26spage%3D1300%26epage%3D1307%26doi%3D10.1063%2F1.1712084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clayden, J.</span>; <span class="NLM_string-name">Greeves, N.</span>; <span class="NLM_string-name">Warren, S. G.</span></span> <i>Organic chemistry</i>. Second ed.; <span class="NLM_publisher-name">Oxford University Press</span>: <span class="NLM_publisher-loc">Oxford</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+Clayden&author=N.+Greeves&author=S.+G.+Warren&title=Organic+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DClayden%26aufirst%3DJ.%26btitle%3DOrganic%2520chemistry%26pub%3DOxford%2520University%2520Press%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mackenzie, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malthouse, J. P.</span></span> <span> </span><span class="NLM_article-title"><sup>13</sup>C NMR study of the stereospecificity of the thiohemiacetals formed on inhibition of papain by specific enantiomeric aldehydes</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2293</span>– <span class="NLM_lpage">2298</span>, <span class="refDoi"> DOI: 10.1021/bi00356a066</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00356a066" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADyaL28Xkt1SrtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1986&pages=2293-2298&author=N.+E.+Mackenzieauthor=S.+K.+Grantauthor=A.+I.+Scottauthor=J.+P.+Malthouse&title=13C+NMR+study+of+the+stereospecificity+of+the+thiohemiacetals+formed+on+inhibition+of+papain+by+specific+enantiomeric+aldehydes&doi=10.1021%2Fbi00356a066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Carbon-13 NMR study of the stereospecificity of the thiohemiacetals formed on inhibition of papain by specific enantiomeric aldehydes</span></div><div class="casAuthors">Mackenzie, Neil E.; Grant, Stephan K.; Scott, A. Ian; Malthouse, J. Paul G.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2293-8</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">The inhibition of papain by N-acetyl-D- and N-acetyl-L-phenylalanyl[1-13C]glycinal was investigated by 13C NMR spectroscopy.  Both the L- and D-aldehyde enantiomers formed thiohemiacetals with papain.  The 13C-enriched C atom of the thiohemiacetals formed with the L- and D-aldehydes has chem. shifts at 74.7 and 75.1 ppm, resp.  The difference in chem. shift for the 2 inhibitor complexes is attributed to each forming a different diastereomeric papain thiohemiacetal.  With papain thiohemiacetal formation is stereospecific.  The D inhibitor is bound only 5-fold less tightly than the L inhibitor, which suggests that in both these inhibitor complexes the Ph ring of the inhibitor phenylalanine is bound at the S2 hydrophobic pocket of papain.  This is supported by computer modeling studies that show that both the N-acetyl-D- and N-acetyl-L-phenylalanine moieties can be sep. fitted into the S2 subsite with the Ph ring of phenylalanine in the S2 hydrophobic pocket.  Thus, thiohemiacetal formation at S1 (S1 and S1' are the active center amino acid binding sites) is stereospecific with both D and L inhibitors.  Computer modeling studies support this, showing that due to steric hindrance between the thiohemiacetal OH group and the backbone amide N atom of serine-24 only 1 of the 2 possible thiohemiacetal enantiomers can be formed at the S1 subsite.  The thiohemiacetals formed from both the D and L aldehyde inhibitors therefore have only 1 permitted conformation at S1.  In this conformation, the thiohemiacetal OH does not point toward the oxyanion hole but instead points away from it into the bottom of the active site cleft of papain, where there are no significant H-bonded interactions with the thiohemiacetal OH group.  It is therefore inferred that the stabilization of the oxyanion of a tetrahedral intermediate by H-bonded interactions with groups in the oxyanion hole may not be possible in papain-catalyzed reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVIJqUcmtcG7Vg90H21EOLACvtfcHk0lh6v5MmNdpZBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28Xkt1SrtLw%253D&md5=87a90c5c8f6d472f181cc9993544ddb4</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fbi00356a066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00356a066%26sid%3Dliteratum%253Aachs%26aulast%3DMackenzie%26aufirst%3DN.%2BE.%26aulast%3DGrant%26aufirst%3DS.%2BK.%26aulast%3DScott%26aufirst%3DA.%2BI.%26aulast%3DMalthouse%26aufirst%3DJ.%2BP.%26atitle%3D13C%2520NMR%2520study%2520of%2520the%2520stereospecificity%2520of%2520the%2520thiohemiacetals%2520formed%2520on%2520inhibition%2520of%2520papain%2520by%2520specific%2520enantiomeric%2520aldehydes%26jtitle%3DBiochemistry%26date%3D1986%26volume%3D25%26spage%3D2293%26epage%3D2298%26doi%3D10.1021%2Fbi00356a066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abdulla, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackey, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajid, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grab, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span> <span> </span><span class="NLM_article-title">RNA interference of trypanosoma brucei cathepsin B and L affects disease progression in a mouse model</span>. <i>PLoS Negl. Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>2</i></span>, <span class="NLM_elocation-id">e298</span> <span class="refDoi"> DOI: 10.1371/journal.pntd.0000298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1371%2Fjournal.pntd.0000298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=18820745" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2008&author=M.+H.+Abdullaauthor=T.+O%E2%80%99Brienauthor=Z.+B.+Mackeyauthor=M.+Sajidauthor=D.+J.+Grabauthor=J.+H.+McKerrow&title=RNA+interference+of+trypanosoma+brucei+cathepsin+B+and+L+affects+disease+progression+in+a+mouse+model&doi=10.1371%2Fjournal.pntd.0000298"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0000298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0000298%26sid%3Dliteratum%253Aachs%26aulast%3DAbdulla%26aufirst%3DM.%2BH.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DT.%26aulast%3DMackey%26aufirst%3DZ.%2BB.%26aulast%3DSajid%26aufirst%3DM.%26aulast%3DGrab%26aufirst%3DD.%2BJ.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26atitle%3DRNA%2520interference%2520of%2520trypanosoma%2520brucei%2520cathepsin%2520B%2520and%2520L%2520affects%2520disease%2520progression%2520in%2520a%2520mouse%2520model%26jtitle%3DPLoS%2520Negl.%2520Trop.%2520Dis.%26date%3D2008%26volume%3D2%26doi%3D10.1371%2Fjournal.pntd.0000298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Enanga, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ariyanayagam, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, M. P.</span></span> <span> </span><span class="NLM_article-title">Activity of megazol, a trypanocidal nitroimidazole, is associated with DNA damage</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">3368</span>– <span class="NLM_lpage">3370</span>, <span class="refDoi"> DOI: 10.1128/AAC.47.10.3368-3370.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1128%2FAAC.47.10.3368-3370.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=14506061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvVWmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2003&pages=3368-3370&author=B.+Enangaauthor=M.+R.+Ariyanayagamauthor=M.+L.+Stewartauthor=M.+P.+Barrett&title=Activity+of+megazol%2C+a+trypanocidal+nitroimidazole%2C+is+associated+with+DNA+damage&doi=10.1128%2FAAC.47.10.3368-3370.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Activity of megazol, a trypanocidal nitroimidazole, is associated with DNA damage</span></div><div class="casAuthors">Enanga, Bertin; Ariyanayagam, Mark R.; Stewart, Mhairi L.; Barrett, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3368-3370</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">DNA damage assocd. with the trypanocidal activity of megazol [2-amino-5-(1-methyl-5-nitro-2-imidazolyl)-1,3,4-thiadiazole] was shown in expts. in which DNA repair-deficient RAD51-/- Trypanosoma brucei mutants were found to be hypersensitive to the drug.  Parasites resistant to megazol were selected and showed modest cross-resistance to other trypanocides, although neither drug efflux nor changes to intracellular thiols correlated with resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcSCWDmmFjwLVg90H21EOLACvtfcHk0liJypAJXbX3bQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvVWmtbg%253D&md5=7365cc05236781f97d01a77b69f084b1</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1128%2FAAC.47.10.3368-3370.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.47.10.3368-3370.2003%26sid%3Dliteratum%253Aachs%26aulast%3DEnanga%26aufirst%3DB.%26aulast%3DAriyanayagam%26aufirst%3DM.%2BR.%26aulast%3DStewart%26aufirst%3DM.%2BL.%26aulast%3DBarrett%26aufirst%3DM.%2BP.%26atitle%3DActivity%2520of%2520megazol%252C%2520a%2520trypanocidal%2520nitroimidazole%252C%2520is%2520associated%2520with%2520DNA%2520damage%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2003%26volume%3D47%26spage%3D3368%26epage%3D3370%26doi%3D10.1128%2FAAC.47.10.3368-3370.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christians, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benet, L. Z.</span></span> <span> </span><span class="NLM_article-title">In vitro evaluation of the disposition of a novel cysteine protease inhibitor</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1343</span>– <span class="NLM_lpage">1351</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=11038163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsFOlsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=1343-1351&author=W.+Jacobsenauthor=U.+Christiansauthor=L.+Z.+Benet&title=In+vitro+evaluation+of+the+disposition+of+a+novel+cysteine+protease+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro evaluation of the disposition of a novel cysteine protease inhibitor</span></div><div class="casAuthors">Jacobsen, Wolfgang; Christians, Uwe; Benet, Leslie Z.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1343-1351</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">K11777 (N-methyl-piperazine-Phe-homoPhe-vinylsulfone-phenyl) is a potent, irreversible cysteine protease inhibitor.  Its therapeutic targets are cruzain, a cysteine protease of the protozoan parasite Trypanosoma cruzi, and cathepsins B and L, which are assocd. with cancer progression.  The authors evaluated the metab. of K11777 by human liver microsomes, isolated cytochrome P 450 (CYP) enzymes, and flavin-contg. monooxygenase 3 (FMO3) in vitro.  K11777 was metabolized by human liver microsomes to three major metabolites: N-oxide K11777 (apparent Km = 14.0 μM and apparent Vmax = 3460 pmol · mg-1 · min-1), β-hydroxy-homoPhe K11777 (Km = 16.8 μM and Vmax = 1260 pmol · mg-1 · min-1), and N-desmethyl K11777 (Km = 18.3 μM and Vmax = 2070 pmol · mg-1 · min-1).  All three K11777 metabolites were formed by isolated CYP3A and their formation by human liver microsomes was inhibited by the CYP3A inhibitor cyclosporine (50 μM, 54-62% inhibition) and antibodies against human CYP3A4/5 (100 μg of antibodies/100 μg microsomal protein, 55-68% inhibition).  CYP2D6 metabolized K11777 to its N-desmethyl metabolite with an apparent Km (9.2 μM) lower than for CYP3A4 (25.0 μM) and human liver microsomes.  The apparent Km for N-oxide K11777 formation by cDNA-expressed FMO3 was 109 μM.  Based on the intrinsic formation clearances and the results of inhibition expts. (CYP2D6, 50 μM bufuralol; FMO3 mediated, 100 mM methionine) using human liver microsomes, it was estd. that CYP3A contributes to >80% of K11777 metabolite formation.  K11777 was a potent (IC50 = 0.06 μM) and efficacious (max. inhibition 85%) NADPH-dependent inhibitor of human CYP3A4 mediated 6'β-hydroxy lovastatin formation, suggesting that K11777 is not only a substrate but also a mechanism-based inhibitor of CYP3A4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnuA6vCCgc0bVg90H21EOLACvtfcHk0liJypAJXbX3bQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsFOlsbw%253D&md5=d4becc1389b076d394ff43b1d7a093f9</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJacobsen%26aufirst%3DW.%26aulast%3DChristians%26aufirst%3DU.%26aulast%3DBenet%26aufirst%3DL.%2BZ.%26atitle%3DIn%2520vitro%2520evaluation%2520of%2520the%2520disposition%2520of%2520a%2520novel%2520cysteine%2520protease%2520inhibitor%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2000%26volume%3D28%26spage%3D1343%26epage%3D1351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Charrier, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durrant, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Studley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, P.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of novel prodrugs of caspase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">485</span>– <span class="NLM_lpage">488</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.10.102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1016%2Fj.bmcl.2011.10.102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=22104150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVymuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=485-488&author=J.+D.+Charrierauthor=S.+J.+Durrantauthor=J.+Studleyauthor=L.+Lawesauthor=P.+Weber&title=Synthesis+and+evaluation+of+novel+prodrugs+of+caspase+inhibitors&doi=10.1016%2Fj.bmcl.2011.10.102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of novel prodrugs of caspase inhibitors</span></div><div class="casAuthors">Charrier, Jean-Damien; Durrant, Steven J.; Studley, John; Lawes, Linda; Weber, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">485-488</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel type of caspase inhibitor prodrug that improves systemic exposure after oral administration in rats has been designed.  Such a prodrug, based on a 6,6a-dihydrofuro[3,2-d]oxazol-5(3aH)-one motif, has the advantage of rapidly liberating the active inhibitor without producing any cleavage byproduct.  Prodrugs are synthesized in a high yielding one-step transformation from emricasan, VX166, and (S)-2-C10H7CONHCH(CH2CO2H)COCH2F with high diastereomeric excess.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0Ed6GTXp617Vg90H21EOLACvtfcHk0lj1V-bbFRk3-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVymuw%253D%253D&md5=b6665ecc9ec4d146cbd5233048e11ba4</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.10.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.10.102%26sid%3Dliteratum%253Aachs%26aulast%3DCharrier%26aufirst%3DJ.%2BD.%26aulast%3DDurrant%26aufirst%3DS.%2BJ.%26aulast%3DStudley%26aufirst%3DJ.%26aulast%3DLawes%26aufirst%3DL.%26aulast%3DWeber%26aufirst%3DP.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520novel%2520prodrugs%2520of%2520caspase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D485%26epage%3D488%26doi%3D10.1016%2Fj.bmcl.2011.10.102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span> <span> </span><span class="NLM_article-title">Human carboxylesterases: A comprehensive review</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">699</span>– <span class="NLM_lpage">712</span>, <span class="refDoi"> DOI: 10.1016/j.apsb.2018.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1016%2Fj.apsb.2018.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=30245959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A280%3ADC%252BB3czhvVOjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=699-712&author=D.+Wangauthor=L.+Zouauthor=Q.+Jinauthor=J.+Houauthor=G.+Geauthor=L.+Yang&title=Human+carboxylesterases%3A+A+comprehensive+review&doi=10.1016%2Fj.apsb.2018.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Human carboxylesterases: a comprehensive review</span></div><div class="casAuthors">Wang Dandan; Zou Liwei; Jin Qiang; Ge Guangbo; Yang Ling; Hou Jie</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmaceutica Sinica. B</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">699-712</span>
        ISSN:<span class="NLM_cas:issn">2211-3835</span>.
    </div><div class="casAbstract">Mammalian carboxylesterases (CEs) are key enzymes from the serine hydrolase superfamily.  In the human body, two predominant carboxylesterases (CES1 and CES2) have been identified and extensively studied over the past decade.  These two enzymes play crucial roles in the metabolism of a wide variety of endogenous esters, ester-containing drugs and environmental toxicants.  The key roles of CES in both human health and xenobiotic metabolism arouse great interest in the discovery of potent CES modulators to regulate endobiotic metabolism or to improve the efficacy of ester drugs.  This review covers the structural and catalytic features of CES, tissue distributions, biological functions, genetic polymorphisms, substrate specificities and inhibitor properties of CES1 and CES2, as well as the significance and recent progress on the discovery of CES modulators.  The information presented here will help pharmacologists explore the relevance of CES to human diseases or to assign the contribution of certain CES in xenobiotic metabolism.  It will also facilitate medicinal chemistry efforts to design prodrugs activated by a given CES isoform, or to develop potent and selective modulators of CES for potential biomedical applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRHzNUaecqdULHHuJhbyicZfW6udTcc2ebE3K9CPABxZrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3czhvVOjug%253D%253D&md5=4c0b70b0208577496c8e0270af5eda8e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2018.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2018.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DD.%26aulast%3DZou%26aufirst%3DL.%26aulast%3DJin%26aufirst%3DQ.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DGe%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DL.%26atitle%3DHuman%2520carboxylesterases%253A%2520A%2520comprehensive%2520review%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2018%26volume%3D8%26spage%3D699%26epage%3D712%26doi%3D10.1016%2Fj.apsb.2018.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zanger, U. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwab, M.</span></span> <span> </span><span class="NLM_article-title">Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">103</span>– <span class="NLM_lpage">141</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2012.12.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1016%2Fj.pharmthera.2012.12.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=23333322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BC3sXislykt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2013&pages=103-141&author=U.+M.+Zangerauthor=M.+Schwab&title=Cytochrome+P450+enzymes+in+drug+metabolism%3A+Regulation+of+gene+expression%2C+enzyme+activities%2C+and+impact+of+genetic+variation&doi=10.1016%2Fj.pharmthera.2012.12.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation</span></div><div class="casAuthors">Zanger, Ulrich M.; Schwab, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">103-141</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Cytochromes P 450 (CYP) are a major source of variability in drug pharmacokinetics and response.  Of 57 putatively functional human CYPs only about a dozen enzymes, belonging to the CYP1, 2, and 3 families, are responsible for the biotransformation of most foreign substances including 70-80% of all drugs in clin. use.  The highest expressed forms in liver are CYPs 3A4, 2C9, 2C8, 2E1, and 1A2, while 2A6, 2D6, 2B6, 2C19 and 3A5 are less abundant and CYPs 2J2, 1A1, and 1B1 are mainly expressed extrahepatically.  Expression of each CYP is influenced by a unique combination of mechanisms and factors including genetic polymorphisms, induction by xenobiotics, regulation by cytokines, hormones and during disease states, as well as sex, age, and others.  Multiallelic genetic polymorphisms, which strongly depend on ethnicity, play a major role for the function of CYPs 2D6, 2C19, 2C9, 2B6, 3A5 and 2A6, and lead to distinct pharmacogenetic phenotypes termed as poor, intermediate, extensive, and ultrarapid metabolizers.  For these CYPs, the evidence for clin. significance regarding adverse drug reactions (ADRs), drug efficacy and dose requirement is rapidly growing.  Polymorphisms in CYPs 1A1, 1A2, 2C8, 2E1, 2J2, and 3A4 are generally less predictive, but new data on CYP3A4 show that predictive variants exist and that addnl. variants in regulatory genes or in NADPH:cytochrome P 450 oxidoreductase (POR) can have an influence.  Here we review the recent progress on drug metab. activity profiles, interindividual variability and regulation of expression, and the functional and clin. impact of genetic variation in drug metabolizing P450s.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyfuepoWIAkLVg90H21EOLACvtfcHk0lj1V-bbFRk3-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXislykt7w%253D&md5=474dd89d1aae3c9d57ff2d33f176602e</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2012.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2012.12.007%26sid%3Dliteratum%253Aachs%26aulast%3DZanger%26aufirst%3DU.%2BM.%26aulast%3DSchwab%26aufirst%3DM.%26atitle%3DCytochrome%2520P450%2520enzymes%2520in%2520drug%2520metabolism%253A%2520Regulation%2520of%2520gene%2520expression%252C%2520enzyme%2520activities%252C%2520and%2520impact%2520of%2520genetic%2520variation%26jtitle%3DPharmacol.%2520Ther.%26date%3D2013%26volume%3D138%26spage%3D103%26epage%3D141%26doi%3D10.1016%2Fj.pharmthera.2012.12.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, G. F.</span></span> <span> </span><span class="NLM_article-title">Both boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">4417</span>, <span class="refDoi"> DOI: 10.1038/s41467-020-18233-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1038%2Fs41467-020-18233-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=32887884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvVSmsr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=4417&author=L.+Fuauthor=F.+Yeauthor=Y.+Fengauthor=F.+Yuauthor=Q.+Wangauthor=Y.+Wuauthor=C.+Zhaoauthor=H.+Sunauthor=B.+Huangauthor=P.+Niuauthor=H.+Songauthor=Y.+Shiauthor=X.+Liauthor=W.+Tanauthor=J.+Qiauthor=G.+F.+Gao&title=Both+boceprevir+and+GC376+efficaciously+inhibit+SARS-CoV-2+by+targeting+its+main+protease&doi=10.1038%2Fs41467-020-18233-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease</span></div><div class="casAuthors">Fu, Lifeng; Ye, Fei; Feng, Yong; Yu, Feng; Wang, Qisheng; Wu, Yan; Zhao, Cheng; Sun, Huan; Huang, Baoying; Niu, Peihua; Song, Hao; Shi, Yi; Li, Xuebing; Tan, Wenjie; Qi, Jianxun; Gao, George Fu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4417</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: COVID-19 was declared a pandemic on March 11 by WHO, due to its great threat to global public health.  The coronavirus main protease (Mpro, also called 3CLpro) is essential for processing and maturation of the viral polyprotein, therefore recognized as an attractive drug target.  Here we show that a clin. approved anti-HCV drug, Boceprevir, and a pre-clin. inhibitor against feline infectious peritonitis (corona) virus (FIPV), GC376, both efficaciously inhibit SARS-CoV-2 in Vero cells by targeting Mpro.  Moreover, combined application of GC376 with Remdesivir, a nucleotide analog that inhibits viral RNA dependent RNA polymerase (RdRp), results in sterilizing additive effect.  Further structural anal. reveals binding of both inhibitors to the catalytically active side of SARS-CoV-2 protease Mpro as main mechanism of inhibition.  Our findings may provide crit. information for the optimization and design of more potent inhibitors against the emerging SARS-CoV-2 virus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt43KcNqLbkLVg90H21EOLACvtfcHk0liq6cY0BFhPhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvVSmsr3F&md5=273b11d16241499f15103885be398b23</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fs41467-020-18233-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-020-18233-x%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DL.%26aulast%3DYe%26aufirst%3DF.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DNiu%26aufirst%3DP.%26aulast%3DSong%26aufirst%3DH.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DTan%26aufirst%3DW.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DG.%2BF.%26atitle%3DBoth%2520boceprevir%2520and%2520GC376%2520efficaciously%2520inhibit%2520SARS-CoV-2%2520by%2520targeting%2520its%2520main%2520protease%26jtitle%3DNat.%2520Commun.%26date%3D2020%26volume%3D11%26spage%3D4417%26doi%3D10.1038%2Fs41467-020-18233-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frank, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritzky, A. R.</span></span> <span> </span><span class="NLM_article-title">Tautomeric pyridines. Part xv. Pyridone–hydroxypyridine equilibria in solvents of differing polarity</span>. <i>J. Chem. Soc., Perkin Trans. 2</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_fpage">1428</span>– <span class="NLM_lpage">1431</span>, <span class="refDoi"> DOI: 10.1039/P29760001428</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1039%2FP29760001428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADyaE2sXntFCntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1976&pages=1428-1431&author=J.+Frankauthor=A.+R.+Katritzky&title=Tautomeric+pyridines.+Part+xv.+Pyridone%E2%80%93hydroxypyridine+equilibria+in+solvents+of+differing+polarity&doi=10.1039%2FP29760001428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Tautomeric pyridines.  Part XV.  Pyridone-hydroxypyridine equilibriums in solvents of differing polarity</span></div><div class="casAuthors">Frank, Judit; Katritzky, Alan R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society, Perkin Transactions 2:  Physical Organic Chemistry (1972-1999)</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1428-31</span>CODEN:
                <span class="NLM_cas:coden">JCPKBH</span>;
        ISSN:<span class="NLM_cas:issn">0300-9580</span>.
    </div><div class="casAbstract">Tautomeric equil. of the pyridone-hydroxypyridine type were studied for 2- and 4-pyridone, 2,6-di-tert-butyl-4-pyridone, 4-quinolone, and 3-decyl-2,8-dimethyl-4-quinolone.  The proportion of pyridone form, dominant for H2O solns., falls approx. linearly with the solvent polarity as measured by Z (Reichardt, C., 1965).  In cyclohexane soln., comparable amts. of both forms are present.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA0cm3aXpoWbVg90H21EOLACvtfcHk0liq6cY0BFhPhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXntFCntw%253D%253D&md5=5261cabc31051791483045fc8717af20</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1039%2FP29760001428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FP29760001428%26sid%3Dliteratum%253Aachs%26aulast%3DFrank%26aufirst%3DJ.%26aulast%3DKatritzky%26aufirst%3DA.%2BR.%26atitle%3DTautomeric%2520pyridines.%2520Part%2520xv.%2520Pyridone%25E2%2580%2593hydroxypyridine%2520equilibria%2520in%2520solvents%2520of%2520differing%2520polarity%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25202%26date%3D1976%26spage%3D1428%26epage%3D1431%26doi%3D10.1039%2FP29760001428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, M.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.-K.</span></span> <span> </span><span class="NLM_article-title">Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development</span>. <i>Sig. Transduct. Target Ther.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">134</span>, <span class="refDoi"> DOI: 10.1038/s41392-021-00558-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1038%2Fs41392-021-00558-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=33774649" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2021&pages=134&author=M.-M.+Zhaoauthor=W.-L.+Yangauthor=F.-Y.+Yangauthor=L.+Zhangauthor=W.+Huangauthor=W.+Houauthor=C.+Fanauthor=R.+Jinauthor=Y.+Fengauthor=Y.+Wangauthor=J.-K.+Yang&title=Cathepsin+L+plays+a+key+role+in+SARS-CoV-2+infection+in+humans+and+humanized+mice+and+is+a+promising+target+for+new+drug+development&doi=10.1038%2Fs41392-021-00558-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fs41392-021-00558-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41392-021-00558-8%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DM.-M.%26aulast%3DYang%26aufirst%3DW.-L.%26aulast%3DYang%26aufirst%3DF.-Y.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DHou%26aufirst%3DW.%26aulast%3DFan%26aufirst%3DC.%26aulast%3DJin%26aufirst%3DR.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DJ.-K.%26atitle%3DCathepsin%2520L%2520plays%2520a%2520key%2520role%2520in%2520SARS-CoV-2%2520infection%2520in%2520humans%2520and%2520humanized%2520mice%2520and%2520is%2520a%2520promising%2520target%2520for%2520new%2520drug%2520development%26jtitle%3DSig.%2520Transduct.%2520Target%2520Ther.%26date%3D2021%26volume%3D6%26spage%3D134%26doi%3D10.1038%2Fs41392-021-00558-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Noisier, A. F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brimble, M. A.</span></span> <span> </span><span class="NLM_article-title">Novel preparation of chiral α-amino acids using the Mitsunobu–Tsunoda reaction</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">7744</span>– <span class="NLM_lpage">7746</span>, <span class="refDoi"> DOI: 10.1039/c3cc44717k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1039%2Fc3cc44717k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=23877629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1elsL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=7744-7746&author=A.+F.+M.+Noisierauthor=C.+S.+Harrisauthor=M.+A.+Brimble&title=Novel+preparation+of+chiral+%CE%B1-amino+acids+using+the+Mitsunobu%E2%80%93Tsunoda+reaction&doi=10.1039%2Fc3cc44717k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Novel preparation of chiral α-amino acids using the Mitsunobu-Tsunoda reaction</span></div><div class="casAuthors">Noisier, Anais F. M.; Harris, Craig S.; Brimble, Margaret A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">70</span>),
    <span class="NLM_cas:pages">7744-7746</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">An efficient synthesis of racemic or optically active α-amino acids by modified-Mitsunobu alkylation of a racemic or chiral glycine template from alcs. was developed.  Libraries of amino acids were prepd. in moderate to good yield with good to high enantioselectivity.  This simple method widens the scope for prepn. of structurally diverse amino acids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6DZLXXLhtLrVg90H21EOLACvtfcHk0lhxEB4WXvzI9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1elsL3L&md5=e688a08962a4099aa986d3baa5f8e200</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1039%2Fc3cc44717k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3cc44717k%26sid%3Dliteratum%253Aachs%26aulast%3DNoisier%26aufirst%3DA.%2BF.%2BM.%26aulast%3DHarris%26aufirst%3DC.%2BS.%26aulast%3DBrimble%26aufirst%3DM.%2BA.%26atitle%3DNovel%2520preparation%2520of%2520chiral%2520%25CE%25B1-amino%2520acids%2520using%2520the%2520Mitsunobu%25E2%2580%2593Tsunoda%2520reaction%26jtitle%3DChem.%2520Commun.%26date%3D2013%26volume%3D49%26spage%3D7744%26epage%3D7746%26doi%3D10.1039%2Fc3cc44717k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, T. D.</span></span> <span> </span><span class="NLM_article-title">Catalytic mechanism of cruzain from <i>Trypanosoma cruzi</i> as determined from solvent kinetic isotope effects of steady-state and pre-steady-state kinetics</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">3176</span>– <span class="NLM_lpage">3190</span>, <span class="refDoi"> DOI: 10.1021/acs.biochem.7b01250</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.7b01250" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotV2nsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=3176-3190&author=X.+Zhaiauthor=T.+D.+Meek&title=Catalytic+mechanism+of+cruzain+from+Trypanosoma+cruzi+as+determined+from+solvent+kinetic+isotope+effects+of+steady-state+and+pre-steady-state+kinetics&doi=10.1021%2Facs.biochem.7b01250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Catalytic Mechanism of Cruzain from Trypanosoma cruzi As Determined from Solvent Kinetic Isotope Effects of Steady-State and Pre-Steady-State Kinetics</span></div><div class="casAuthors">Zhai, Xiang; Meek, Thomas D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3176-3190</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cruzain, an important drug target for Chagas disease, is a member of Clan CA of the cysteine proteases.  Understanding the catalytic mechanism of cruzain is vital to the design of new inhibitors.  To this end, we have performed pH-rate profiles for substrates and affinity agents, and have detd. solvent kinetic isotope effects in pre-steady-state and steady-state modes using three substrates: Cbz-Phe-Arg-AMC, Cbz-Arg-Arg-AMC and Cbz-Arg-Ala-AMC.  The pH-rate profile of kcat/Km for Cbz-Arg-Arg-AMC indicated groups of pK1 = 6.6 (unprotonated) and pK2 ∼ 9.6 (protonated) required for catalysis.  The temp. dependence of the group of pK = 6.2 - 6.6 exhibited a values of ΔHion = 8.4 kcal/mol, typical of histidine.  The pH-rate profile of inactivation by iodoacetamide confirmed that the catalytic cysteine possesses a pKa of 9.8.  Normal solvent kinetic isotope effects were obsd. for both D2Okcat = 1.6 - 2.1 and D2Okcat/Km = 1.1 - 1.4 for all three substrates.  Pre-steady-state kinetics revealed exponential bursts of AMC prodn. for Cbz-Phe-Arg-AMC and Cbz-Arg-Arg-AMC, but not for Cbz-Arg-Ala-AMC.  The overall solvent isotope effect on kcat is attributable to the solvent isotope effect on the deacylation step.  Our results suggest that cruzain is unique among papain-like cysteine proteases in that the catalytic cysteine and histidine are neutral in charge in the free enzyme.  The generation of the active thiolate of the catalytic cysteine is likely proceeded (and possibly triggered) by a ligand-induced conformational change, which could bring the catalytic dyad to close proximity in order to effect proton transfer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGNPkhmnRHYbVg90H21EOLACvtfcHk0li2S_cVy274MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotV2nsw%253D%253D&md5=c9905e633b50aab71fe3450428aa4c84</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.7b01250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.7b01250%26sid%3Dliteratum%253Aachs%26aulast%3DZhai%26aufirst%3DX.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26atitle%3DCatalytic%2520mechanism%2520of%2520cruzain%2520from%2520Trypanosoma%2520cruzi%2520as%2520determined%2520from%2520solvent%2520kinetic%2520isotope%2520effects%2520of%2520steady-state%2520and%2520pre-steady-state%2520kinetics%26jtitle%3DBiochemistry%26date%3D2018%26volume%3D57%26spage%3D3176%26epage%3D3190%26doi%3D10.1021%2Facs.biochem.7b01250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chenna, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellott, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siqueira-Neto, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvet Alvarez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernatchez, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desormeaux, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez Hernandez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruz-Reyes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, T. D.</span></span> <span> </span><span class="NLM_article-title">Peptidomimetic vinyl heterocyclic inhibitors of cruzain effect antitrypanosomal activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">3298</span>– <span class="NLM_lpage">3316</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b02078</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b02078" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BB3cXktlOhurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=3298-3316&author=B.+C.+Chennaauthor=L.+Liauthor=D.+M.+Mellottauthor=X.+Zhaiauthor=J.+L.+Siqueira-Netoauthor=C.+Calvet+Alvarezauthor=J.+A.+Bernatchezauthor=E.+Desormeauxauthor=E.+Alvarez+Hernandezauthor=J.+Gomezauthor=J.+H.+McKerrowauthor=J.+Cruz-Reyesauthor=T.+D.+Meek&title=Peptidomimetic+vinyl+heterocyclic+inhibitors+of+cruzain+effect+antitrypanosomal+activity&doi=10.1021%2Facs.jmedchem.9b02078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Peptidomimetic vinyl heterocyclic inhibitors of cruzain effect antitrypanosomal activity</span></div><div class="casAuthors">Chenna, Bala C.; Li, Linfeng; Mellott, Drake M.; Zhai, Xiang; Siqueira-Neto, Jair L.; Calvet Alvarez, Claudia; Bernatchez, Jean A.; Desormeaux, Emily; Alvarez Hernandez, Elizabeth; Gomez, Jana; McKerrow, James H.; Cruz-Reyes, Jorge; Meek, Thomas D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3298-3316</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cruzain, an essential cysteine protease of the parasitic protozoan, Trypanosoma cruzi, is an important drug target for Chagas disease.  We describe here a new series of reversible but time-dependent inhibitors of cruzain, composed of a dipeptide scaffold appended to vinyl heterocycles meant to provide replacements for the irreversible reactive "warheads" of vinyl sulfone inactivators of cruzain.  Peptidomimetic vinyl heterocyclic inhibitors (PVHIs) contg. Cbz-Phe-Phe/homoPhe scaffolds with vinyl-2-pyrimidine, vinyl-2-pyridine, and vinyl-2-(N-methyl)-pyridine groups conferred reversible, time-dependent inhibition of cruzain (Ki* = 0.1-0.4μM).  These cruzain inhibitors exhibited moderate to excellent selectivity vs. human cathepsins B, L, and S and showed no apparent toxicity to human cells but were effective in cell cultures of Trypanosoma brucei brucei (EC50 = 1-15μM) and eliminated T. cruzi in infected murine cardiomyoblasts (EC50 = 5-8μM).  PVHIs represent a new class of cruzain inhibitors that could progress to viable candidate compds. to treat Chagas disease and human sleeping sickness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCRV5dvomK1LVg90H21EOLACvtfcHk0li2S_cVy274MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXktlOhurc%253D&md5=4115cfac549b94207be86837b81d32dc</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b02078%26sid%3Dliteratum%253Aachs%26aulast%3DChenna%26aufirst%3DB.%2BC.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DMellott%26aufirst%3DD.%2BM.%26aulast%3DZhai%26aufirst%3DX.%26aulast%3DSiqueira-Neto%26aufirst%3DJ.%2BL.%26aulast%3DCalvet%2BAlvarez%26aufirst%3DC.%26aulast%3DBernatchez%26aufirst%3DJ.%2BA.%26aulast%3DDesormeaux%26aufirst%3DE.%26aulast%3DAlvarez%2BHernandez%26aufirst%3DE.%26aulast%3DGomez%26aufirst%3DJ.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DCruz-Reyes%26aufirst%3DJ.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26atitle%3DPeptidomimetic%2520vinyl%2520heterocyclic%2520inhibitors%2520of%2520cruzain%2520effect%2520antitrypanosomal%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D3298%26epage%3D3316%26doi%3D10.1021%2Facs.jmedchem.9b02078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drew, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Englund, P. T.</span></span> <span> </span><span class="NLM_article-title">Inhibition of <i>Trypanosoma brucei</i> gene expression by RNA interference using an integratable vector with opposing T7 promoters</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">40174</span>– <span class="NLM_lpage">40179</span>, <span class="refDoi"> DOI: 10.1074/jbc.M008405200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1074%2Fjbc.M008405200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=11013266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsFemsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=40174-40179&author=Z.+Wangauthor=J.+C.+Morrisauthor=M.+E.+Drewauthor=P.+T.+Englund&title=Inhibition+of+Trypanosoma+brucei+gene+expression+by+RNA+interference+using+an+integratable+vector+with+opposing+T7+promoters&doi=10.1074%2Fjbc.M008405200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Trypanosoma brucei gene expression by RNA interference using an integratable vector with opposing T7 promoters</span></div><div class="casAuthors">Wang, Zefeng; Morris, James C.; Drew, Mark E.; Englund, Paul T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">40174-40179</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">RNA interference is a powerful method for inhibition of gene expression in Trypanosoma brucei.  Here we describe a vector (pZJM) for in vivo tetracycline-inducible synthesis of double-stranded RNA (dsRNA) in stably transformed cells.  The dsRNA is synthesized from opposing T7 promoters.  We tested the vector with genes involved in processes such as kinetoplast DNA replication, mitochondrial mRNA synthesis, glycosyl phosphatidylinositol biosynthesis, glycosome biogenesis, and polyamine biosynthesis.  In most cases the induction of dsRNA caused specific and dramatic loss of the appropriate mRNA, and in many cases there was growth inhibition or cell death.  One striking phenotype was the loss of kinetoplast DNA after interference with expression of a topoisomerase II.  The gene being analyzed by this procedure need not even be fully sequenced.  In fact, many of the genes we tested were derived from partial sequences in the T. brucei genome data base that were identified by homol. with known proteins.  It takes as little as 3 wk from identification of a gene sequence in the data base to the appearance of a phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTXMR58EDtiLVg90H21EOLACvtfcHk0lhs7TicqPeQ_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsFemsw%253D%253D&md5=9126412d958c757a3d748eb655fa99be</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M008405200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M008405200%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DDrew%26aufirst%3DM.%2BE.%26aulast%3DEnglund%26aufirst%3DP.%2BT.%26atitle%3DInhibition%2520of%2520Trypanosoma%2520brucei%2520gene%2520expression%2520by%2520RNA%2520interference%2520using%2520an%2520integratable%2520vector%2520with%2520opposing%2520T7%2520promoters%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D40174%26epage%3D40179%26doi%3D10.1074%2Fjbc.M008405200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huber, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koella, J. C.</span></span> <span> </span><span class="NLM_article-title">A comparison of three methods of estimating EC<sub>50</sub> in studies of drug resistance of malaria parasites</span>. <i>Acta Trop.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">257</span>– <span class="NLM_lpage">261</span>, <span class="refDoi"> DOI: 10.1016/0001-706X(93)90083-N</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1016%2F0001-706X%2893%2990083-N" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=8147282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A280%3ADyaK2c7pslSktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1993&pages=257-261&author=W.+Huberauthor=J.+C.+Koella&title=A+comparison+of+three+methods+of+estimating+EC50+in+studies+of+drug+resistance+of+malaria+parasites&doi=10.1016%2F0001-706X%2893%2990083-N"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites</span></div><div class="casAuthors">Huber W; Koella J C</div><div class="citationInfo"><span class="NLM_cas:title">Acta tropica</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">257-61</span>
        ISSN:<span class="NLM_cas:issn">0001-706X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCnHrDefzn2skU0YCbOU3EfW6udTcc2ebM2IWsECvVNbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c7pslSktQ%253D%253D&md5=4d08dce20a9b83bc996d3ab05dab73e4</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2F0001-706X%2893%2990083-N&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0001-706X%252893%252990083-N%26sid%3Dliteratum%253Aachs%26aulast%3DHuber%26aufirst%3DW.%26aulast%3DKoella%26aufirst%3DJ.%2BC.%26atitle%3DA%2520comparison%2520of%2520three%2520methods%2520of%2520estimating%2520EC50%2520in%2520studies%2520of%2520drug%2520resistance%2520of%2520malaria%2520parasites%26jtitle%3DActa%2520Trop.%26date%3D1993%26volume%3D55%26spage%3D257%26epage%3D261%26doi%3D10.1016%2F0001-706X%2893%2990083-N" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Delaglio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grzesiek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuister, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeifer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bax, A.</span></span> <span> </span><span class="NLM_article-title">NMRpipe: A multidimensional spectral processing system based on Unix pipes</span>. <i>J. Biomol. NMR</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">293</span>, <span class="refDoi"> DOI: 10.1007/BF00197809</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1007%2FBF00197809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=8520220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADyaK2MXhtVSmurfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1995&pages=277-293&author=F.+Delaglioauthor=S.+Grzesiekauthor=G.+W.+Vuisterauthor=G.+Zhuauthor=J.+Pfeiferauthor=A.+Bax&title=NMRpipe%3A+A+multidimensional+spectral+processing+system+based+on+Unix+pipes&doi=10.1007%2FBF00197809"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">NMRPipe: a multidimensional spectral processing system based on UNIX pipes</span></div><div class="casAuthors">Delaglio, Frank; Grzesiek, Stephan; Vuister, Geerten W.; Zhu, Guang; Pfeifer, John; Bax, Ad</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular NMR</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">277-93</span>CODEN:
                <span class="NLM_cas:coden">JBNME9</span>;
        ISSN:<span class="NLM_cas:issn">0925-2738</span>.
    
            (<span class="NLM_cas:orgname">ESCOM</span>)
        </div><div class="casAbstract">The NMRPipe system is a UNIX software environment of processing, graphics, and anal. tools designed to meet current routine and research-oriented multidimensional processing requirements, and to anticipate and accommodate future demands and developments.  The system is based on UNIX pipes, which allow programs running simultaneously to exchange streams of data under user control.  In an NMRPipe processing scheme, a stream of spectral data flows through a pipeline of processing programs, each of which performs one component of the overall scheme, such as Fourier transformation or linear prediction.  Complete multidimensional processing schemes are constructed as simple UNIX shell scripts.  The processing modules themselves maintain and exploit accurate records of data sizes, detection modes, and calibration information in all dimensions, so that schemes can be constructed without the need to explicitly define or anticipate data sizes or storage details of real and imaginary channels during processing.  The asynchronous pipeline scheme provides other substantial advantages, including high flexibility, favorable processing speeds, choice of both all-in-memory and disk-bound processing, easy adaptation to different data formats, simpler software development and maintenance, and the ability to distribute processing tasks on multi-CPU computers and computer networks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSIUdXrdcEgbVg90H21EOLACvtfcHk0lhs7TicqPeQ_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXhtVSmurfK&md5=a670fca5b164083e2178fafd2fb951ff</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2FBF00197809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00197809%26sid%3Dliteratum%253Aachs%26aulast%3DDelaglio%26aufirst%3DF.%26aulast%3DGrzesiek%26aufirst%3DS.%26aulast%3DVuister%26aufirst%3DG.%2BW.%26aulast%3DZhu%26aufirst%3DG.%26aulast%3DPfeifer%26aufirst%3DJ.%26aulast%3DBax%26aufirst%3DA.%26atitle%3DNMRpipe%253A%2520A%2520multidimensional%2520spectral%2520processing%2520system%2520based%2520on%2520Unix%2520pipes%26jtitle%3DJ.%2520Biomol.%2520NMR%26date%3D1995%26volume%3D6%26spage%3D277%26epage%3D293%26doi%3D10.1007%2FBF00197809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markley, J. L.</span></span> <span> </span><span class="NLM_article-title">NMRFAM-SPARKY: Enhanced software for biomolecular NMR spectroscopy</span>. <i>Bioinformatics</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1325</span>– <span class="NLM_lpage">1327</span>, <span class="refDoi"> DOI: 10.1093/bioinformatics/btu830</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1093%2Fbioinformatics%2Fbtu830" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=25505092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A280%3ADC%252BC2MznslWjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2015&pages=1325-1327&author=W.+Leeauthor=M.+Tonelliauthor=J.+L.+Markley&title=NMRFAM-SPARKY%3A+Enhanced+software+for+biomolecular+NMR+spectroscopy&doi=10.1093%2Fbioinformatics%2Fbtu830"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">NMRFAM-SPARKY: enhanced software for biomolecular NMR spectroscopy</span></div><div class="casAuthors">Lee Woonghee; Tonelli Marco; Markley John L</div><div class="citationInfo"><span class="NLM_cas:title">Bioinformatics (Oxford, England)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1325-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">UNLABELLED:  SPARKY (Goddard and Kneller, SPARKY 3) remains the most popular software program for NMR data analysis, despite the fact that development of the package by its originators ceased in 2001.  We have taken over the development of this package and describe NMRFAM-SPARKY, which implements new functions reflecting advances in the biomolecular NMR field.  NMRFAM-SPARKY has been repackaged with current versions of Python and Tcl/Tk, which support new tools for NMR peak simulation and graphical assignment determination.  These tools, along with chemical shift predictions from the PACSY database, greatly accelerate protein side chain assignments.  NMRFAM-SPARKY supports automated data format interconversion for interfacing with a variety of web servers including, PECAN , PINE, TALOS-N, CS-Rosetta, SHIFTX2 and PONDEROSA-C/S.  AVAILABILITY AND IMPLEMENTATION:  The software package, along with binary and source codes, if desired, can be downloaded freely from http://pine.nmrfam.wisc.edu/download_packages.html.  Instruction manuals and video tutorials can be found at http://www.nmrfam.wisc.edu/nmrfam-sparky-distribution.htm.  CONTACT:  <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="0e7966626b6b4e60637c686f632079677d6d206b6a7b">[email protected]</a> or <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="f19c90839a9d9488b19f9c8397909cdf86988292df949584">[email protected]</a>  SUPPLEMENTARY INFORMATION:  Supplementary data are available at Bioinformatics online.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSXhk7kdjQcojAyhZbj3lKdfW6udTcc2eYs3W_q7qnSvLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MznslWjug%253D%253D&md5=6bcf1b3b73f8d80fff0698e6b56e183e</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1093%2Fbioinformatics%2Fbtu830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbioinformatics%252Fbtu830%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DW.%26aulast%3DTonelli%26aufirst%3DM.%26aulast%3DMarkley%26aufirst%3DJ.%2BL.%26atitle%3DNMRFAM-SPARKY%253A%2520Enhanced%2520software%2520for%2520biomolecular%2520NMR%2520spectroscopy%26jtitle%3DBioinformatics%26date%3D2015%26volume%3D31%26spage%3D1325%26epage%3D1327%26doi%3D10.1093%2Fbioinformatics%2Fbtu830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Willcott, M. R.</span></span> <span> </span><span class="NLM_article-title">Mestre Nova</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">13180</span>– <span class="NLM_lpage">13180</span>, <span class="refDoi"> DOI: 10.1021/ja906709t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja906709t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVKksLzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=13180-13180&author=M.+R.+Willcott&title=Mestre+Nova&doi=10.1021%2Fja906709t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">MestRe Nova</span></div><div class="casAuthors">Willcott, Mark Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">13180</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTWkkT-BofpbVg90H21EOLACvtfcHk0lh5vtqlLoIMwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVKksLzN&md5=f3bc685169d5eee2f710a04d40340a89</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fja906709t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja906709t%26sid%3Dliteratum%253Aachs%26aulast%3DWillcott%26aufirst%3DM.%2BR.%26atitle%3DMestre%2520Nova%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D13180%26epage%3D13180%26doi%3D10.1021%2Fja906709t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alugubelli, Y. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vatansever, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drelich, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sankaran, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, Z. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blankenship, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kratch, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayatshahi, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fierke, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W. R.</span></span> <span> </span><span class="NLM_article-title">A quick route to multiple highly potent SARS-CoV-2 Main protease inhibitors</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">942</span>– <span class="NLM_lpage">948</span>, <span class="refDoi"> DOI: 10.1002/cmdc.202000924</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1002%2Fcmdc.202000924" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=33283984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisFeltrnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2021&pages=942-948&author=K.+S.+Yangauthor=X.+R.+Maauthor=Y.+Maauthor=Y.+R.+Alugubelliauthor=D.+A.+Scottauthor=E.+C.+Vatanseverauthor=A.+K.+Drelichauthor=B.+Sankaranauthor=Z.+Z.+Gengauthor=L.+R.+Blankenshipauthor=H.+E.+Wardauthor=Y.+J.+Shengauthor=J.+C.+Hsuauthor=K.+C.+Kratchauthor=B.+Zhaoauthor=H.+S.+Hayatshahiauthor=J.+Liuauthor=P.+Liauthor=C.+A.+Fierkeauthor=C.+K.+Tsengauthor=S.+Xuauthor=W.+R.+Liu&title=A+quick+route+to+multiple+highly+potent+SARS-CoV-2+Main+protease+inhibitors&doi=10.1002%2Fcmdc.202000924"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A quick route to multiple highly potent SARS-CoV-2 main protease inhibitors</span></div><div class="casAuthors">Yang, Kai S.; Ma, Xinyu R.; Ma, Yuying; Alugubelli, Yugendar R.; Scott, Danielle A.; Vatansever, Erol C.; Drelich, Aleksandra K.; Sankaran, Banumathi; Geng, Zhi Z.; Blankenship, Lauren R.; Ward, Hannah E.; Sheng, Yan J.; Hsu, Jason C.; Kratch, Kaci C.; Zhao, Baoyu; Hayatshahi, Hamed S.; Liu, Jin; Li, Pingwei; Fierke, Carol A.; Tseng, Chien-Te K.; Xu, Shiqing; Liu, Wenshe Ray</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">942-948</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The COVID-19 pathogen, SARS-CoV-2, requires its main protease (SC2MPro) to digest two of its translated long polypeptides to form a no. of mature proteins that are essential for viral replication and pathogenesis.  Inhibition of this vital proteolytic process is effective in preventing the virus from replicating in infected cells and therefore provides a potential COVID-19 treatment option.  Guided by previous medicinal chem. studies about SARS-CoV-1 main protease (SC1MPro), we have designed and synthesized a series of SC2MPro inhibitors that contain β-(S-2-oxopyrrolidin-3-yl)-alaninal (Opal) for the formation of a reversible covalent bond with the SC2MPro active-site cysteine C145.  All inhibitors display high potency with Ki values at or below 100 nM.  The most potent compd., MPI3, has as a Ki value of 8.3 nM.  Crystallog. analyses of SC2MPro bound to seven inhibitors indicated both formation of a covalent bond with C145 and structural rearrangement from the apoenzyme to accommodate the inhibitors.  Virus inhibition assays revealed that several inhibitors have high potency in inhibiting the SARS-CoV-2-induced cytopathogenic effect in both Vero E6 and A549/ACE2 cells.  Two inhibitors, MPI5 and MPI8, completely prevented the SARS-CoV-2-induced cytopathogenic effect in Vero E6 cells at 2.5-5μM and A549/ACE2 cells at 0.16-0.31μM.  Their virus inhibition potency is much higher than that of some existing mols. that are under preclin. and clin. investigations for the treatment of COVID-19.  Our study indicates that there is a large chem. space that needs to be explored for the development of SC2MPro inhibitors with ultra-high antiviral potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRlIuItljsvLVg90H21EOLACvtfcHk0lh5vtqlLoIMwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisFeltrnM&md5=bccda05c82b6358d5d0e38d0e0ebe757</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.202000924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.202000924%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DK.%2BS.%26aulast%3DMa%26aufirst%3DX.%2BR.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DAlugubelli%26aufirst%3DY.%2BR.%26aulast%3DScott%26aufirst%3DD.%2BA.%26aulast%3DVatansever%26aufirst%3DE.%2BC.%26aulast%3DDrelich%26aufirst%3DA.%2BK.%26aulast%3DSankaran%26aufirst%3DB.%26aulast%3DGeng%26aufirst%3DZ.%2BZ.%26aulast%3DBlankenship%26aufirst%3DL.%2BR.%26aulast%3DWard%26aufirst%3DH.%2BE.%26aulast%3DSheng%26aufirst%3DY.%2BJ.%26aulast%3DHsu%26aufirst%3DJ.%2BC.%26aulast%3DKratch%26aufirst%3DK.%2BC.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DHayatshahi%26aufirst%3DH.%2BS.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DFierke%26aufirst%3DC.%2BA.%26aulast%3DTseng%26aufirst%3DC.%2BK.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DW.%2BR.%26atitle%3DA%2520quick%2520route%2520to%2520multiple%2520highly%2520potent%2520SARS-CoV-2%2520Main%2520protease%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2021%26volume%3D16%26spage%3D942%26epage%3D948%26doi%3D10.1002%2Fcmdc.202000924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keegan, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krissinel, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, A. G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNicholas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannu, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potterton, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K. S.</span></span> <span> </span><span class="NLM_article-title">Overview of the CCP4 suite and current developments</span>. <i>Acta Crystallogr. D</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1107/S0907444910045749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=21460441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=235-242&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+W.+Leslieauthor=A.+McCoyauthor=S.+J.+McNicholasauthor=G.+N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+suite+and+current+developments&doi=10.1107%2FS0907444910045749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0lhe-7hT5IHnsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520suite%2520and%2520current%2520developments%26jtitle%3DActa%2520Crystallogr.%2520D%26date%3D2011%26volume%3D67%26spage%3D235%26epage%3D242%26doi%3D10.1107%2FS0907444910045749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curth, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drosten, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauerhering, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilgenfeld, R.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of SARS-CoV-2 Main protease provides a basis for design of improved α-ketoamide inhibitors</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>368</i></span>,  <span class="NLM_fpage">409</span>– <span class="NLM_lpage">412</span>, <span class="refDoi"> DOI: 10.1126/science.abb3405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1126%2Fscience.abb3405" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=32198291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnslKrtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2020&pages=409-412&author=L.+Zhangauthor=D.+Linauthor=X.+Sunauthor=U.+Curthauthor=C.+Drostenauthor=L.+Sauerheringauthor=S.+Beckerauthor=K.+Roxauthor=R.+Hilgenfeld&title=Crystal+structure+of+SARS-CoV-2+Main+protease+provides+a+basis+for+design+of+improved+%CE%B1-ketoamide+inhibitors&doi=10.1126%2Fscience.abb3405"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors</span></div><div class="casAuthors">Zhang, Linlin; Lin, Daizong; Sun, Xinyuanyuan; Curth, Ute; Drosten, Christian; Sauerhering, Lucie; Becker, Stephan; Rox, Katharina; Hilgenfeld, Rolf</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">6489</span>),
    <span class="NLM_cas:pages">409-412</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">1095-9203</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is a global health emergency.  An attractive drug target among coronaviruses is the main protease (Mpro, also called 3CLpro) because of its essential role in processing the polyproteins that are translated from the viral RNA.  We report the x-ray structures of the unliganded SARS-CoV-2 Mpro and its complex with an α-ketoamide inhibitor.  This was derived from a previously designed inhibitor but with the P3-P2 amide bond incorporated into a pyridone ring to enhance the half-life of the compd. in plasma.  On the basis of the unliganded structure, we developed the lead compd. into a potent inhibitor of the SARS-CoV-2 Mpro.  The pharmacokinetic characterization of the optimized inhibitor reveals a pronounced lung tropism and suitability for administration by the inhalative route.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT531N47m4BbVg90H21EOLACvtfcHk0lhe-7hT5IHnsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnslKrtL8%253D&md5=9ac417c20f54c3327f9de9088b512d52</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1126%2Fscience.abb3405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.abb3405%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DCurth%26aufirst%3DU.%26aulast%3DDrosten%26aufirst%3DC.%26aulast%3DSauerhering%26aufirst%3DL.%26aulast%3DBecker%26aufirst%3DS.%26aulast%3DRox%26aufirst%3DK.%26aulast%3DHilgenfeld%26aufirst%3DR.%26atitle%3DCrystal%2520structure%2520of%2520SARS-CoV-2%2520Main%2520protease%2520provides%2520a%2520basis%2520for%2520design%2520of%2520improved%2520%25CE%25B1-ketoamide%2520inhibitors%26jtitle%3DScience%26date%3D2020%26volume%3D368%26spage%3D409%26epage%3D412%26doi%3D10.1126%2Fscience.abb3405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afonine, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunkóczi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echols, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, L.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oeffner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, P. H.</span></span> <span> </span><span class="NLM_article-title">PHENIX: A comprehensive python-based system for macromolecular structure solution</span>. <i>Acta Crystallogr. D</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunk%C3%B3cziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.-W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+A+comprehensive+python-based+system+for+macromolecular+structure+solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0ljGPouM57Pdow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunk%25C3%25B3czi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.-W.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520A%2520comprehensive%2520python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%2520D%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr. D</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0ljGPouM57Pdow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%2520D%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, C. T.</span></span> <span> </span><span class="NLM_article-title">The behavior and significance of slow-binding enzyme inhibitors</span>. <i>Adv. Enzymol. Relat. Areas Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">201</span>– <span class="NLM_lpage">301</span>, <span class="refDoi"> DOI: 10.1002/9780470123072.ch5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1002%2F9780470123072.ch5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=3281418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=1%3ACAS%3A528%3ADyaL1MXhtlSrtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1988&pages=201-301&author=J.+F.+Morrisonauthor=C.+T.+Walsh&title=The+behavior+and+significance+of+slow-binding+enzyme+inhibitors&doi=10.1002%2F9780470123072.ch5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The behavior and significance of slow-binding enzyme inhibitors</span></div><div class="casAuthors">Morrison, John F.; Walsh, Christopher T.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Enzymology and Related Areas of Molecular Biology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">201-301</span>CODEN:
                <span class="NLM_cas:coden">AERAAD</span>;
        ISSN:<span class="NLM_cas:issn">0065-258X</span>.
    </div><div class="casAbstract">A review with 112 refs. on the anal. and properties of slow-binding enzyme inhibitors.  The topics discussed include formation of complexes of enzymes and slow-binding inhibitors, slow-binding inhibitors as drugs, characteristics and anal. of progress curves for slow-binding inhibitors, and specific cases of slow-binding inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1MoW3TRk0ubVg90H21EOLACvtfcHk0lii5vMwxHoA_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhtlSrtbk%253D&md5=6c0d34ce86e49cd63c44b30d7fefa016</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2F9780470123072.ch5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F9780470123072.ch5%26sid%3Dliteratum%253Aachs%26aulast%3DMorrison%26aufirst%3DJ.%2BF.%26aulast%3DWalsh%26aufirst%3DC.%2BT.%26atitle%3DThe%2520behavior%2520and%2520significance%2520of%2520slow-binding%2520enzyme%2520inhibitors%26jtitle%3DAdv.%2520Enzymol.%2520Relat.%2520Areas%2520Mol.%2520Biol.%26date%3D1988%26volume%3D61%26spage%3D201%26epage%3D301%26doi%3D10.1002%2F9780470123072.ch5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span> <span> </span><span class="NLM_article-title">Tight binding inhibitors</span>. In  <i>Enzymes: A practical introduction to structure, mechanism, and data analysis</i>, <span class="NLM_publisher-loc">VCH</span>: <span class="NLM_publisher-name">New York</span>, <span class="NLM_year">2000</span>;  <span class="NLM_fpage">305</span>– <span class="NLM_lpage">317</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1002%2F0471220639.ch9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=305-317&author=R.+A.+Copeland&title=Enzymes%3A+A+practical+introduction+to+structure%2C+mechanism%2C+and+data+analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2F0471220639.ch9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0471220639.ch9%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26atitle%3DTight%2520binding%2520inhibitors%26btitle%3DEnzymes%253A%2520A%2520practical%2520introduction%2520to%2520structure%252C%2520mechanism%252C%2520and%2520data%2520analysis%26pub%3DNew%2520York%26date%3D2000%26spage%3D305%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinen, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roush, W. R.</span></span> <span> </span><span class="NLM_article-title"><i>In vitro</i> and <i>in vivo</i> studies of the trypanocidal properties of WRR-483 against <i>Trypanosoma cruzi</i></span>. <i>PLoS Negl. Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e825</span> <span class="refDoi"> DOI: 10.1371/journal.pntd.0000825</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=10.1371%2Fjournal.pntd.0000825" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;key=20856868" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2010&author=Y.+T.+Chenauthor=L.+S.+Brinenauthor=I.+D.+Kerrauthor=E.+Hansellauthor=P.+S.+Doyleauthor=J.+H.+McKerrowauthor=W.+R.+Roush&title=In+vitro+and+in+vivo+studies+of+the+trypanocidal+properties+of+WRR-483+against+Trypanosoma+cruzi&doi=10.1371%2Fjournal.pntd.0000825"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0000825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0000825%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%2BT.%26aulast%3DBrinen%26aufirst%3DL.%2BS.%26aulast%3DKerr%26aufirst%3DI.%2BD.%26aulast%3DHansell%26aufirst%3DE.%26aulast%3DDoyle%26aufirst%3DP.%2BS.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DRoush%26aufirst%3DW.%2BR.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520studies%2520of%2520the%2520trypanocidal%2520properties%2520of%2520WRR-483%2520against%2520Trypanosoma%2520cruzi%26jtitle%3DPLoS%2520Negl.%2520Trop.%2520Dis.%26date%3D2010%26volume%3D4%26doi%3D10.1371%2Fjournal.pntd.0000825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i65"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00628">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_38860"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00628?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00628</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Kinetic parameters obtained from rapid dilution assays, details of peaks in <sup>1</sup>H-<sup>13</sup>C HSQC NMR, statistic summary of the cocrystal structure of 3CL<sup>pro</sup>-<b>18</b>, LC-MS of <sup>13</sup>C-labeled <b>12</b>, kinetic analysis of cruzain inhibition by <b>11</b> and <b>13</b>, growth curves for <i>T. b. brucei</i> BSFs, cell viability of <i>T. cruzi</i>-infected murine cardiomyoblasts, and NMR spectra of the synthesized compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_002.csv">CSV</a>)</p></li><li><p class="inline">Model coordinates for <b>2</b> bound to cruzain in its free aldehyde form (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_003.pdb">PDB</a>) and its lactol form (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_004.pdb">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_001.pdf">jm1c00628_si_001.pdf (3.97 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_002.csv">jm1c00628_si_002.csv (1.89 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_003.pdb">jm1c00628_si_003.pdb (157.0 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00628/suppl_file/jm1c00628_si_004.pdb">jm1c00628_si_004.pdb (149.06 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.1c00628&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.1c00628%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.1c00628" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67997c45ea313c70","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
